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Abstract 
Background: There have been many epidemiological studies into the 
influence of exposure to the most toxic elements on the risk of cancer 
in the workplace, mainly due to the exposure of certain occupational 
groups, or perhaps in populations near industrial sources. Toxic 
elements include arsenic, copper, nickel, and uranium; and many 
more of these elements have been shown to increase the risk of 
several different types of cancers in these highly-exposed groups. 
Many of these elements naturally exist in the soil, and the health 
impact of these levels of environmental exposures on the general 
population has received little attention to date possibly due to the 
belief that soil concentrations of these elements are too low to cause 
harm to the general population. Therefore, the long-term effect of 
such chronic exposure to metals in the soil remains unclear. 
Aims and objectives: The goals are to utilise a new resource known as 
THIN-GBASE for conducting a series of environmental epidemiological 
studies to test the hypothesis that BCC, lung and GIT cancers are 
associated with high exposure to certain low-level metals in soil. We 
sought to use this resource in determining which soil metals should be 
tested for predicting each of the cancer outcomes. 
Methods: For BCC, an ecological study was initially undertaken to 
assess the overall regional variation in BCC to provide national and 
contemporary breakdowns of incidence rates across the UK. The 
primary exposure of interest for BCC was low-level soil arsenic, and 
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we therefore quantified soil arsenic exposure levels based on the UK 
national safety limits for arsenic [i.e. As-C4SLs = 35 mg/kg]. A 
population-based cohort study was conducted to quantify the risks 
associated between the development of BCC and increasing levels of 
exposure to soil arsenic. For lung cancer, a two-stage process was 
adopted: 1) data mining analysis using the correlation-based filter 
selection model was used to find the restricted set of soil metals were 
best predictors for lung cancer; and 2) a prospective cohort study was 
use where these sets of elements were fitted together (adjusted for 
confounding variables) in a multivariable Cox proportional-hazards 
model to determine the risks associated between the development of 
lung cancer, with increasing levels of exposure to each specific 
element. For GIT cancers, a three-stage process was adopted: stages 1 
and 2 used a similar methodology for the lung cancer study. In stage 
3, all GIT cancers were divided into three broader outcomes i.e. upper 
GIT (includes mouth & oesophagus), stomach (as standalone) and 
colorectal (includes small, large, rectum and anal canal) cancers. A 
multivariate competing risk survival model was adjusted for the three 
different GIT cancers as competing events to identify associations 
between any of the selected group of metals found in stage 1 and GIT-
specific cancers.    
Results: For BCC, the findings for the ecological study show that 
overall EASRs & WASRs for BCC in the UK was 98.6 and 66.9 per 
100,000 person-years, respectively. It indicates a large geographical 
variation in age-sex standardised incidence of BCC with the South East 
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having the highest incidence of BCC (202.7/100,000 person-years), 
followed by South Central (193.5/100,000 person-years) and Wales 
(185.7/100,000 person-years). Incidence rates of BCC were 
substantially higher in the least socioeconomically deprived groups. It 
was observed that increasing levels of deprivation led to a decreased 
rate of BCC (p < 0.001). In terms of age groups, the largest annual 
increase was observed among those aged 30-49 years. Assessment for 
soil arsenic indicated that individuals living in areas with 
concentrations ≥35mg/kg significantly had an increased hazard of 
developing BCC (35-70mg/kg: adjusted HR 1.08, 95% CI: 1.02-1.14; 
≥70mg/kg: adjusted HR 1.17, 95% CI: 1.09-1.28). Urban residents with 
the highest exposure of soil arsenic had the greatest risk of developing 
BCC (≥ 70.0 mg/kg: HR 1.18, 95% CI: 1.06-1.36). For lung cancer, the 
correlation-based filter selection model identified aluminium, lead 
and uranium as the appropriate set of exposures for modelling lung 
cancer risk. Complete adjustments of hazards model showed evidence 
of an increased risk of developing lung cancer with elevated 
concentrations for only soil aluminium at medium levels ranging 
between 47,000-61,600mg/kg. Urban residents with the highest 
exposure of soil aluminium had the greatest risk of developing lung 
cancer (≥ 61,600mg/kg: HR 1.12, 95% CI: 1.04-1.22). For GIT cancers, 
the correlation-based filter selection model identified seven elements 
i.e. aluminium, phosphorus, zinc, uranium, calcium, manganese, and 
lead, as the appropriate set of exposures for predicting GIT cancer 
risk. The complete adjustment for hazards model indicated that the 
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risk of developing overall GIT cancers were significantly associated 
with elevated exposure levels of soil phosphorus only (873-
1,127mg/kg: HR 1.08, 95% CI: 1.02-1.14; 1,127-1,456mg/kg: HR 1.07, 
95% CI: 1.01-1.13; and ≥1,145mg/kg: HR 1.07, 95% CI: 1.01-1.13). 
There were no consistent relationships identified between any of the 
selected groups of elements and the GIT-specific cancer outcomes 
when adjusting for different GIT cancers as competing events.    
Conclusion: There appears to be slight evidence of BCC, respiratory 
and GIT cancer risk with elevated exposure to soil arsenic, aluminium 
and phosphorus, respectively. The series of investigations conducted 
for this research are one of the first, if not, contemporary UK-based 
study to present novel estimates for a group of ill-defined pollutants. 
This research demonstrates that linking geochemical data with 
electronic primary care medical records can be a valuable approach of 
proving whether long term exposure to low-level soil contaminants 
may have a health consequence in the population. 
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1 Background 
The earth’s crust is the greatest source of all metals (metallic 
elements or compounds) that exists in the environment.1,2 The vast 
majority of metals are ubiquitous, and are naturally occurring 
constituents of the lithosphere – the part of the earth’s environment 
formed by crustal and uppermost solid mantle which is covered with 
soil.3 Metallic elements in soil are heterogeneously distributed at 
varying concentrations,4 and exist in a variety of chemical forms. 
Some, such as calcium, magnesium, iron, iodine, selenium and zinc, 
are essential to plants, animals (including humans) in trace amounts,5–
7 whilst others (such as cadmium, lead and mercury) have limited or 
no biological value.7,8 In excess, all of these are typically naturally 
occurring elements can lead to toxicity in living organisms.9–12 
Over the past decades, there has been interest in the assessment of 
geochemical and biological interactions characterised especially by 
the relationships between cancer and soil.1,2,13–15 A concern has 
emerged among some public health practitioners and medical 
geologists that: (1) long-term low-level toxic effects of exposure to 
metals emerging from soil may have adverse health consequences,16–18 
and (2) that metals from soil entering the human bloodstream through 
long-term exposure may accumulate within tissues, leading to more 
severe adverse effects more typically associated with high-level 
exposure.16–18 
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There are three major routes for metals to leave the soil and enter 
the human body. The most prominent is the oral/ingestion pathway 
route of exposure, followed by the dermal and respiratory 
pathways.18–20 Research in the UK and other middle to high income 
countries has used in-vitro methods to derive theoretical estimates of 
the oral bioaccessibility of potentially harmful soil metals21–26 – that is, 
the fraction of the total concentration of a metal bound to soil (in 
various chemical forms) that is soluble in the gastrointestinal 
environmental and available for absorption (or uptake) into the 
bloodstream.18 This group of studies has shown a close correlation 
between bioaccessible metal fractions and overall topsoil 
concentration levels of several metals,27–29 and that these theoretical 
estimates are, in turn, positively associated with a range of 
biomarkers of human uptake (from hair, toe & finger nails and urine 
sample). 27–29 Furthermore, previous clinical studies have shown that 
these biomarkers are a proxy measure for the actual cause of adverse 
health conditions (including cancers).22,27–31 This collection of studies 
has concluded that such harmful soil metals may potentially play an 
important role in adversely impacting human health and have 
advocated the need for further investigation to evaluate the direct 
associations between topsoil harmful metals and adverse health 
outcomes (including cancer).22,27–31 
Direct epidemiological evidence supporting an association between 
potentially harmful soil metals and the development of cancers is 
substantially limited. The number of cases of cancer, and the time 
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that cases take to develop, are dependent on dose, duration and 
relative carcinogenicity of the exposure.19,32,33 Except in areas of very 
severe soil contamination (where previous individual-level studies 
have tended to focus), human exposure to potentially harmful 
elements from soil is typically at relatively low levels (especially in 
high and middle-income countries where soil quality is assessed prior 
to granting permission for residential development), so a large cohort 
followed over a long period of time would be necessary to detect any 
increased risk.  There is a lack of availability of individual-level 
datasets containing details of both soil exposures and health outcomes 
of a sufficient scale to provide the necessary statistical power34 and 
area-level comparisons using overall diagnosis rates are problematic 
as they are especially vulnerable to ecological fallacies: areas which 
are highly polluted (where soils may contain relatively high levels of 
metallic elements of anthropogenic origin) are often inhabited by 
individuals who are relatively highly susceptible to cancer due to 
other factors (such as lower socio-economic status, tobacco use and 
poor diet).19,32 This thesis will attempt to address this gap in 
knowledge by using a uniquely linked database between primary 
health care records from The Health Improvement Network (THIN) and 
geochemical data from the Geochemical Baseline Survey of the 
Environment (G–BASE) developed by the British Geological Survey 
(BGS). 
This chapter introduces the key classifications of the most important 
metallic elements in soils and discusses their origins from soil & 
5 
 
minerals, and natural and anthropogenic metallic input into soil from 
external sources. A plausible framework for the major exposure 
pathways to soil metals, sources of exposure, and how they may lead 
to cancer is described. Finally, the importance of the UK soil guideline 
value – the Category 4 Screening Level (C4SL) - for specific soil metals 
is discussed, and the approach to testing the appropriateness of the 
current levels in the studies included in the remainder of the thesis is 
described.  
1.1 Metallic elements and their classifications for 
carcinogenicity in humans 
About 80.0% of the chemical elements occupying the periodic table 
are metallic in nature. Metallic elements are broadly classified as 
heavy35–38 or light metals39–41. The majority of these elements are 
heavy metals, and they are found on the periodic table in groups III-
XVI with periods ranging between IV and VII.42 Heavy metals have 
atomic densities ranging from 3.5-5.0 g/cm3. Common examples of 
heavy metals include arsenic, cadmium, lead, nickel, mercury and 
zinc. Light metals, on the other hand, are few in number having lower 
atomic densities than heavier metals. They are typically located 
outside groups III-XVI on the periodic table.42 Examples of light metals 
are aluminium, silicon, magnesium and titanium.39–41 
The carcinogenic potency metallic elements may exhibit in humans 
has been assessed using a variety of experimental studies on cancer in 
laboratory animals and through human health assessments and 
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epidemiological research.9–12,43–45 Based on these findings, more than 
900 agents with different properties (chemical, biological or physical 
in nature) have been evaluated by the International Agency for Cancer 
Research (IARC) and catalogued in monographs.46 The main purpose of 
the IARC Monographs programme is to identify and evaluate potential 
environmental causes of cancer in humans.46 Agents of focus include 
elements in pure, inorganic or organic forms;, chemicals (e.g. 
formaldehyde); complex mixtures present in air, soil and water (often 
arising from pollution, such as factory or automobile emissions); 
occupational exposures (e.g. asbestos fibres, sawdust); and physical 
agents (such as solar and ionising radiation).46 
These agents (or carcinogens) are ranked accordingly into five 
categories (i.e. group 1, 2-A, 2-B, 3 and 4) ranging from agents that 
are deemed to be carcinogenic to humans (i.e. group I) to probably 
not carcinogenic to humans (i.e. group IV).46 Agents categorised into 
group I are deemed carcinogenic to humans due to convincing 
evidence derived from epidemiological studies. 9–12,43–45 Group II agents 
are classed into two subcategories: group II-A refers to agents that are 
deemed probably carcinogenic to humans, whilst those in group II-B 
are possibly carcinogenic to humans. Agents are classified into the 
former group (II-A) when there is limited indication of carcinogenicity 
in humans and sufficient evidence in animal studies.46 Limited 
evidence means that a positive association has been observed 
between the exposure of interest (i.e. agent) and cancer but that 
other explanations for the observations could not be ruled out.46 The 
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latter (group II-B) comprises agents with limited evidence of 
carcinogenicity in humans and less than sufficient but acceptable 
evidence of carcinogenicity in experimental animals. 46 Group III 
comprises agents not classifiable as to [their] carcinogenicity to 
humans due to inadequate evidence of carcinogenicity found in most 
animal studies. When there is no evidence or a demonstrated lack of 
carcinogenicity in human and in experimental animals, they are 
classed as probably not carcinogenic in humans. 46 The IARC 
classification system for agents indicates only the strength of evidence 
that they may cause cancer; it is not intended to (and does not) 
indicate the degree of risk associated with exposure.46 
Only a few metallic elements are found in group 1 and 2 (-A or -B) 9–
12,43–45. Inorganic arsenic, chromium (VI) and cadmium are examples of 
highly toxic metals classified as group 1 agents.9,10,19,46,47 They are 
deemed carcinogenic to humans due to substantial evidence found 
from epidemiological studies focused on populations exposed such to 
metals largely from contaminated air and drinking water 
environments,19,48,49 and from occupational hazards.19,33,50 On the 
other hand, while inorganic lead, nickel and cobalt are also highly 
toxic to humans; they are classified as group 2 agents with the 
potential to be carcinogenic to humans due to the limited amount of 
evidence from clinical studies.11,33,51,52 Overall, most metallic 
elements fall under group 3 (i.e. not classifiable as to its 
carcinogenicity to humans) because studies have not yet been carried 
out to ascertain the health effects.46 
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Metallic elements, including those that are classified as group 1 and 2 
agent under the IARC monograph’s classification system occur 
naturally in soil.53 The concentrations of these metals in soil are 
dependent on the underlying minerology and processes of weathering 
which release metals into the soil, and on external (or anthropogenic) 
factors that influence the deposition of metallic elements on topsoil, 
but they are ubiquitous, and environmental exposure is therefore 
widespread among humans.4,13,37,54,55 Long-term low-level uptake of 
these elements exposures in the UK and other middle to high income 
countries occurs primarily via inadvertent soil ingestion, inhalation 
and dermal absorption.18–20 The effects on human health is not known 
– this thesis aims to address this knowledge gap.     
1.2 Sources of metallic elements found in soil 
1.2.1 Mineralogical sources of metallic elements  
Soils contain a large range of metallic elements which are present at 
widely-varying concentrations. Most metals in soil are derived from 
mineral and bedrocks.4,13,37,54,55 In soil, they may exist as inorganic 
substances, or be component of a complex compound in a mineral. 
They are locked in minerals and are released into the soil’s 
environment naturally through chemical and physical weathering. 
4,13,37,54,55  
Atmospheric processes are a major contributing factor to the chemical 
breakdown of minerals and release of their constituents into the soil. 
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In particular, atmospheric oxidation of iron (which is one of the 
commonest metals and part of the complex structure of most 
minerals) causes chemical decomposition through rusting, weakening 
the physical structure of the rocks and enabling the release of other 
metallic compounds into the soil via weathering.4,13,37,54,55 Another 
major contributor is the action of acidic rain, which chemically 
dissolves minerals and washes them into soil.4,13,37,54,55  
In addition, physical factors facilitate the mechanical breakdown of 
most minerals into soil particles without altering their geochemical 
composition. 4,13,37,54,55 Fluctuations in solar radiation and atmospheric 
temperature cause minerals to undergo thermal expansion and 
contraction.  Expansion of the mineral occurs during the day as the 
outer layer is heated greatly, whilst contraction occurs during the 
night as it cooled. This repetitive process causes an alteration in the 
shape of the mineral, weakening the bonds between particles that 
form the mineral as a whole.4,13,37,54,55 This eventually results in 
physical weathering. 
Metallic elements are distributed throughout soil; however, certain 
metals may become highly accumulated in soils depending on the type 
of minerals that are geologically abundant in the area. For example, 
arsenopyrite is a mineral ore primarily composed of arsenic, iron and 
sulphide; therefore, chemical weathering by means of atmospheric 
oxidation in areas with high abundance of arsenopyrite (FeAsS) will 
lead to significant saturation of these three elements in the 
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accompanying soils.4,47,56 The background concentrations of metallic 
elements in soil are therefore typically characterised by the mineral 
(or rock) that happens to geologically abundant (Table 1.1).   
 
  
 
1
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Table 1.1: Showing examples of a few mineral ores that metalliferous in nature with primary metals that appear to be 
native to them, as well as secondary metals that coexist but at constituent levels  
Ore mineral1  Native metallic element2  Metallic elements contained in ore at constituent levels3 
  Arsenopyrite (FeAsS)    arsenic   antimony, copper, gold, mercury, molybdenum, silver, tin, uranium 
  Sphalerite (ZnS)    cadmium   copper, lead, zinc 
  Chromite (Fe, Cr2O4)    chromium   nickel, cobalt 
  Galena (PbS)    lead   antimony, cadmium, copper, selenium, silver, thallium, zinc 
  Cinnabar (HgS)    mercury   antimony, lead, selenium, silver, tellurium, zinc 
  Uraninite (UO2)    uranium   arsenic, cobalt, copper, lead, molybdenum, selenium, vanadium 
1Selected mineral ores that are metalliferous in nature 
2Primary element (or metal that is most native to the mineral ore) 
3Secondary elements (or metals known to be at constituent levels within ore) 
Note: arsenic, selenium, tellurium are metalloids; uranium is a radioactive metal; and the rest are all heavy metals 
Adapted from information in Alloway BJ. Sources of heavy metals and metalloids in soils. In: Chapter 2 Heavy Metals in Soils: Trace Metals and 
Metalloids in Soils and their Bioavailability; 2012. Section 2.3.1.1. Table 2.3. p. 23.  
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1.2.2 Other external and anthropogenic sources of metallic 
elements 
The fast growth of urbanised and industrialised countries has led to 
significant changes in the environment and has resulted in 
environmental pollution due the heavy traffic-use and expanding 
industrial activities taking place in middle to high income countries. 
4,13,37,54,55 Anthropogenic activities, which include industry and motor 
& vehicles usage, have caused widespread pollution of topsoil with a 
variety of metallic metals, such cadmium, copper and lead. Traffic or 
industrial activities involving with pyrometallurgy are major sources 
for emissions that contain airborne particulate-bound metallic 
elements.4,13,37,54,55 Through atmospheric deposition, these elements 
are deposited on topsoil, and enter into our food chain (i.e. soil > 
plants > humans or soil > plants > animals > humans) directly via plant 
absorption.4,13,37,54,55 
1.3 Soil contamination in the UK 
1.3.1 Brief history on the occurrence of land contamination in 
UK 
The accumulation of contaminants in UK soils can be attributed to 
anthropogenic practices that occurred since the start of Britain’s 
industrial revolution,57,58 and also to certain events linked to the 
World War II.59  The legacy of Britain’s industrialisation since the mid-
18th century is not only one of economic prosperity, change in the 
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population’s standards of living and scientific advancement;60 but 
also, and unfortunately, the environmental impacts of industrial 
emissions and waste management practices that have occurred during 
that this time period.57,58 
By the 1780’s, Britain had already experienced a large growth in 
population density and was playing a global role in terms of 
international trade.60 The growth in population and foreign trade 
created an environment where there was an increased demand for 
manufactured goods and services. 60 In order to meet this demand, 
Britain adopted a model that enabled the mass production of goods.60 
This feat was achieved by completely overhauling the traditional 
systems of manufacturing goods which relied mainly on man, animal 
and water power, and replacing them with mechanical technologies 
that were steam powered.57,58,60 This was Britain’s ‘factory-age’, 
57,58,60 during which factories and furnaces responsible for the 
production and refinery of goods and raw materials, respectively, 
were built by the dozens, and functioned purely on technologies that 
were powered by steam.57,58,60 From 1830 to 1922, a vast network of 
railways that relied exclusively on steam engine transportation was 
created connecting, for the first time, towns and major cities in 
England.57,58,60 All these steam powered engines and technologies 
were dependent on coal. 57,58,61 
Coal had to be mined on a large-scale thus becoming one of the most 
important minerals.60 While many deep and open mine pits were 
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already established across Britain for extracting coal, it was from the 
mid-18th to 21st century that the levels of coal production escalated 
most significantly, growing from 4.7 million to 250 million tonnes. 
57,58,60,61 By the 1930s, the new anthropogenic activities related to 
mining, factories and transportation emerging from this industrial era 
had introduced new sources for air, water and land pollution.57,58 
Many studies that specifically addressed the problems of pollution in 
the UK have made irrefutable cases that the cause stemmed from 
practices during these centuries. A notable example is the Byker 
incinerator which was built in the late 1890s, and has been operating 
in Newcastle upon Tyne for over a century. This facility, which has 
recently been decommissioned, was responsible for the severe 
contamination of land situated in Newcastle upon Tyne due to the 
expulsion of waste ash into the atmosphere.62–64 
Mining activities also generated vast amounts of landfill. In 1936, 
parliament passed the Public Health Act, which made initial provisions 
(in sections 101-105, 140 and 141) to mitigate the impacts of 
pollutants.65 However, shortly afterwards, major cities such as 
London, Birmingham, Liverpool, Plymouth, Bristol, Glasgow, 
Southampton and Hull (and 18 other British cities) suffered further 
widespread contamination of air and land due to the war that 
emerged in Europe: between September 1940 and May 1941,59 these 
cities suffered heavy aerial bombardment with incendiary and 
explosive devices from German warplanes, ensuring widespread 
contamination of soils with explosives (and bomb casings and 
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mechanisms), their by-products and combustion products from the 
ensuing fires.59 
1.3.2 Formation of numerical values for soil safety limits and 
classification 
After World War II, a group of policy makers and land developers 
formed the Inter-Department Committee on the Redevelopment of 
Contaminated Land (ICRCL) in 1976.66 One of their initial technical 
notes published (i.e. ICRCL note 17/78 on landfill sites) advocated 
against the development of landfills. By 1980, a major conference 
focussed on curbing land contamination took place in Eastbourne, 
where a paper presented for the first time a set of numerical values 
for certain toxic metals and compounds intended for soil classification 
purposes that soon became used as screening values for chemically 
impacted in situ soils.66  
In 1983, and in 1987, the ICRCL would made significant revisions to 
these values in order to use them for health evaluation and risk 
assessment – these sets of new values were published and named soil 
“trigger” and “intervention” values.66 However, by 2002, these values 
had become outdated due to significant changes in concentrations of 
most geochemical elements. Most metals in UK soil exist at low-level 
concentrations not exceeding beyond 100.0 mg/kg. Previous values 
known as the Generic Assessment Criteria (GAC) were withdrawn in 
2002, and the first set of Soil Guideline Values (SGV) was published67 - 
these values were developed based on the regulations under the 
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statutory guidance (sections 4.1) which provides the definitions for 
what constitutes a significant harm caused by contaminated land; and 
Part 2A of the environmental protection act (1990) - a key piece of 
legislation for risk assessment of land contamination. Finally, the 
current system in use is an improved version of the SGVs, known as 
the category 4 screening levels, which were published in 2014.68 
1.3.2.1 UK category 4 screening levels 
The UK category-4 screening levels (C4SLs) were developed to monitor 
low contamination levels of a group of ill-defined elements.68–72 They 
are used in the risk assessment of four different type of land-uses (i.e. 
includes garden allotments, residential, public use and industrial) to 
monitor low-level soil contamination in these settings. 68–72 In terms of 
soil and land contamination, these screening values were developed 
for the sole purpose of aiding land-users and developers to determine 
whether concentrations of an element have reached an unacceptable 
threshold in terms of the potential impact on public safety. 68–72 
C4SLs also describe a 4-stage warning system to inform the land-user 
or investigator to decide whether the land is contaminated. 68–72 
Figure 1.1, shows how land can fall into one of four categories 
depending on the contamination levels of a particular contaminant: 1) 
Categories 1 and 2 describes land at which concentration of soil 
contaminants are present at exceedingly high levels, and exposure to 
such levels can cause acute adverse health outcomes;73 2) Categories 
3 and 4 describe land at where concentrations of soil contaminants 
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are lower.73 Although lands classed as 3 and 4 are deem 
uncontaminated areas, the focus on acute (and known) health impacts 
mean that the possibility that exposure to these low-level 
concentrations of soil elements may still pose a significant risk to 
human health over a longer term cannot be excluded. 
According to section 4.1 of the UK statutory guidance, the definition 
of significant harm is graded into two levels, as ‘always’ or ‘may’, 
depending on whether the health impacts of land contamination: 1) 
always constitute significant harm which includes outcomes of death, 
life-threatening diseases (e.g. cancers) and other illness likely to 
result in serious health impacts such as physical deformity, impaired 
reproductive and congenital birth defects;73 2) may constitute 
significant harm which may include outcomes such as cancer, 
gastrointestinal disturbances, respiratory and cardiovascular effects, 
as well as skin ailments and effects on internal organs (e.g. liver or 
kidney).73 Although the C4SLs were derived for the purposes of 
environmental monitoring of land contamination, they are also used as 
“trigger values” - meaning that where soil concentration of a metal 
exceeds recommended limit threshold value, there may be a cause for 
concern for the potential impact it may have on the general 
population.73 
 
 
  
1
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Figure 1.1: Illustrating the UK category-4 screening system. Straight-black (solid) line - point above which land is defined as 'contaminated land' 
under Part 2A Environmental Protection Act; Black (dashed) line – previous SGV & GAC values under category-4 to monitor low-level contamination; 
Red (dashed) line – current C4SLs under category-4 to monitor low-level soil contamination. Adapted information from Naima B et al. Essentials of 
environmental public health science (chapter 6, fig 6.1.); Original from - ‘simplification of the contaminated land: impact assessment’, Defra, and 
Cranfield University.  
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Derivations for all C4SLs or “trigger values” were based on the key 
assumption that health risks are attributable to long-term exposure to 
individual chemicals in soils.68–72 Table 1.2 shows the current C4SLs 
values for residential areas of urban, rural and suburban built 
environments.  
Table 1.2: List of current C4SLs values for 3 (out of 6) soil contaminants for UK 
residential settings; Previous guideline values from SGV and GAC have been 
withdrawn 
 C4SL1 SGV2  GAC3 
Elements (in mg/kg)    
    
  Arsenic 35 32 - 
  Cadmium 87 84  
  Chromium 21 - 4.3 
  Lead 130 450 - 
  Nickel - 130 - 
  Selenium - 350 - 
For residential soil only 
1Current UK category-4 screening levels (C4SLs) (2014) 
2Soil guideline values (SGVs) (2009) Outdated 
3Generic Assessment Criteria (GACs) Outdated  
 
Although only three C4SLs (for arsenic, chromium and lead) are 
currently defined, they are important because evidence of widespread 
low-level contamination in many areas of England and Wales with soil 
concentrations exceeding these national safety limits.68–72 According 
to the geochemical maps developed by the British Geological Survey – 
about 10% of land coverage has soil concentrations of arsenic and lead 
above national safety limits of 35 mg/kg and 130 mg/kg, respectively; 
while 80% of English and Welsh soil levels of chromium beyond 10,000 
mg/kg.53 The spatial variations in the soil concentration levels for 
these elements may suggest that a segment of the UK population may 
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have continuous low-level exposure which may have significant health 
implications, in particular, cancer. Furthermore, the derivation of the 
limits themselves incorporates only very limited population-level 
evidence (due to a lack of epidemiological studies in suitable settings) 
so it may be the case that increased risks are observable at 
supposedly “safe” concentrations. When assessing the health impacts 
of metallic elements for which C4SLs are defined, this thesis aims to 
determine whether increased risks of cancer are observable among 
those living in areas with soil concentrations both above and below 
the given limit, by defining a series of exposure categories based on 
multiples and fractions of the limit. Incorporating the limits into the 
exposure definitions in this way ensures that both the appropriateness 
of the current levels, and the impact of living in an area where they 
are exceeded, can be quantified.  The implications of any observation 
of an increased risk on current policy and regulations can thereby be 
directly assessed by those responsible for setting and revising the 
limits.  
1.4 The potential health impact of soil metals 
There is emerging evidence that the presence of toxic elements such 
as arsenic, cadmium, chromium, nickel and lead in topsoil may pose a 
considerable risk towards human health. There are broad categories 
of exposure – 1) external exposure, which refers to individuals that 
are chronically exposed to moderate to high levels of contaminants 
that emerge from the environment (e.g. air, soil and water);15,18,74–76 
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2) internal exposure, which occurs within the body. This form of 
exposure relates to tissues and vital organs being in contact with 
excess amounts either of the contaminant itself or the derived 
metabolites remaining in vivo in the body’s system when they are 
unable to be metabolised due to chemical over-saturation. This can 
occur in the serum of the target tissue, or in fluids produced by 
certain organs.77–82 Alternatively, a tissue can be exposed to a particle 
that contains contaminants and becomes trapped in the associated 
organ during absorption. This may cause long-term irritation of a 
tissue resulting in adverse health effects.15,18,74–76  
Chronic exposure to external contaminants that emerge from topsoil 
leads to elements gaining entry into the human body through the 
mouth, nostrils and skin at a continuous rate. Where these elements 
become absorbed into the body, internal susceptibility to toxicity 
occurs once the metabolic system reaches a critical point where it 
becomes incapable of breaking down any excess amount of either the 
soil metal itself or the derived metabolite that remain in vivo in the 
body’s system. At this point there is a potential for these chemicals to 
accumulate within certain tissues.77–82 The factors that influence 
bioaccumulation of chemical elements in tissues are usually 
dependent on the body’s rate of eliminating any rogue substance 
through the processes of metabolism and excretion, as well as the 
overall propensity for tissues to store77–82 or otherwise enable 
chemical elements to accumulate within them (i.e. tissue 
burden).15,18,74–76 
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1.4.1 The exposure pathways from soils to human 
1.4.1.1 The external exposure from soil to human intake 
There are 4 major ways through which external exposure to soil 
contaminants can occur to the human body: 1) ingestion; 2) inhalation 
of soil particulates; 3) dermal absorption (or skin contact) of soil 
particulates or entry through breakages of the skin; and 4) indirect 
contact through inhalation of dust which contains soil particles, or 
ingestion of drinking water contaminated with soil or from other 
sources.15,18,74–76  
Consumption of soil is a widespread phenomenon. Children, especially 
those under three years of age, have a high propensity to accidentally 
ingest soil while playing outdoors. Young children are much more 
sensitive to contaminants and considered to be the group with the 
highest risk from being exposed to contaminants from soil (e.g. the 
absorption rate of lead via the digestion tract of children is 5 times 
efficient than that of adults).74,76,83–85 In both adults and children, soils 
can be accidentally ingested by consuming fruit and vegetable with 
soil particulates attached to them, through lack of cleanliness after 
coming into contact with soils, or through swallowing of airborne soil 
particles which become trapped in the mucous of the mouth and nose. 
In addition, metals originating in soils may accumulate in the tissues 
of both plants and animals used as human foods. The ingestion of soil 
contaminants is considered to be the largest and most direct form of 
external exposure to soil metals due to their presence at all levels of 
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our food chain – e.g. plant-specific food chain: from soil > to plants > 
and to humans, and animal-specific food chain: from soil > to plants > 
to animals > and to humans7 
Compared to the ingestion route, inhalation is considered to be a 
slightly less significant source for external exposure to soil metals, but 
nevertheless, may be important to those that experience repeated 
exposure over a long period of time. Any disturbance of the soil can 
lead to the release of soil particulates into the air where they remain 
ambient. Children that play on soil, as well as adults that practice 
gardening and other agricultural activities, and those living in areas 
where soils become dry and susceptible to wind erosion are at high 
risk of directly inhaling through the mouth and nostrils ambient soil 
particulates that may contain traces of heavy metals. 74,76,83–85 
Dermal absorption can also occur, although this process tends to be 
most significant for certain volatile and organic soil compounds (such 
as benzene, ethyl benzene, toluene and xylene), but may be less of a 
problem for most heavy metals,10,11,44,45,52 since it will require long-
term exposure for the skin to absorb sufficient amounts to cause skin 
damage, although certain forms of Cr(VI) and mercury are known 
exceptions and can become absorbed in significant quantities on only 
brief contact.9,12 
Finally, soil contaminants have the ability to migrate from the soil to 
other environments such as the indoors of household to settle as 
household dust,86 or into surface water. For examples, indirect 
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contact to high levels arsenic can occur from drinking water supplies 
which are often linked with arsenic-contaminated soil, although 
arsenic may also be naturally present at the source through which the 
drinking waters are exhumed.47,48,56,87–89  Another example of indirect 
contact with contaminants may include inhalation of household dust 
which contains constituent elements in them. 
1.4.1.2 The internal exposure and uptake by tissues 
Internal exposure can occur once soil contaminants have found entry 
via one or more of the major pathways for external exposure (i.e. 
ingestion, inhalation, dermal or indirect). Contaminants may become 
trapped in a tissue: for example, ingested soil particulates containing 
metallic elements will travel through the gastrointestinal tract (GIT) 
organs responsible for digestion (i.e. mouth, oesophagus, stomach, 
intestines etc.) of food before being absorbed through their walls. 
While these substances are absorbed into the body and transported to 
the liver, they are further processed into other micro-substances such 
as bile and metabolites90–93 Where undigested particulates fail to have 
passed through the GIT during absorption remain trapped within the 
crevices of the associated digestive tissue,77–82 at this point, the tissue 
with the trapped contaminant becomes exposed because it is in 
constant contact with the contaminant, potentially leading to 
irritation and consequent adverse health effects.77–82 
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1.4.1.3 Generalised framework of showing the biological 
mechanisms and carcinogenic effects of elements from soil 
Data from animal studies (which have been extrapolated to humans) 
have suggested that tissues exposed to metallic elements can undergo 
induced genotoxicity – i.e. the production of harmful agents that 
damages tissues and cells causing mutations, thus leading to 
carcinogenesis. These harmful agents are known as reactive oxygen 
species (ROS) [i.e. hydroxyl (•OH), superoxide (O2•-) and hydrogen 
peroxide (H2O2)].94–98 
These studies have indicated that the presence of metals triggers 
oxidation reactions in cells which lead to the rapid production of ROS. 
94–98 There is a defence mechanism known as the ‘antioxidant defence 
system’ which is intrinsically initiated to prevent oxidation reactions, 
and to abate the number of free radicals produced in cells; 94–98 
however, when oxidation reactions occur due to heavy metal-induced 
toxicity, the rate of oxidation reactions and rapid generation of ROS 
overwhelms this defence mechanism - this process in cells results in a 
condition known as oxidative stress.94–98 Cells under duress of 
oxidative stress tend to malfunction as the ROS targets, and oxidises, 
the nucleic acidic part of the cell [Deoxyribonucleic acid (DNA)] – 
resulting in impairment of DNA reparation.94–98 Continued impairment 
and lack of DNA repair eventually leads to cell mutations that are 
cancerous.94–98 
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It possible that the processes that we have illustrate in section 1.4.1.2 
can trigger such genotoxic response which may lead to the 
development of cancer. A summarised view of the possible 
mechanisms involved with soil-based metal-induced oxidative stress 
and cancer occurrence are shown in Figure 1.2. 
 27 
 
 
Figure 1.2: Illustrate the two broad categories of exposure to environmental 
contaminants - i.e. external and internal exposure; and how they play a crucial 
role on human carcinogenesis 
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1.5 Justification for assessing the health impacts of 
exposure to low-level soil concentration of metallic 
elements 
In the UK, research has shown that naturally occurring metals are 
widely distributed at varying geologic concentrations which have 
implications for human health within the general population.53 To my 
knowledge, in the past two decades, there has not been little 
research assessing the health impacts of soil elements in the UK. This 
is because most soil contaminants in many areas of today’s 
environment remain effectively at low-level concentrations. This is, in 
part, due to positive efforts of the UK Environmental Agency (EA) and 
Department of Environment, Food and Rural Affairs (Defra). These 
agencies ensure that local authorities across the country monitor 
levels of contamination and make sure that they do not reach a 
threshold where they may pose as a significant health risk.68–72 
Unfortunately, this has brought about the common belief, as yet 
unproven, that soil contaminants at low-levels do not pose any health 
risks and thus this area of research have received little attention to 
date. 
In contrast, before the 1980s (i.e. 1950-1980) in England and Wales, 
there was a considerable interest in assessing such links because a 
number of studies at the time found a modest association between 
certain soil elements (i.e. cadmium, chromium, cobalt, nickel and 
lead) with stomach, colon and ovarian cancers.99–104 These studies are 
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historical, and were conducted at a time period where soils were 
more highly contaminated due to the many mining activities that took 
place at the time. There is therefore a need to update the evidence in 
relation to the modern environment. A further problem is that these 
studies were only focused on smaller and rural English and Welsh 
communities (i.e. in Cheshire, Devon, Anglesey and Montgomery), 
where the participants were most likely farmers and miners. In 
addition, the study designs adopted an ecological framework which is 
highly vulnerable to confounding by differences in cancer 
susceptibility (due to behaviour, other carcinogenic exposures, 
socioeconomic status and other factors) among the populations 
compared. 
The absence of up-to-date and high-quality epidemiological evidence; 
and consequent reliance on extrapolations from laboratory studies, 
when setting safety limits for soil contaminants urgently requires to 
be addressed if confidence in the system of regulation is to be 
maintained, and the zoning of potentially harmful environments for 
housing development is to be avoided. Highly detailed, direct-contact, 
individual-level studies are inherently time-consuming and costly due 
to the time taken for cancer to develop, therefore there is a need to 
develop methodologies to identify the mostly likely sources of any 
increased risk and the populations most susceptible (and therefore 
most suitable for detailed further investigation), and to provide an 
evidence base to support further research. Therefore, a unique 
linkage between primary care medical records from The Health 
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Improvement Network (THIN) and the British Geological Survey’s 
Geochemical Baseline Survey of the Environment (GBASE) has been 
created, enabling this avenue of research to be explored. With this 
database, this thesis uses contemporary and novel approaches to 
establish evidence for adverse carcinogenic effects from 
environmental soil exposures.  
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Chapter 2: Aims & Objectives 
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2 Overview of research objectives 
This PhD research used data from two major sources: (1) The Health 
Improvement Network (THIN) database, and (2) the Geochemical 
Baseline Survey of the Environment (G-BASE). In collaboration with 
the research community at the British Geological Survey (BGS), 
experts from the University of Nottingham had used data from these 
databases and linked them together creating a new resource for 
investigating environmental impacts of soil metals on human health. 
G-BASE database contains geochemical information on the normal 
background concentrations for different trace elements in UK topsoil. 
Soil samples were collected throughout England and Wales from urban 
and rural soils within 1-2km of an individual’s home. Soil samples were 
analysed using the X-ray fluorescence spectroscopy to detect 
geochemical composition and concentrations levels for each element. 
The soil concentrations for fifteen elements were spatially 
interpolated over a continuous raster shapefile for England and Wales 
to produce point estimates at a pixel-level. Spatially referenced point 
estimates that overlapped the street postcode of patient registered to 
a general practice using the THIN were merged to produce the THIN-
GBASE database.    
My role as the investigator is to utilise this resource for my PhD thesis. 
Broadly, the aim of this PhD is to test a series of hypotheses that the 
risk of site specific cancers is associated with higher exposure to 
heavy metals in soils in England and Wales. The site-specific cancers 
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were chosen based on the routes of exposure - basal cell carcinoma 
(skin cancer) from dermal contact, lung cancer from inhalation, and 
gastrointestinal cancers from ingestion. 
2.1 Study 1: Basal cell carcinoma 
Specific objectives are: 
1. To perform an ecological study to provide contemporary estimates 
of the overall and regional variation in the incidence of basal cell 
carcinoma (BCC) skin cancer in England and Wales over the last 10 
years.  
2. To use an individual level population-based cohort study design to 
determine the association between arsenic levels in residential 
soils and the risk of developing a BCC. 
2.2 Study 2: Lung cancer 
The second study will consist of 2-stage process with the following 
objectives: 
1. To apply data mining techniques to identify an optimal subset of 
metallic elements which independently predict the risk of the 
development of lung cancer. 
2. To use an individual level population-based cohort study design to 
determine the magnitude of association between exposure to the 
subset of elements identified and the risk of developing lung 
cancer. 
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2.3 Study 3: Gastrointestinal tract cancer 
The third study consists of 3-stage process with each stage having the 
following objectives: 
1. To apply data mining techniques to identify an optimal subset of 
metallic elements in residential soils which independently predict 
the risk of the development of gastrointestinal cancers. 
2. To use an individual level population-based cohort study to 
determine the association between exposure to the subset of 
elements identified and the risk of developing gastrointestinal 
cancer. 
3. To apply multivariate analysis to the individual level population-
based cohort study using competing risk modelling to determine 
the association between exposure to the subset of elements and 
the risk of developing site-specific gastrointestinal cancer (upper 
gastrointestinal cancer, stomach cancer, colorectal cancer). 
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3.1 The Health Improvement Network 
The Health Improvement Network (THIN) is a large database for 
storage of electronic medical records (EMRs) collected from primary 
care general practices (GP) throughout the UK. The information stored 
in THIN database contains substantial information on all diagnoses 
made by or reported to general practitioners. It includes, not only 
data on medical events, but essential details of a patient’s 
demographic characteristics, prescriptions, important data relating to 
their lifestyle and area-level information linked his their postcode.105  
The THIN database is an important resource for academics and 
medical practitioners in epidemiology to study health outcomes, it 
provides researchers access to four major unique structured data files 
which are harmoniously linked to one another via identifiers (i.e. 
patient’s identification code and their practice of registration). 
Currently, there are at least 587 participating GPs across the UK 
contributing to the THIN database of which the percentage coverage is 
at most 6.0% of the total practices in the country. The computerised 
information contained in THIN comprises a total of 12,374,853 
patients of which 30.0% (i.e. 3,609,061 patients) are alive and actively 
contributing to the data in THIN. The overall number of patients 
contributing computerised data in THIN is 85,803,247 person-years.106 
Despite the coverage of practices contributing to THIN is relatively 
small; several studies have shown that data derived from THIN are 
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generalizable. Many health outcomes have been validated, including 
mortality, demonstrating the data representativeness of the UK 
population105,107–110 
3.2 Geochemical Baseline Survey of the Environment 
The British Geological Survey’s (BGS) joint project - Geochemical 
Baseline Survey of the Environment (G-BASE) and BGS re-analysis of 
the National Soil Inventory x-ray fluorescence spectrometry 
[NSI(XRFS)] samples, is a nationwide project aimed for determining 
the normal background concentration (NBC) levels of several 
geochemical (or trace) elements in UK topsoil. The programme, which 
was initiated in the late 1960s, seeks to establish a baseline (i.e. a 
point of reference) to monitor variations in NBCs of elements in 
topsoil.34,111–113  
The project has achieved complete coverage of the English and Welsh 
land surface through routine soil sampling of areas with stream 
sediments, and topsoil situated in urban and rural regions.111,114 The 
G-BASE project has currently determined NBCs for 48 different 
elements in which their information are spatially referenced and 
stored electronically in large database.111,114 This information is 
generated on high resolution maps to represent its distribution across 
the English and Welsh land surface.53  
Usage of the data greatly supports the exploration for beneficial 
mineral resource for UK economic development. It aids in the planning 
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and suitability of land-use for agricultural and social purposes. It helps 
to identify contaminated land and affected areas to quickly prioritise 
& mobilise measures of land remediation. It is a resource to advance 
our understanding of the potential health impacts of soil elements on 
humans.34,112     
3.3 Linkage of THIN to soil quality data in G-BASE 
To re-emphasis, the linkage was performed through the joint efforts 
from experts at the University of Nottingham and the BGS. 
Furthermore, I did not have any involvement initial the linkage 
process. However, my role was focused on using the derived database 
to build a formatted dataset that will enable the analyses of the soil 
data through a series of epidemiological studies that are presented in 
this thesis. Section 3.3 presents a detailed explanation of the soil 
sampling process carried out by the BGS, the linkage procedure, and 
an overall descriptive analysis for the distribution of the soil 
concentration levels for metals in linked database.   
3.3.1 The primary soil data sets 
The three primary soil datasets used as part of the G-BASE project are 
the G-BASE rural, G-BASE urban and NSI(XRFS) soil data. The G-BASE 
rural and urban soil samples are collected in a consistent manner that 
provides total soil concentration estimates for forty-eight different 
elements at a very high density (i.e. 1 site per 0.25km2 for urban and 
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1 site per 2.0km2 for rural) to enable interpretations to be made down 
to a local scale.115  
The G-BASE rural and urban soil data only has coverage for central and 
eastern England. However, the areas that are not covered by G-BASE 
are supplemented by the NSI(XRFS) soil dataset which has complete 
coverage for the whole of England and Wales.115–117 The NSI(XRFS) 
topsoil samples, which were collected and prepared in a similar 
fashion to the G-BASE rural or urban samples, has been reanalysed at 
BGS to determine total concentrations for each element. The 
NSI(XRFS) sampling sites were established in non-urban lands at a 
density of 1 site per 25.0km2.115–117 The combined number of G-BASE 
rural and urban sampling points in England are 37,269 (with 23,686 
established in rural and 13,583 in urban areas); and for NSI(XRFS) 
sample sites are 6,127 (with 4,864 collected from English soil and 
1,263 derived from Welsh soils).115–117 
3.3.2 Soil sampling at G-BASE (rural & urban) and NSI(XRFS) 
sites 
This section provides a detailed description of how the soil samples 
were collected. G-BASE soil sampling strategy was based on a regular 
grid across England and Wales using a standard British Ordnance Scale 
of 1:25,000. Sampling locations the for G-BASE database were 
determined at different densities depending on the type of 
environment and as well as the origin of the surface [i.e. urban 
terrain (concrete surface) or rural terrain (stream sediment, surface 
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soil or deep soil)] in which soil sample was collected from.118 
Whereas, samples from the NSI(XRFS) provided completeness of 
coverage for England and Wales for areas that have yet to be surveyed 
by the G-BASE project.    
For G-BASE rural zones, suitable sampling points were identified in 
rural areas whereby soil samples were collected at a density of 1 per 
2.0km2, at alternating grids, across the rural terrain. The rural G-BASE 
data are mostly concentrated in eastern and central areas of England, 
with additional samples collected from the Tamar catchment of South 
West England. G-BASE urban are classed in urban centres whereby soil 
samples were collected at a much finer, and higher resolution 
compared to G-BASE rural samples at a density of 1 per 0.25km2 (or 4 
per 1.0km2). The NSI(XRFS) sampling points for collecting soil samples 
were conducted at a much coarser resolution when compared to both 
G-BASE urban and rural soils, at a density of 1 per 25.0km2 (Figure 
3.1).118  
At all sampling points on the grid (Figure 3.1), irrespective of whether 
soils were defined as G-BASE rural, urban or NSI(XRFS), an area with 
dimensions of 20.0m x 20.0m was carved for soil collection. A total of 
five samples were collected from the vertices and at centre of the 
area with augur flights at a depth of 2-15cm (>0-2cm for concrete 
terrains; 2-5cm for topsoil sampling; 5-15cm for deep soil sampling) 
(Figure 3.2).118 
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The soil materials were aggregated and taken to BGS laboratories for 
analyses using x-ray fluorescence spectroscopy (XRFS) as the standard 
method to detect the geochemical composition, as well as total and 
extractable concentrations for major and trace elements present in 
the soil sample. These measurements were spatially referenced to the 
location of collection and stored electronically in BGSs G-BASE 
database; whilst aggregated soil samples were preserved and archived 
in BGS storerooms for future reference.118 
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Figure 3.1: Map of G-BASE & NSI(XRFS) sample sites across England & Wales1,2 
 
 
 
 
 
                                         
1 Black colour denotes G-BASE urban regions with sampling points are at a density of 1 per 
0.25km2. Grey colour denotes G-BASE rural regions with sampling points at a density of 1 per 
2km2. Grey dots indicate locations of NSI(XRFS) at a density of 1 per 25km2 
2 Permission was granted by to use above material. Figure 3.1 was originally published by Jack 
E. Gibson et al., (2016) 
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Figure 3.2: Shows an area marked at a sampling location for soil 
collection. 
20m 
20m 
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3.3.3 Linkage procedure 
The overall number of sampling points from G-BASE and NSI(XRFS) 
described in section 3.1.1 were treated as a point-layer, where each 
site contains the total concentrations measured for each metal. The 
point-layer is loaded into GIS software [ArcGIS desktop 10.3 (ESRI, 
Redland, California, USA)] and mapped over the cartographies of 
England and Wales which contains the spatial features i.e. residential 
postcodes areas.  
For each metal, interpolated layers were produced, with the inverse 
distance weighting (IDW) option (using a search radius of 5.0km and 
an output cell size of 1.0km) to predict values for substances at 
locations that were unsurveyed. The estimates derived for each metal 
covered the entire cartographies for England and Wales, where a 
predicted value(s) intersected the centroid of a feature that defined a 
residential postcode – the summary estimate would be linked to that 
specific postcode.  
15 out of 48 elements from G-BASE were selected for the linkage with 
EMRs; these were aluminium, arsenic, calcium, chromium, copper, 
iron, lead, manganese, nickel, phosphorous, selenium, silicon, 
uranium, vanadium and zinc. Elements in the linkage were outputted 
with one of the three indicators: as -2 if linked XRFS measurements 
were missing; as -1 if constituent measurements for elements from a 
soil sample collected at a sampling area were below the detection 
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limit (DL) (Table 3.1); and a positive continuous value – which 
indicates a concentrations level. 
 
Table 3.1: Shows the lower limits of detection for the 15 soil elements as 
part of the GBASE sampling strategy used to distinguish the presence or 
absence of substance in a soil sample 
Soil element (symbol)  XRFS detection limits (mg/kg) 
  Aluminium (Al)  2,000.0 
  Arsenic (As)  0.5 
  Calcium (Ca)  500.0 
  Chromium (Cr)  5.0 
  Copper (Cu)  1.3 
  Iron (Fe)  70.0 
  Lead (Pb)  1.3 
  Manganese (Mn)  70.0 
  Nickel (Ni)  1.3 
  Phosphorus (P)  220.0 
  Silicon (Si)  470.0 
  Selenium (Se)  0.2 
  Uranium (U)  0.5 
  Vanadium (V)  5.0 
  Zinc (Zn)  7.0 
 
 
The spatially interpolated dataset was passed on to THIN for linking 
the concentration values to a patient’s postcode of residence. Prior to 
the linkage THIN had to ensure that practices falling within the G-
BASE coverage area had to provide formal consent, after the linkage, 
THIN had to ensure that patient confidentiality was preserved by 
rendering a patient’s private details such as name, the exact location 
and registered practice anonymous. The data used for this PhD project 
was kept completely anonymised.  
At the time of the linkage, 377 out of 395 English & Welsh GPs 
contributing to THIN database agree to participate in the linkage. The 
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total number of patients ever registered participating practices in 
THIN was 7,137,365 (includes alive or deceased patients). Of these, 
6,825,382 patients were merged successfully to G-BASE soil data. 
From the cohort of patients with linked data about 6.24 million had 
complete NBC values for all 15 elements. Those that were alive and 
actively contributing to THIN amounted to approximately 2.88 million 
patients with G-BASE data. 
For each of the 15 soil elements the observed NBC levels of the 
linkage measurements were validated by comparing the distribution 
among the THIN population with those expected among the general 
UK population, which has shown to be similar. This section of this 
thesis regarding the methodology for linking THIN & G-BASE and 
validation has been described extensively elsewhere.119  
From this point, and onwards, we will be referring to the linked 
database as THIN-GBASE. It should be noted that the dataset used for 
this research contained approximately 2.3 million patients with G-
BASE soil data. Depending on the type of cancer outcome, this dataset 
was further formatted according to specific set of inclusion and 
exclusion criteria which are discussed more in subsequent chapters. In 
subsequent analysis, the applied formats will result in sample size of 
at least 1.8 million participants.  
The next section provides a descriptive account for each of the fifteen 
soil elements that are present in THIN-GBASE. The descriptive analysis 
was limited to participants having all data across fifteen elements 
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(regardless of it being coded as the following: concentration value, 
below detection limit (-1), not available (-2)) – these patients were 
typically at the ages of 18 years or above without any history of any 
cancer diagnosis before 1st January 2004. The descriptive analysis was 
restricted to participants who were registered at general practice for 
at least one year before the 1st of January 2004, and their general 
practices having an Acceptable Mortality Recording before 1st of 
January 2004.    
3.3.4 Descriptive analysis of geochemical data in THIN-GBASE 
Descriptive analyses were performed accordingly on 1,742,205 
patients in the THIN-GBASE who have soil data across all 15 elements. 
Table 3.2 provides the statistical summaries in a form of median, 
interquartile ranges (IQRs) and maximum value observed among the 
cohort of participants who are contributing data to the THIN-GBASE 
database. For instance, 1,664,155 (out of 1,742,205) (95.52%) 
participants have a concentration value for aluminium – among the 
participants the estimates typically ranged between 2,000 to 116,700 
mg/kg with a median of 51,000 mg/kg (IQR: 40,300-59,300 mg/kg). 
The remaining participants (4.48%) either had concentrations for 
aluminium that were deemed as estimates below detection limits (i.e. 
less than 2,000 mg/kg (coded as -1)) or not available (coded -2).      
The soil concentrations for aluminium, calcium, iron and silicon were 
vastly higher than those measured for the remaining elements – 
arsenic, chromium, copper, lead, nickel, manganese, phosphorus, 
 48 
 
uranium, vanadium and zinc. The concentrations in soil samples for 
these constituent elements that were detected at large abundance 
typically ranged from measurements exceeding levels of 10,000 
mg/kg. Overall, the elements with highest median concentrations 
were aluminium (median: 51,000 mg/kg, IQR: 40,300-59,300 mg/kg) 
followed by silicon (median: 29,900 mg/kg, IQR: 26,500-32,900 
mg/kg), iron (median: 27,406 mg/kg, IQR: 21,575-34,830 mg/kg) and 
calcium (median: 3,300 mg/kg, IQR: 670.0–14,300 mg/kg). Soil 
elements with median concentrations between 100.0-1,000.0 mg/kg 
included phosphorus (median: 995.0 mg/kg, IQR: 730.0-1,358.0 
mg/kg) and manganese (median: 496.0 mg/kg, IQR: 380.0-771.0 
mg/kg) (Table 3.2). The remaining soil elements in this scenario are 
considered as low-level trace elements typically because their median 
concentration levels detected in soil samples did not exceed 100.0 
mg/kg.]
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Table 3.2: Descriptive soil analysis was performed on all 15 elements in linked database (THIN-GBASE) to derive the following summary 
statistics – median concentration levels, interquartile ranges (IQR) and maximum value observed 
 Median (IQR) [mg/kg] Maximum value [mg/kg] Total (1,742,205) (%) 
Soil element    
  Aluminium  51,000 (40,300-59,300) 116,700 1,664,155 (95.52%) 
  Arsenic  15.6 (11.5-19.8) 1032.2 1,671,441 (95.94%) 
  Calcium  3,300 (670.0-14,300) 214,400 1,654,706 (94.98%) 
  Chromium  70.0 (58.0-83.0) 1,141.0 1,671,486 (95.94%) 
  Copper  27.2 (17.9-50.1) 1,320.9 1,671,486 (95.94%) 
  Iron  27,406 (21,575-34,830) 137,888 1,670,842 (95.90%) 
  Lead  74.0 (47.0-162.0) 3,045.0 1,671,486 (95.94%) 
  Manganese  496.0 (380.0-771.0) 19,159 1,671,713 (95.95%) 
  Nickel 23.9 (17.7-32.1) 178.8 1,671,486 (95.94%) 
  Phosphorus  995.0 (730.0-1,358.0) 6,110.0 1,660,318 (95.30%) 
  Silicon 29,900 (26,500-32,900) 467,000 1,659,074 (95.23%) 
  Selenium  0.5 (0.37-0.70) 11.3 1,658,164 (95.18%) 
  Uranium  1.97 (1.57-2.38) 61.7 1,668,515 (95.77%) 
  Vanadium  75.0 (61.0-95.0) 653.0 1,671,486 (95.94%) 
  Zinc 100.0 (68.0-168.0) 4,681.0 1,671,486 (95.94%) 
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The overall distribution for all soil elements in terms of their 
concentration levels was non-normal. A skewed-right distribution was 
observed whereby a large proportion of patients in the linkage living 
on residential soil significantly contained low concentration. A series 
of two-way histograms with cumulative proportions (percentiles) were 
generated to illustrate the skewedness of the concentration levels for 
each soil element (Figure 3.3-3.17). For some trace elements, such 
copper and lead – it depicts that the mounded part of their 
distribution falls below the 75th percentile value. The tailed part or 
group of observations above this value were the remaining 25% of 
patients in the cohort that had somewhat medium to very high 
concentrations of copper (Figure 3.7) or lead (Figure 3.9). 
We use soil copper in this context to further illustrate such feature - 
the mounded part of the distribution falling 75th percentile score 
corresponds to patients in the linkage with soil copper levels that 
ranged between the lowest detection (1.3 mg/kg) to 50.1 mg/kg. The 
remaining 25% of the distribution above this score corresponds to 
those residing in areas with soil copper concentration ≥ 50.1 mg/kg. 
Please note that the few in the 99th percentile bracket have the 
highest exposure ranging from 170.0 to 1,320.9 mg/kg (Figure 3.7). 
Other trace metals such as arsenic (Figure 3.4), chromium (Figure 
3.6), nickel (Figure 3.11), selenium (Figure 3.13), uranium (Figure 
3.15), vanadium (Figure 3.16) and zinc (Figure 3.17) – the mounded 
part of the distribution is the below 90th percentile point. The tailed 
part of observations that fall above this value were the remaining 10% 
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of patients in the linkage living in areas with residential soil having 
higher concentrations of these elements. For instance - the mounded 
part of the distribution below the 90th percentile as illustrated for soil 
chromium ranged from the lowest detection limit (5.0 mg/kg) to 92.0 
mg/kg. Those with residing in areas with soil chromium above this 
value corresponded to patients ranked in the 90th percentile bracket 
with chromium levels ranging ≥ 92.0 mg/kg to the maximum observed 
value of 1,141.0 mg/kg (Figure 3.6). 
When accounting for recent C4SLs for special elements that are 
toxicological concern in the UK, we observed the following: only 4.0% 
of patients contributing to the THIN-GBASE database lived in areas 
with arsenic concentration in English and Welsh above the C4SL soil 
guideline value of 35.0 mg/kg (Figure 3.4); 45.0% of patients in the 
cohort lived on soil with lead levels exceeding the C4SL soil guideline 
value of 86.0 mg/kg (Figure 3.9); and 98.0% of patients resided in 
areas with soil chromium above the CS4L of 21.0 mg/kg (Figure 3.6).                
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Figure 3.3: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
aluminium. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of aluminium. Right y-axis: Black dots correspond to a percentile 
score – i.e. the proportion of patients that fall under specific soil concentration value for aluminium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles 
(i.e. 31,000, 40,000, 51,000, 59,300 and 70,500 mg/kg respectively). The concentrations for aluminium were converted to a weight percentage (mg/kg÷10,000), 
whereby 1.0% = 10,000 (of aluminium) parts-per million.
  
 
5
3
 
 
Figure 3.4: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
arsenic. Dashed black line represents the UK arsenic C4SL soil guideline value (35.0 mg/kg). Left y-axis: corresponds to the observed proportion of patients with 
specific soil levels of arsenic. Right y-axis: Black dots correspond to a percentile score – i.e. the proportion of patients that fall under specific soil concentration 
value for arsenic; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 8.5, 11.6, 15.6, 19.8 and 29.0 mg/kg respectively) 
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Figure 3.5: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
calcium. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of calcium. Right y-axis: Black dots correspond to a percentile score 
– i.e. the proportion of patients that fall under specific soil concentration value for calcium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 200.0, 
670.0, 3,300, 14,300 and 34,000 mg/kg respectively). The concentrations for calcium were converted to a weight percentage (mg/kg÷10,000), whereby 1.0% = 
10,000 (of calcium) parts-per million 
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Figure 3.6: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
chromium. Dashed black line represents the UK chromium C4SL soil guideline value (21.0 mg/kg). Left y-axis: corresponds to the observed proportion of patients 
with specific soil levels of chromium. Right y-axis: Black dots correspond to a percentile score – i.e. the proportion of patients that fall under specific soil 
concentration value for chromium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 44.0, 58.0, 70.0, 83.0 and 93.0 mg/kg respectively) 
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Figure 3.7: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
copper. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of copper. Right y-axis: Black dots correspond to a percentile score – 
i.e. the proportion of patients that fall under specific soil concentration value for copper; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 13.0, 
17.9, 27.2, 50.1 and 88.0 mg/kg respectively) 
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Figure 3.8: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
iron. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of iron. Right y-axis: Black dots correspond to a percentile score – i.e. 
the proportion of patients that fall under specific soil concentration value for iron; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 13,000, 21,575, 
27,406, 34,830 and 43,000 mg/kg respectively) 
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Figure 3.9: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
lead. Dashed black line represents the UK lead C4SL soil guideline value (86.0 mg/kg). Left y-axis: corresponds to the observed proportion of patients with specific 
soil levels of lead. Right y-axis: Black dots correspond to a percentile score – i.e. the proportion of patients that fall under specific soil concentration value for lead; 
Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 36.0, 47.0, 74.0, 147.0 and 290.0 mg/kg respectively) 
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Figure 3.10: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
manganese. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of manganese. Right y-axis: Black dots correspond to a percentile 
score – i.e. the proportion of patients that fall under specific soil concentration value for manganese; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles 
(i.e. 223.0, 380.0, 496.0, 771.0 and 1200.0 mg/kg respectively) 
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Figure 3.11: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
nickel. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of nickel. Right y-axis: Black dots correspond to a percentile score – 
i.e. the proportion of patients that fall under specific soil concentration value for nickel; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 11.0, 
17.7, 23.9, 32.1 and 38.4 mg/kg respectively) 
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Figure 3.12: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
phosphorus. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of phosphorus. Right y-axis: Black dots correspond to a 
percentile score – i.e. the proportion of patients that fall under specific soil concentration value for phosphorus; Red line indicates: 10th, 25th, 50th, 75th and 90th 
percentiles (i.e. 570.0, 730.0, 995.0, 1,358.0 and 1,730.0 mg/kg respectively) 
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Figure 3.13: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
selenium. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of selenium. Right y-axis: Black dots correspond to a percentile 
score – i.e. the proportion of patients that fall under specific soil concentration value for selenium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 
0.25, 0.37, 0.5, 0.7 and 1.0 mg/kg respectively) 
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Figure 3.14: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
silicon. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of silicon. Right y-axis: Black dots correspond to a percentile score – 
i.e. the proportion of patients that fall under specific soil concentration value for silicon; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 20,100, 
26,500, 29,900, 32,900 and 35,900 mg/kg respectively). The concentrations for silicon were converted to weight percentage (mg/kg÷10,000), whereby 1.0% = 
10,000 (of silicon) parts-per million 
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Figure 3.15: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
uranium. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of uranium. Right y-axis: Black dots correspond to a percentile 
score – i.e. the proportion of patients that fall under specific soil concentration value for uranium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 
1.23, 1.57, 1.97, 2.38 and 2.78 mg/kg respectively) 
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Figure 3.16: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
vanadium. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of vanadium. Right y-axis: Black dots correspond to a percentile 
score – i.e. the proportion of patients that fall under specific soil concentration value for vanadium; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 
45.0, 61.0, 75.0, 95.0 and 114.0 mg/kg respectively) 
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Figure 3.17: Two-way histogram with cumulative proportions showing the overall distribution of patients in THIN-GBASE with specific soil concentration levels for 
zinc. Left y-axis: corresponds to the observed proportion of patients with specific soil levels of zinc. Right y-axis: Black dots correspond to a percentile score – i.e. 
the proportion of patients that fall under specific soil concentration value for zinc; Red line indicates: 10th, 25th, 50th, 75th and 90th percentiles (i.e. 46.0, 68.0, 
100.0, 168.0 and 260.0 mg/kg respectively) 
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4 Summary 
Basal cell carcinoma (BCC) is one of the most common types of non-
melanoma skin cancer in the UK. There is a well-established link 
between environmental arsenic exposure and the development of 
BCC, but at considerably higher levels of exposure than those likely to 
be observed in the UK. We therefore carried out a study to determine 
whether there is evidence that more modest levels of arsenic in soil 
increase the risk of BCC, as an example of testing a specific, 
evidence-informed hypothesis using the new data source (other 
elements were therefore not considered, except where there was 
concern they might modify the effect of arsenic). As little is known 
about how the incidence of BCC varies across the UK, we first took the 
opportunity to quantify the variation. Therefore, this chapter 
describes two studies: 
1. Population-based ecological study design:  
We sought to determine the variation in BCC throughout the UK. All 
adults with a first recorded diagnosis of BCC between 1-January-2004 
and 31-December-2010 were extracted from the THIN-GBASE. 
European and world age-standardised incidence rates (EASRs and 
WASRs were obtained for country-level estimates and levels of 
socioeconomic deprivation, while strategic health authority (SHA)-
level estimates were directly age-sex standardised to the UK standard 
population. Incidence-rate ratios were estimated using multivariable 
Poisson regression models to specifically assess the effects of calendar 
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year of diagnosis, socioeconomic deprivations, and geographical 
location (i.e. ten English SHAs, Wales, Northern Ireland and Scotland). 
The overall EASR and WASR of BCC in the UK were 98.6 and 66.9 per 
100,000 person-years, respectively. Regional-level incidence rates 
indicated a significant geographical variation in the distribution of 
BCC, which was more pronounced in the southern parts of the UK. The 
South East Coast had the highest BCC rate followed by South Central, 
Wales and South West. Incidence rates were substantially higher in 
the least socioeconomically deprived groups. It was observed that 
increasing levels of deprivation led to a decreased rate of BCC (p < 
0.001). In terms of age groups, the largest annual increase was 
observed among those aged 30-49 years. 
2. Population-based cohort study design:  
In accordance with the UK category 4 screen levels (C4SLs) for soil 
arsenic, we sought to determine whether residential soil arsenic 
exposure above the soil guideline value (i.e. arsenic-C4SL = 35.0 
mg/kg) was associated with an increased risk of developing BCC in the 
UK population. 
All patients with a first diagnosis of BCC between 1-January-2004 and 
31-December-2011, and with X-ray fluorescence spectroscopic 
measurements of total soil arsenic levels were extracted from THIN-
GBASE. Multivariable Cox regression models were used to quantify 
associations between BCC and soil arsenic. 
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The adjusted hazard ratio (HR) for participants with exposures of 
35.0-70.0 mg/kg (HR 1.08, 95% CI: 1.02-1.14) and ≥70.0 mg/kg (HR 
1.17, 95% CI: 1.09-1.28) had increased hazards of developing BCC 
compared to those with exposures <17.5 mg/kg. Urban residents with 
the highest exposure significantly had the greatest risk of developing 
BCC (≥ 70.0 mg/kg: HR 1.18, 95% CI: 1.06-1.36). 
Conclusion: BCC is an increasing health problem in the UK. In our 
ecological study, it is established that southern regions of the 
England; and those in the least deprived socioeconomic group have a 
much higher incidence rate of BCC. In addition, our findings from our 
cohort study provides evident that exposure to soil arsenic is an 
important risk factor. Residential soil concentration levels for arsenic 
should be considered for further investigation of BCC aetiology.  
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4.1 Background 
Non-melanoma skin cancers (NMSC) are a group of neoplasms that 
develop in the epidermis of the skin. NMSCs are named according to 
the skin cell-type from which the tumour originates.120 There are two 
major types of NMSCs: basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC).120–123 BCCs are tumours that originate from the basal 
cells situated in the lowest layer of the skin’s epidermis. SCCs 
originate from the squamous cells located in the mid-section of the 
epidermis. Unlike BCCs, SCCs are more life threatening as their 
tumours can potentially spread to other organs if left untreated. 
Other rarer forms of NMSCs include Merkel cell carcinoma, Kaposi 
sarcoma and T-cell lymphoma of the skin.120–123  
BCCs are the most common form accounting for 75% of cases 
diagnosed with NMSC, which globally affects close to 1.5 million 
individuals annually.122 Past studies have shown individuals at risk of 
BCC are those of Caucasian descent living in US, Canada, Australia and 
most European countries.124–128 The main risk factor for NMSC is 
exposure to Ultraviolet (UV) light, through sun exposure or the use of 
tanning lights, and individual tanning behaviour.129–131 Other major 
risk factors are advancement of age,132 gender,132,133 skin type (i.e. 
fair, white or freckled skin)132,134–136 and a prior history of skin 
cancer.123 
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4.2 Regional variations of Basal cell carcinoma incidence in 
UK 
4.2.1 Background 
In the UK, BCC incidence is increasing at an unprecedented rate. The 
overall incidence of NMSC is estimated to be well over 100,000 cases 
per year, with BCC accounting for 75% of cases, SCC for 20% and other 
rare skin cancer types (i.e. Merkel cell carcinoma, Kaposi’s sarcoma 
and T-cell lymphoma of the skin) for 5%.121  
Recent studies have shown that whilst the incidence of BCC varies 
geographically in the UK,124,137 rapidly increasing incidence has been 
observed in many areas. For instance, in West Glamorgan (Wales) the 
incidence rate increased by 60% between 1988 and 1998.138 Similarly, 
in England, the incidence of BCC in North Humberside tripled over the 
13 year period from 1978 to 1991.124,139 Scotland and Northern Ireland 
have lower incidence of BCC relative to England and Wales, however, 
within the past two decades the incidence of BCC among men has 
risen approximately by 16% in Scotland and 18% in Northern 
Ireland.140,141 The elderly population contributes substantially to the 
disease burden, with risk of BCC increasing after 40 years of age, 
however, we are now seeing an increased incidence among younger 
people and in particular those of ≤ 30 years of age.142  
Socioeconomic status and deprivation are also known to modify the 
risk of BCC. Some studies suggest that BCC appears to be more 
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common in those belonging to higher social class;136,143,144 however, 
such associations are not well understood and the distribution of BCC 
in terms of levels socioeconomic deprivation in the UK population is 
unknown. 
We therefore used data from a UK-wide database of primary care 
medical records to derive contemporary regional breakdowns of the 
incidence of BCC in UK. We present novel incidence rate estimates 
stratified by level of socioeconomic deprivation in the UK and 
additional analyses examining whether BCC incidence has continued to 
increase in recent years, particularly in the younger age groups. 
4.2.2 Methods 
4.2.2.1 Study design 
We conducted a large population-based study using data from THIN. 
THIN is a large database comprised of anonymised primary care 
electronic medical records of more than 10 million patients from 
across all regions of the UK. The information contained within THIN 
includes details on all diagnoses made by or reported to the general 
practitioner, as well as other additional health information relevant to 
primary care. THIN is recognised for its completeness and accuracy of 
data recording, and has been validated for its suitability for use in 
medical research,107 including specific validation of diagnoses of 
BCC.145 In addition, a range of socio-demographic indicators are 
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available in THIN, including quintiles of Townsend Deprivation Index146 
in each patient’s postcode of residence. 
4.2.2.2 Case definition for Basal cell carcinoma 
The medical histories and deprivation indicators of all adults aged 18 
years or above with a first recorded diagnosis of BCC between January 
1st, 2004 and December 31st, 2010, were extracted from THIN. 
Subjects diagnosed with Basal cell nevus syndrome (or Gorlin’s 
syndrome), organoid naevi or other genetic syndromes were excluded 
from the study. Patient ages were categorised into 10-year bands (18–
29, 30–39, 40–49, 50–64, 65–79 and 80+ years). Patients were 
categorised into thirteen regional based (in England) on the SHA or 
devolved government administration (Wales, Scotland and Northern 
Ireland) to which each patient’s primary care practice belongs as 
follows: North East, North West, Yorkshire and Humber, East Midlands, 
West Midlands, East of England, London, South East Coast, South 
Central, South West, Wales, Scotland and Northern Ireland. This is the 
only spatially referenced data available from the anonymised patient 
records. 
4.2.2.3 Statistical analysis 
4.2.2.3.1 Methodology for calculating incidence rates 
The primary outcome measures were incidence rates (IR) of BCC in 
the whole UK, in its constituent countries and principalities, and each 
English SHA region. We also estimated the incidence of BCC across 
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quintiles of socioeconomic deprivation groups. IRs was calculated as 
the number of patients receiving their first diagnosis of BCC divided 
by the total number of person-years at risk. Diagnoses within the first 
year of registration with a participating primary care practice were 
excluded as such recordings can relate to prevalent, rather than 
incident, events (being an artefact of back-entry of records from a 
previous practitioner). Second or subsequent diagnoses were also 
excluded as these are difficult to differentiate from recurrences and 
follow-up consultations in primary care records. Population 
denominators were mid-year (1st July) total numbers of persons 
registered for at least one year at a primary care practice enrolled in 
THIN. IRs was presented as rates per 100,000 person-years. We 
derived estimates for European and World Age-Standardised incidence 
Rates (EASRs and WASRs, respectively) using the direct standardisation 
method to allow direct comparisons between country-level incidence 
rates (i.e. UK, England, Scotland, Northern Ireland and Wales) with 
other populations.147 IRs of BCC at a regional level were directly age-
sex standardised to the UK standard population.148 
4.2.2.3.2 Multivariable Poisson regression modelling 
Poisson multivariable regression model was used to examine the 
effects of all factors (i.e. calendar year of diagnosis, socioeconomic 
deprivation and regions) on the incidence of BCC adjusted for sex and 
age groups. Stratified Poisson multivariable analyses were used to 
determine whether associations between all factors and the incidence 
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of BCC were modified by sex, while controlling for age groups. For 
secondary analyses, we further used stratified models by age groups 
to assess calendar years as a continuous variable to determine the 
average change (per year) in incidence of BCC. Incidence rate ratios 
(IRR) were estimated with 95% confidence intervals (CI). All statistical 
analyses were carried out using STATA version 12 (STATA Corporation, 
College Station, TX, USA). 
4.2.3 Results 
There were 38,121 incident cases of BCC were identified from 546 GPs 
in the THIN database. Mean age was 64 years (standard deviation, SD 
13 years) with slightly more men (52.4%) diagnosed with a BCC. 
4.2.3.1 BCC incidence at country and regional level 
The crude IR of BCC between 2004 and 2010 in our THIN database was 
171.9 per 100,000 person-years (95% CI: 170.1–173.6). The crude IR of 
BCC was higher among men (183.1 per 100,000 person-years; 95% CI: 
180.5–185.6) than women (161.0 per 100,000 person-years; 95% CI: 
158.7–163.4) (Table 4.1). When comparing the overall figures between 
2004 and 2010, we found that there was an increase from 154.0 per 
100,000 person-years to 182.0 per 100,000 person-years. Our Poisson 
multivariable regression model show that the overall significant 16% 
increase in incidence in 2010 as compared to 2004 (IRR 1.16, 95% CI: 
1.11–1.20), which equates to an average increase of 2.5% per year 
(95% CI: 1.9% – 3.0%; p for trend = 0.001) (Table 4.3). 
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Comparatively, at a country-level, Wales has significantly the highest 
overall crude rate of BCC (IR 196.4, 95% CI: 189.2–203.8) followed by 
England (IR 178.5, 95% CI: 176.5–180.5). We observed the incidences 
were low in Scotland (IR 128.7, 95% CI: 124.6–133.0) and Northern 
Ireland (IR 131.6, 95% CI: 123.3–140.3) (Table 4.1). We observed the 
incidences are low, and similar for Scotland and Northern Ireland. 
We observed important geographical variations in the distribution of 
BCC (Figure 4.1). The age-sex standardised incidence rate of BCC in 
South East Coast, South West, South Central and Wales are 
significantly higher than other regions of the UK (Table 4.2). 
Our models show that the incidence of BCC were significantly lower in 
West Midlands (IRR 0.92, 95% CI: 0.88–0.97), Northern Ireland (IRR 
0.92, 95% CI: 0.85–0.98) and Scotland (IRR 0.87, 95% CI: 0.83–0.91) 
than in London (the referent). Conversely, we found that the 
incidence of BCC was significantly higher in South East Coast (IRR 
1.28, 95% CI: 1.22–1.34), Wales (IRR 1.23, 95% CI: 1.16–1.29), South 
Central (IRR 1.21, 95% CI: 1.15–1.27), South West (IRR 1.15, 95% CI: 
1.09–1.21) than in London. Our results show no substantial sex-specific 
difference in the incidence of BCC in any regions (Table 4.3). 
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Figure 4.1: Thematic map showing direct age & sex- standardised incidence rates of BCC in the UK standard population 
(THIN database) 2004-2010
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Table 4.1: Crude and sex-specific age-standardised incidence rates of Basal cell carcinoma in UK and countries, THIN 
database (2004–2010) 
 Men; IR (n) Women; IR (n) Overall; IR (N) 
United Kingdom    
  Crude 183.1 (19,960) 161.0 (18,161) 171.9 (38,121) 
  EASRa 112.2 88.1 98.6 
  WASRb 74.8 60.7 66.9 
England    
  Crude 189.9 (16,079) 167.5 (14,671) 178.5 (30,750) 
  EASR 114.9 91.4 101.5 
  WASR 76.6 63.1 69.0 
Northern Ireland    
  Crude 144.7 (502) 119.3 (439) 131.6 (941) 
  EASR 99.6 67.5 81.6 
  WASR 66.2 45.2 54.6 
Scotland    
  Crude 137.9 (1,904) 119.8 (1,704) 128.7 (3,608) 
  EASR 89.3 65.6 75.9 
  WASR 59.1 44.7 51.1 
Wales    
  Crude 208.1 (1,475) 185.0 (1,347) 196.4 (2,822) 
  EASR 128.7 103.1 114.4 
  WASR 86.4 71.3 78.1 
aEASR, European age-standardised rate. 
bWASR, World age-standardised rate. 
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Table 4.2: Regional-level estimates for sex-specific and age-sex standardised incidence rates of Basal cell carcinoma in UK, THIN 
database (2004–2010) 
 Age-sex standardised ratea  Sex-specific age standardised rateb  
Regions Overall (N)  Men (n) Women (n)  
Scotland 127.9  139.5 (1,904) 116.8 (1,704)  
Northern Ireland 138.4  155.4 (502) 122.2 (439)  
London 144.0  148.6 (1,432) 139.6 (1,415)  
West Midlands 144.1  152.2 (1,537) 136.3 (1,422)  
North West 146.5  156.6 (1,785) 136.8 (1,627)  
Yorkshire & Humber 151.4  163.3 (686) 140.0 (618)  
North East 156.0  165.2 (539) 147.2 (503)  
East Midlands 158.6  166.4 (776) 151.2 (718)  
East of England 161.1  170.7 (1,457) 151.8 (1,325)  
South West 180.2  196.2 (2,438) 165.0 (2,123)  
Wales 185.7  197.6 (1,475) 174.4 (1,347)  
South Central 193.5  208.7 (2,998) 178.9 (2,645)  
South East Coast 202.7  215.0 (2,431) 191.0 (2,275)  
aEstimates are directly age-sex standardised using UK as the standard population. 
bSex-specific estimates are directly age-standardised using the UK as the standard population. 
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Table 4.3: Overall & sex-specific incidence rate ratio (IRR) estimates showing associations between incidence of BCC and 
risk factors 
  Mena  Womena  Overallb 
  IRR   (95% CI)c  IRR   (95% CI)  IRR   (95% CI) 
Years       
  2004  1  1  1 
  2005  1.07   (1.02 – 1.14)  1.00   (0.94 – 1.06)  1.04   (0.99 – 1.08) 
  2006  1.10   (1.04 – 1.16)  1.07   (1.07 – 1.13)  1.09   (1.04 – 1.13) 
  2007  1.14   (1.08 – 1.21)  1.16   (1.10 – 1.23)  1.15   (1.10 – 1.20) 
  2008  1.16   (1.10 – 1.22)  1.16   (1.10 – 1.23)  1.16   (1.12 – 1.20) 
  2009  1.15   (1.09 – 1.22)  1.13   (1.07 – 1.20)  1.15   (1.10 – 1.19) 
  2010  1.12   (1.06 – 1.18)  1.21   (1.14 – 1.27)  1.16   (1.12 – 1.21) 
       
Annual increase  1.8% (1.1% – 2.5%)  3.2% (2.5% – 4.0%)  2.5% (1.9% – 3.0%) 
  (p for trend)  p = 0.003  p = 0.008  p < 0.001 
       
Socioeconomic deprivationd       
  5th (Most deprived)  1  1  1 
  4th   1.13   (1.06 – 1.20)  1.01   (0.95 – 1.08)  1.07   (1.02 – 1.12) 
  3rd   1.28   (1.21 – 1.36)  1.13   (1.07 – 1.20)  1.21   (1.16 – 1.26) 
  2nd   1.47   (1.39 – 1.56)  1.26   (1.19 – 1.33)  1.37   (1.31 – 1.43) 
  1st (Least deprived)  1.62   (1.53 – 1.72)  1.36   (1.28 – 1.44)  1.50   (1.44 – 1.56) 
  Unknown  1.22   (1.11 – 1.35)  1.12   (1.01 – 1.23)  1.17   (1.09 – 1.25) 
  (p for trend)  p < 0.001  p < 0.001  p < 0.001 
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Regions       
  London  1  1  1 
  Scotland  0.91   (0.85 – 0.98)  0.82   (0.76 – 0.88)  0.87   (0.83 – 0.91) 
  Northern Ireland  0.99   (0.89 – 1.10)  0.84   (0.76 – 0.94)  0.92   (0.85 – 0.98) 
  West Midlands  0.93   (0.87 – 1.00)  0.92   (0.85 – 0.99)  0.92   (0.88 – 0.97) 
  North West  0.98   (0.91 – 1.05)  0.93   (0.87 – 1.00)  0.96   (0.91 – 1.01) 
  Yorkshire & Humber  1.04   (0.96 – 1.15)  0.98   (0.89 – 1.08)  1.01   (0.95 – 1.08) 
  East Midlands  1.02   (0.93 – 1.11)  1.02   (0.93 – 1.12)  1.02   (0.96 – 1.09) 
  North East  1.08   (0.97 – 1.19)  1.03   (0.93 – 1.14)  1.05   (0.98 – 1.13) 
  East of England  1.05   (0.98 – 1.13)  1.02   (0.95 – 1.10)  1.04   (0.98 – 1.09) 
  Wales  1.25   (1.17 – 1.35)  1.19   (1.11 – 1.29)  1.23   (1.16 – 1.29) 
  South Central  1.24   (1.16 – 1.32)  1.18   (1.10 – 1.26)  1.21   (1.15 – 1.27) 
  South West  1.19   (1.12 – 1.28)  1.10   (1.03 – 1.18)  1.15   (1.09 – 1.21) 
  South East Coast  1.30   (1.21 – 1.39)  1.27   (1.18 – 1.36)  1.28   (1.22 – 1.34) 
aModels were stratified by sex, includes all covariates and adjusted for age groups: i.e. 18–29, 30–39, 40–49, 50–64, 65–79 and 
80+ years. 
bOverall model includes all covariates and adjusted for sex and age bands: i.e. 18–29, 30–39, 40–49, 50–64, 65–79 and 80+ 
years. 
cIRR, incidence rate ratio; CI, 95% confidence interval. 
dQuintiles of Townsend deprivation index. 
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4.2.3.2 BCC trends over time by age group 
Models were stratified by age groups to determine the effects of 
calendar years on the incidence of BCC. Our results show a small 
average increase of 0.4% per year in the age group of 18–29 years, 
however, this failed to reach statistical significance (95% CI: -8.0% to 
9.3%; p = 0.91). In particular, the largest average increase in 
incidence was observed for those in 30–39 years (3.9% per year, 95% 
CI: 0.2% to 7.7%; p = 0.04) and 40–49 (4.0% per year, 95% CI: 2.0% to 
6.1%; p < 0.001) age groups (Figure 4.2). 
4.2.3.3 BCC incidence by socioeconomic deprivation 
The crude incidence of BCC was significantly highest for those living in 
areas with the lower levels of deprivation, with estimates of 222.5 per 
100,000 person-years (95% CI: 218.5–226.5) and 203.2 per 100,000 
person-years (95% CI: 199.1–207.3) for those in the 1st quintile (least 
deprived) and 2nd quintile, respectively (Table 4.4). We observed that 
the incidence of BCC was lowest for those living in the most deprived 
areas (IR 110.6, 95% CI: 106.8–114.7). Using our models, there 
appeared to be a linear effect of decreasing incidence of BCC with 
increasing levels of deprivation (p for trend < 0.001). We found that 
those living in the least deprived areas were 50% significantly more 
likely to have a BCC than those with the highest levels of deprivation 
(IRR 1.50, 95% CI: 1.44–1.56). Our models also show substantial 
difference in magnitude of the incidence of BCC between men and 
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women, where the IRRs for socioeconomic deprivation were higher in 
men than in women (Table 4.3).
  
 
8
5
 
 
Figure 4.2: Average change in incidence of BCC in the UK stratified age-groups (18-29, 30-39, 40-49, 50-64, 65-79 & 80+)  (THIN database) 
2004 – 2010. Grey shaded area represent 95% confidence intervals for the year-on-year change in incidence rates.
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Table 4.4: Crude and sex-specific age-standardised incidence rates of Basal cell carcinoma in the UK, by quintiles of 
Townsend deprivation index (THIN database 2004–2010) 
Deprivation index 1 2 3 4 5 Unknown 
Overall       
  Crude 222.5 (12,070) 203.2 (9,575) 162.1 (7,175) 131.7 (5,173) 110.7 (3,013) 115.6 (1,115) 
  EASRa 120.2 106.9 92.2 79.4 70.6 – 
  WASRb 82.1 72.7 62.4 53.5 47.2 – 
Men       
  Crude 246.7 (6,602) 220.8 (5,097) 169.7 (3,677) 134.3 (2,583) 106.0 (1,441) 119.0 (560) 
  EASR 137.5 122.0 104.7 90.4 77.4 – 
  WASR 92.3 81.5 69.6 59.7 50.9 – 
Women       
  Crude 198.9 (5,468) 186.2 (4,478) 154.7 (3,498) 129.2 (2,590) 115.3 (1,572) 112.4 (555) 
  EASR 105.7 94.9 83.1 71.9 66.2 – 
  WASR 73.2 65.7 57.1 49.2 44.7 – 
aEASR, European age-standardised rate. 
bWASR, World age-standardised rate. 
Incidence rates (per 100,000) 
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4.2.4 Discussion 
Our results indicate that the incidence rate of BCC is increasing in the 
general population, in particular amongst those aged 30 to 49 years. It 
shows that Wales and the southern parts of England have the highest 
recorded rates of skin BCC. For socioeconomic deprivation, incidence 
of BCC was consistently higher in the least deprived groups.  Based on 
our estimates (i.e. EASRs), they show that approximately 61,500 new 
cases of BCC are diagnosed annually in the UK population. Previous 
reports using EASRs have estimated that 53,000 cases of BCC were 
reported yearly using a cohort between 1996 and 2003,137 
comparatively; this represents an overall increase of 16% in diagnosis 
rates in the past decade.   
This study has several strengths; to our knowledge, it uses the largest 
sample size of incident cases of BCC compared to previous research 
conducted in the UK.136–141,143 Due to our large sample size means that 
our findings are unlikely to be due by chance. Also, the data was 
obtained from a national database and prospectively recorded by GPs, 
thus excluding the possibility of recording or recall bias in both our 
exposure and outcome. The major limitation is our inability to 
account for important factors such as history of sun exposure during 
childhood and adolescence (i.e. frequency of sunburns and overseas 
holidays),149,150 latitudinal position (i.e. proximity to the 
equator),132,151 settings of occupation (i.e. indoor, mixed or 
outdoor)152 and skin type (i.e. fair, white or freckled skin).136 In 
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addition, we were unable to classify adults according to subtypes of 
BCC (i.e. superficial, nodular or infiltrative). 
Our results for country-level incidence rates were consistent with 
previous studies showing escalating rates in England, Northern Ireland, 
Scotland and Wales.138–141 The most likely explanation for the rise in 
incidence may be linked to previous behaviour with regards to sun 
exposure during childhood or adolescence. Exposure to UV radiation 
during this stage plays a significant role in the future development of 
BCC. Previous studies have shown that subjects to have reported to 
travel frequently and spend more than 4 or 5 weeks (per year) at the 
beach before the age of 20 years were more likely to have developed 
the skin malignancy in their adulthood.149,150 Although we were unable 
to account for this factor, history of sun exposure through frequent 
holidays to sunnier places has been a strong predictor for BCC. 
Another likely explanation may be possibly due to UK’s aging 
population. BCC is highly prevalent in the older age groups; in our 
cohort, the number of cases diagnosed with the skin malignancy was 
consistently high among those aged 50+ years.  
We found a significant increase among those aged 30–39 and 40–49 
years. A previous study has shown similar findings, where the annual 
increase in incidence was estimated to be approximately 3.9% and 
5.2% for 30–39 and 40–49 years, respectively, although these estimates 
did not reach statistical significance.137 Interestingly, we found an 
increase among those aged 18–29 years is increasing, although our 
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models showed no statistical significance. The incidence of BCC in this 
particular age group have risen to approximately 5.2 per 100,000 
person-year in 2009 (Figure 4.2), which is consistent with escalating 
rates observed by others.142 
We observed especially high incidence in areas of South East Coast, 
South Central, South West and Wales. Compared to London, we found 
there were significant increases in the risk of developing BCC in these 
areas. This observation may be linked to several environment factors. 
The most prominent is the latitudinal position of a location.132,151 
Areas in proximity to the equator, but situated in the temperate zone 
usually experience prolonged duration of sunlight in the summer 
season. In the UK, the hours of sunshine normally last longer in the 
south than the northern regions of UK, especially during the summer 
season, the southern parts of England and Wales are usually known to 
receive the greatest hours of annual sunshine.153  
Our findings for socioeconomic deprivation showed that the incidence 
was high among the least deprived groups, and that the risks for BCC 
tends to decrease as the level of deprivation increased. Our results 
are consistent with previous studies conducted in the UK and 
Netherlands.136,144 It is interesting to note the wide difference in 
incidence of BCC between the least and most deprived groups which 
may be an indication that socioeconomic status or deprivation is risk 
factor for BCC. This observation may be linked to higher levels of 
income for frequent holidays overseas to sunnier places, thereby 
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exposing the skin to sunlight, or having available funds for pursuing 
other lifestyle habits which are risk factors for BCC, for instance, the 
frequent use of tanning beds131–133 or consumption of alcohol.154 
Interestingly, we also observed that the incidences differ substantially 
between sexes, perhaps, this may possibly be due to differences in 
behaviour in terms of sun exposure, clothing habits and tanning 
behaviour.136,144 
BCC is an increasingly important health problem in the UK, with 
extremely high levels observed in the least deprived groups, and in 
the southern parts of the UK. Due to the multi-factorial nature of 
BCC, further work is warranted to identify causes, as well as, 
investigate the detailed reasons of these findings. Our results 
demonstrate that the incidence of BCC will continue to rise much 
higher in all age bands if it remains unchecked, which will have a 
significant impact on the workload and costs for health services. 
Better strategies are required to inform the public of the risk factors 
associated with the skin malignancy, as well as, which preventive 
measures can be implemented to avoid future development of BCC. 
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4.3 Potential exposure to soil arsenic and risk of Basal cell 
carcinoma in UK 
4.3.1 Background 
Arsenic is well-known for its notoriety as a result of its presence in 
groundwater which has led to widespread contamination of drinking 
water in more than 70 countries throughout the world, including the 
USA, some parts of Eastern Europe and Bangladesh.47,56 Arsenic is an 
environmentally persistent element which is found naturally occurring 
in soil and groundwater.19 The primary pathways for exposure for 
arsenic are inhalation and ingestion of particulate matter that are 
transported from the earth (or soil) to the atmosphere as a result of 
anthropogenic activities or wind erosion, ingestion of contaminated 
foods or drinking water obtained from contaminated areas, and 
through direct contact with the skin.32,33,155 
Arsenic is a recognised carcinogen shown to be linked with several 
types of cancers.48,156,157 The most prominent are the effects of 
arsenic on the risk of BCC and SCC.87,158–160 Epidemiological studies 
have been documented extensively, and focused on populations 
exposed through drinking water emerging from arsenic-contaminated 
underground aquifers.47,56 However, there has been little or no focus 
on the potential health impacts of arsenic emerging from lithological 
sources, in particular soils, due to the belief that exposures at 
environmental concentrations are low and insufficient to have an 
effect.15,76  
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It has been implied that the potential mechanism for cancer 
development in consequence of geochemical arsenic exposures from 
topsoil are somewhat similar to those which apply to exposures from 
occupational settings, except that the processes are ongoing and long-
term.1,2,13 The individual is exposed to arsenic emerging from the 
environment (soils) via the primary pathways; continued exposure 
eventually leads to accumulation of such toxicants which are broken 
down to metabolites causing toxicity to the body which, in turn, have 
genotoxic effects on various tissues such as the lungs, kidney or skin 
thereby resulting in significant DNA damage which leads to cancer.38 
In the UK, there are widespread areas with elevated concentrations of 
arsenic, with specific geologic formations yielding especially high 
concentrations in some areas of England and Wales.161–163 These 
increased concentrations resulted mainly from the extensive mining 
activities that took place before the 1970s, and also due to natural 
lithological processes occurring in soils such as mineralisation and rock 
formation.161 DEFRA have provided screening values known as the 
C4SLs for assessing soil safety for arsenic, and recommends 
concentration levels in residential soils should not exceed 35 mg/kg.71 
However, there are residential soils in many urban and rural areas of 
England and Wales with arsenic concentrations exceeding 100 
mg/kg;164 whether this kind of long-term exposure for people living on 
soils with elevated arsenic concentration is contributory to the BCC 
incidence in UK remains unclear. A small number of studies have 
found concentrations of soil arsenic in the environment to correlate 
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with biomarkers of exposure (urine, hair and toe or fingernail 
samples),27,31,92, and that these biomarkers are, in turn, a proxy 
measurements for increased risk of skin cancer.30,158 
To our knowledge, there has been no research directly examining the 
relationships between geochemical arsenic exposure, at typical and 
widespread environmental concentrations, and BCC risk in the UK. 
Thus, the aim of the study was to quantify the risk of BCC with 
increasing soil arsenic concentration through applying specified cut-
off values which included the UKs C4SLs for soil arsenic using a 
population based cohort. 
4.3.2 Methods 
4.3.2.1 Geochemical soil arsenic data 
The geochemical data used for this population based cohort study 
were derived from the BGSs G-BASE database,113,165 and from the NSI-
XRFS project which have been re-analysed to extend the number of 
elements and upgrade the analytical quality to match the G-BASE 
data.53,166 Based on a systematic grid across England and Wales using 
the British Ordnance Scale (OS) of 1:25,000. Soil samples were 
collected at different densities depending on the type of environment 
at a fixed time point. For G-BASE rural areas, suitable sampling points 
(or sites) were identified at a density of 1 per 2km2 alternate-grid 
across England and Wales, while sample points from G-BASE urban 
areas were chosen at a density of 1 per 0.25km2. Most of G-BASE data 
 94 
 
were concentrated in the eastern and central parts of England with 
additional samples from the Tamar catchment of South England. 
Existing data from the NSI collected at a density of 1 per 25km2 was 
re-analysed by the BGS, and was augmented with the G-BASE database 
to achieve completeness of coverage (Figure 3.1).  
For the G-BASE samples, a composite of five soil samples was taken 
from the topsoil at each location, at a depth of 2–15cm using the 
augur flights. For NSI samples, 25 cores of soil were taken at the 
nodes of a 4m grid within a 20m by 20m square centred on each OS 5-
km grid point across England and Wales. The aggregated soil materials 
were analysed using x-ray fluorescence spectrometry (XRFS) to detect 
the geochemical composition, and measure the concentration levels 
for arsenic present in soil. The measurements for soil arsenic were 
spatially referenced, and loaded into ArcGIS desktop 10.3 (ESRI, 
Redlands, California, USA) to create an interpolated surface map for 
arsenic so as to derive estimates at finer resolution (at a patient 
postcode level). These estimates were uniquely linked to the primary 
care electronic medical records (EMRs) of eight million individuals 
throughout England and Wales. Each individual was registered at a one 
of 377 GPs contributing to The Health Improvement Network database 
(THIN) that agreed to participate in the linkage project.119 
4.3.2.2 Study design 
The population based cohort study was between the period of 1st 
January, 2004, and 31st December, 2011. Participants were extracted 
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from the linked database (from GPs contributing to THIN with G-BASE 
coverage) if they were registered with a GP for at least one year 
before 1st January, 2004, and if their GP has an AMR date before the 
1st January 2004. The overall selection criterion for participants was 
they must be at least the age of 18 years or above without any 
previous history of any cancer diagnosis before the start date of the 
study. 
4.3.2.3 Case definition for Basal cell carcinoma 
The case definition for BCC at follow-up was based on our previously 
validated code list for THIN.107,145 Cases were excluded if they have 
history (or any recurrent form) of NMSCs or malignant melanoma 
cancer prior to the start date, or during the follow-up period of the 
cohort study. Patients found with Basal cell nevus syndrome (or 
Gorlin’s syndrome), organoid naevi or other BCC-related genetic 
disease were also excluded from the study population. Patients that 
experienced the outcome between the time periods were right-
censored at the date of their initial BCC recording in THIN. 
Participants with a death record within the duration of the study were 
censored right, at the recorded death date. Those with no failures 
throughout the time course of the study were automatically right-
censored on the 31st December 2011. 
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4.3.2.4 Exposure and confounding variables 
Soil concentration levels for arsenic were classified in four major 
groups using the UK C4SL 35 mg/kg,71 where soil levels up to half the 
C4SL (18.0 mg/kg) were classified as the lowest exposure (group I, 
referent exposure); soil levels between half & up to the C4SL (18.0-
34.9 mg/kg) were group II; soils levels that were 1-2 times the C4SL 
(35.0-69.9 mg/kg) were  group III, and concentrations that were 2 
times (and beyond) the C4SL (≥ 70 mg/kg) were classed as the highest 
exposure (group IV).  
Potential confounding variables included the age (at baseline), 
gender, socioeconomic deprivation (i.e. Townsend index categorised 
as quintiles) status of the participants and lifetime sunlight exposure. 
The monthly data on the total duration of bright sunlight hours 
spanning from the 1890s to 2013 was obtained from 35 UK 
Meteorological Office (Met Office) climate stations that were based in 
several locations across England and Wales.167 Sunlight data from 
climate stations that was specific to SHA and Wales were aggregated 
to derive monthly daylight averages at a English SHA, and Welsh-level. 
These monthly daylight averages were used as a proxy to quantify the 
cumulative sunlight exposure for each participant from their date of 
birth, and up to the baseline (or start date) of the cohort study. Soil 
concentration of iron and phosphorus (in mg/kg) was included as 
environmental confounders, as these were elements are known to 
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influence the geochemical distribution of arsenic in soil, and it’s 
presence edible plants. 
4.3.2.5 Statistical analysis 
Univariable Cox regression analysis was used to compute the crude 
association between BCC and increasing levels of soil arsenic, while a 
multivariable Cox regression model was used to allow for confounding 
variables. A stratified analysis was conducted to assess the impact by 
type of residential setting (urban, suburban or rural) to determine 
whether associations between arsenic exposure and BCC were 
significantly modified.  
The results were presented as Hazard ratios (HR) with 95% confidence 
intervals (CI), where statistical significance was determined by p-
values of 0.05 or less. P-value for linear trend was derived to assess 
whether patterns of dose relationships were significant. The chosen 
method for testing the proportional hazards assumption was the 
Schoenfeld’s residual, which provided p-values for the global model 
and exposure categories vs. referent group (i.e. for any variable) to 
assess whether there was non-proportionality in the overall model fit 
and exposure groups, respectively.  
In the case where a variable (or category) is in violation of the 
proportional hazards assumption, we used Aalen plots as a visual 
diagnostic tool to identify the time points where the hazard function 
changed significantly so as to impose cut points on those changes in 
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order to create interval specific variables (or categories), and refit 
them into the regression model. The advantage of using this 
procedure eliminates the time-vary artefact present in the data.168 All 
statistical analyses were carried out using Stata/MP 12.0 (Stata 
Corporation, College Station, Texas, US). 
4.3.3 Results 
4.3.3.1 Descriptive results of study population  
The study was based on a prospective UK cohort of 1,812,372 persons 
in the English and Welsh areas. The total follow-up time in our study 
population between 2004 and 2011 was 13.7 million years. Among the 
participants, 28,783 developed BCC with an average duration of 
follow-up time of 3.97 years (SE: 0.013, median: 3.92 years, IQR: 
1.97–5.94). Demographic characteristics of the cohort population are 
presented in (Table 4.5). The proportion of men was greater among 
those with BCC than for those without. Participants developing BCC 
were more likely to be in the older age groups and from the least 
deprived groups (Group I: 35.2%; Group II: 25.6%). 
The overall median was 16.0 mg/kg (IQR: 11.6-20.0 mg/kg) and the 
maximum observed exposure amongst participants was 1039.2 mg/kg. 
Approximately 96% of the study population have soil arsenic 
concentration below the C4SL value (35.0 mg/kg). Only 1.0% of the 
population have soil arsenic concentrations exceeding 70.0 mg/kg. 
The median residential soil arsenic concentration was 14.9 mg/kg 
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among BCC cases and 15.6 mg/kg among those without BCC. Visual 
comparisons of outcome do not show any stark difference (Figure 4.3). 
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Table 4.5: Baseline demographic characteristics of the study population, using The Health Improvement Network (THIN) 
database from 2004 to 2011 
Characteristics Without BCC 
(N1 = 1,783,589) 
 With BCC 
(N2 = 28,783) 
 Total 
(N =1,812,372) 
          
n1 %  n2 %  N % 
         
Sex 
  
 
  
 
 
 
  Male 878,768 49.3  15,058 52.3  893,826 49.3 
  Female 904,821 50.7  13,725 47.7  918,546 50.7 
Age group 
  
 
  
 
 
 
  18-29 288,533 16.2  134 0.5  288,667 15.9 
  30-39 352,712 19.8  899 3.1  353,611 19.5 
  40-49 347,099 19.5  2,409 8.4  349,508 19.3 
  50-59 310,579 17.4  5,302 18.4  315,881 17.4 
  60-69 224,946 12.6  7,586 26.4  232,532 12.8 
  70-79 159,263 8.9  7,975 27.7  167,238 9.2 
  80+ 100,457 5.6  4,478 15.6  104,935 5.8 
Socioeconomic deprivation 
  
 
  
 
 
 
  1st (least deprived) 502,316 28.2  10,143 35.2  512,459 28.3 
  2nd 393,881 22.1  7,363 25.6  401,244 22.1 
  3rd 361,753 20.3  5,354 18.6  367,107 20.3 
  4th 310,608 17.4  3,749 13.0  314,357 17.3 
  5th (most deprived) 200,396 11.2  1,971 6.8  202,367 11.2 
  Unknown 14,635 0.8  203 0.7  14,838 0.8 
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Residence classification 
  
 
  
 
 
 
  Urban 1,422,102 79.7  21,723 75.5  1,443,825 79.7 
  Suburban 210,428 11.8  4,232 14.7  214,660 11.8 
  Rural 137,184 7.7  2,660 9.2  139,844 7.7 
  Unknown 13,875 0.8  168 0.6  14,043 0.8 
SHA 
  
 
  
 
 
 
  London 228,984 12.8  2,577 9.0  231,561 12.8 
  East Midlands 57,273 3.2  915 3.2  58,188 3.2 
  East England 134,315 7.5  2,107 7.3  136,422 7.5 
  West Midlands 205,640 11.5  2,885 10.0  208,525 11.5 
  North East 59,602 3.3  1,017 3.5  60,619 3.3 
  North West 219,276 12.3  3,254 11.3  222,530 12.3 
  Yorkshire Humber 40,558 2.3  592 2.1  41,150 2.3 
  South Central 284,786 16.0  5,212 18.1  289,998 16.0 
  South East 225,137 12.6  4,004 13.9  229,141 12.6 
  South West 195,500 11.0  3,811 13.2  199,311 11.0 
  Wales 132,518 7.4  2,409 8.4  134,927 7.4 
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Figure 4.3: Joint histograms plotted on the same axes to show the observed distribution (proportion) of participants registered to practices contributing to THIN 
their soil arsenic concentration levels. Upper-light grey histogram corresponds to BCC patients; lower-dark grey histogram corresponds to controls. The lower and 
upper dashed bars were used to mark off soil arsenic concentrations levels at points 18.0 mg/kg and 70.0 mg/kg, respectively. The solid bar corresponds to the 
current UK C4SL for soil arsenic (35.0 mg/kg) 
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4.3.3.2 Multivariable Cox regression analysis 
Results from unadjusted analyses found evidence of a J-shaped 
relationship where the lowest risk of developing a BCC was in 
participants living in areas with arsenic concentrations between 18.0 
and 35.0 mg/kg (HR 0.82, 95% CI: 0.81–0.85). The hazard for 
developing BCC was similar between those living in areas with arsenic 
concentrations between 35.0 and 70.0 mg/kg and the reference group 
(< 18.0 mg/kg). However, we found that those living on residential 
soils with exposure levels above 70.0 mg/kg had a significant 
increased risk of developing BCC (HR 1.08, 95% CI: 1.01–1.17) (Table 
4.6).  
After including adjustments for confounding, a clearer pattern 
emerged (p-value for trend < 0.01) where participants with residential 
exposures between 35.0 and 70.0 mg/kg and greater than 70.0 mg/kg 
had a 9% and 20% significant increased hazards of developing BCC, 
respectively (35–70 mg/kg: HR 1.09, 95% CI: 1.04–1.16; > 70.0 mg/kg: 
HR 1.20, 95% CI: 1.09–1.32), compared with those living in areas with 
arsenic concentrations < 18.0 mg/kg (Table 4.6). 
4.3.3.3 Stratified analysis based on residential settings 
The pattern of BCC risk in relation to the four soil arsenic exposure 
categories differed substantially across urban, suburban and rural 
residents (Figure 4.4). Urban residents with the highest exposure of 
arsenic (≥ 70 mg/kg) were the only group to have a significant 
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increase in risk of BCC (HR 1.18, 95% CI: 1.06–1.36). The pattern of 
association amongst urban residents indicates a significant positive 
trend across urban exposure groups (p < 0.001). Even though there 
appears to be positive dose-response relationship between increasing 
levels of arsenic exposure and the risk of BCC in suburban residents, 
our trends test indicates that such linear patterns were not significant 
(p = 0.06), and individual comparisons for exposures in suburban areas 
were not significant at the 5% level. There was no evidence of an 
effect of arsenic concentrations on the development of BCC for rural 
residents. 
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Table 4.6: Using Cox regression model to estimate hazard ratios (HR) for BCC in association with potential exposure to soil 
arsenic, using THIN linked G-BASE database from 2004 to 2011 
Cox regression model  Unadjusted1 Adjusted2 
  Hazard ratio 95% CI  Hazard ratio 95% CI  
        
Arsenic (As) (mg/kg)        
As < 18.0 mg kg-1  1.00 referent  1.00 referent  
18.0 ≤ As < 35.0 mg/kg  0.82 (0.81–0.85)  0.96 (0.96–1.00)  
35.0 ≤ As < 70.0 mg/kg  0.99 (0.95–1.04)  1.08 (1.02–1.14)  
As ≥ 70.0 mg/kg  1.08 (1.00–1.17)  1.17 (1.09–1.28)  
        
  p-value for trend3  -  p < 0.001  
1 Proportion hazards (PH) assumption test was based on Schoenfeld residuals – using the overall global test, we find no evidence 
that our specification for arsenic violates the PH assumption (p=0.87). A category-by-category test shows no violation of the PH 
assumption: category 2 vs. category 1 (p=0.93), category 3 vs. category 1 (p=0.43) and category 4 vs. category 1 (p=0.89)    
2 Adjusted for age at baseline, gender, lifetime sunlight exposure (hours) prior to start date, socioeconomic deprivation (quintiles 
of Townsend index), soil concentration levels of iron (mg/kg) and phosphorus (mg/kg) 
3 Orthogonal polynomial contrasts were fitted to test for significant linear trends across exposure categories. Parameter 
estimates for the unadjusted model shows both a significant linear and non-linear trend indicating a more complex pattern.  
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Figure 4.4: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified 
Cox regression model based on residential classification to show the association between BCC risk and soil arsenic. Models 
were adjusted for sex, age group, cumulative sunlight exposure, socioeconomic deprivation, soil concentrations for iron 
and phosphorus.
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4.3.4 Discussion 
This is the first study to use a UK-based population cohort to assess 
the effect of soil arsenic levels and the development of BCC. Our 
findings show evidence of an increased risk for BCC in association with 
potential exposure to soil arsenic. We found that residents living in 
areas with soil arsenic concentration above the current UKs 2014 
provisional category for screening levels (C4SL) (As ≥ 35.0 mg/kg) 
have approximately 9.0% (35.0–70.0 mg/kg) and 20.0% (> 70.0 mg/kg) 
increased risk of BCC. We also found that elevated risk appeared to be 
confined to residents with the highest exposure in urban settings. 
By adopting a population-based retrospective cohort design and using 
the THIN database, we believe that we minimised the potential for 
selection bias. We extracted incident records of BCC that were 
recorded in THIN by the time this study was being conducted. 
Selection bias is not a major concern as we attempted to use the 
entire cohort of eligible patients in the THIN-GBASE, we have a clearly 
defined inclusion and exclusion criteria that limits our sample of 
interests to adults (aged 18 years and above) registered at a GP 
practice at least 1-year before start date of study (i.e. January 1st, 
2004), who have measurements for soil arsenic. However, a source of 
selection bias can arise from the way we had chosen the study 
periods, since we are only observing incident cases of BCC that have 
occurred after the beginning of 2004. We must acknowledge, the 
study periods in which the participants were observed retrospectively 
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was short (2004-2011). We chose this date because of its significance, 
which marks the introduction of the Quality and Outcomes Framework 
(QOF) which encourages GPs to record all new cases of clinical 
outcomes (including cancers and non-melanoma) when they are 
examined. 
In terms of completeness, the BCC records used for this study are 
from a reliable source. We know from previous studies that all BCC 
patients were referred to hospitals or dermatology clinics, with 93.0% 
diagnosis of BCCs being confirmed either by letters from hospitals or 
histological (or pathology) reports.107 Although BCC records are not 
defined according to the different subtypes of BCC (superficial, 
nodular or infiltrative); however, validation studies for THIN have 
confirmed that recordings (as well as the medical read codes) for BCC 
in THIN are complete and sufficiently accurate for medical 
research.105,107 The only issue that was beyond our ability to account 
for was the differences in terms of BCC ascertainment rates at a GP-
level across England and Wales, which may introduce some bias in the 
effects detected for arsenic, if BCC ascertainment rates at a practice-
level are associated with geographical variation in soil arsenic 
exposure.169 Although, we attempted to control for this with the 
inclusion of the Strategic Health Authorities’ variable; however, a 
proficient adjustment would have been such of the inclusion of a 
performance indicator at a practice-level measured as a proxy for 
denoting how well practices tend to record clinical outcomes; 
however, this information is seldom available in THIN. 
 109 
 
The linkage between THIN and G-BASE has been validated to ensure 
that the soil arsenic concentration levels for the observed distribution 
of patients in THIN are representative of the general UK population.119 
By modelling the hazards of soil arsenic using a multivariable, and 
stratified Cox regression, we were able to take into account the 
implicit time factor that exists for participants in terms of their 
potential exposure to soil arsenic from the beginning of the study 
period until BCC development. Additionally, we attempted to reduce 
the effects of confounding by adjusting for meaningful covariates such 
as the inclusion of sunlight data as a proxy for UV-exposure. Due to 
the paucity of appropriate UV-exposure indicators in THIN, we 
therefore obtained area-level monthly sunshine data (in hours) from 
the UK meteorological office167 to quantify a person’s cumulative 
sunlight exposure. While, it is correct to adjust for sunlight; however, 
we must acknowledge that these estimates are not as robust as they 
do not account for: .1) the actual time spent outside in the sun by an 
individual, .2) the surface area of a body exposed to sunlight, and .3) 
individual behaviour (e.g. holiday habits etc.).130,149,152,170 The 
estimates quantified were based on area-level measurements, and 
therefore, this may introduce ecological bias in our risk assessment.      
The major limitation to this study was our inability to use in our 
analysis the exact location of a patient where their soil concentration 
samples for arsenic were determined, due to ethical implications. A 
recent study has shown using G–BASE data, spatially, the locations (As-
domains) for where arsenic are naturally mineralised, and where they 
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are highly concentrated due to the presence of ironstone and 
phosphorus – these As–domains are specifically located in major areas 
of North West, South West and parts of central regions of England, 
and southern Wales.161,163 The background concentrations for topsoil in 
those environments exceed the 2014 C4SL for soil arsenic.71,164 It could 
be possible that the observed risk found in this study might be related 
to exposures within those specified As–domains; however, it is 
difficult to determine whether this assertion is true because we were 
unable to cluster participants according to those As–domains. To 
verify this claim, a new cohort study would be needed as currently the 
data is not available in our linked database. Our inability to account 
for important factors such as occupational settings;33,156 household 
measurements of arsenic from drinking water;87,160 and other 
biomarkers for long-term exposures (finger nails, toenails and 
hair),27,31 as well as not being able to adjust for the amounts of 
arsenic that can be potentially ingested via the digestive tract (which 
can be calculated with an exposure assessment model) may give rise 
to residual confounding in our analysis. 
From a spatial epidemiologic point of view, another major limitation 
was our inability to utilise the following data in our analysis: 1.) 
Information related to a patient’s addresses; 2.) the location of 
general practices he/she attended; and 3.) the georeferenced 
sampling points for the soil samples that were collected at different 
densities. We mentioned earlier that this was a limitation due ethical 
and legal implications outlined by THIN. The geospatial details of 
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patients were anonymised, and therefore, we could not utilise this 
data to ascertain the distribution of participants that fall within, or on 
to a sampling point; let alone, determine the distribution of those 
that lived on soils classified as either G-BASE urban, G-BASE rural, or 
NSI(XRFS) areas. If this information were available, we could have 
stratified the population at risk of BCC in accordance to these three 
zones. We attempted to rectify this issue of differentiating 
participants that lived on urban and rural terrain (i.e. G-BASE urban, 
rural and NSI(XRFS)) by using a stratified Cox regression analyses 
based on the type of residential setting indicators recorded in THIN, 
to minimise the possibility of information bias that may affect our risk 
estimates for BCC because of the systematic differences in potential 
exposure to arsenic due to the samples being collected at densities. 
Our study showed those in the higher exposure groups (35.0-70.0 
mg/kg and above 70.0 mg/kg) significantly had an increased risk of 
BCC. Similar findings were established in other studies for skin cancer 
(i.e. melanoma and NMSCs) although the risks were quantified using 
different sources or biomarkers for exposure, as well as different cell-
types for skin cancer.30,158,160 For instance, previous findings in 
Hungary, Romania and Slovakia found a significant association for BCC 
and exposure to arsenic through drinking water with concentration at 
modest levels.160 The most likely explanation for our overall findings 
could be attributed to the fact that elevated levels of arsenic in the 
soil tends to positively correlate with other environments 
(groundwater, drinking–water and air quality) giving rise to multiple 
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pathways for exposure. The long-term exposure (directly or indirectly) 
to such environmental concentrations could possibly ensure continued 
absorption of arsenic into the body, which will eventually cause to 
some degree genotoxic effects leading to BCC development. 
The results from our subgroup analysis defined by residential 
classification suggested that the elevated risks of BCC in relation to 
higher soil arsenic exposures were confined to urban residents. An 
explanation for this may be related to the relative mobility of arsenic 
in soils from different environments. Recent studies have shown that 
urban soils had higher bioaccessibility than rural soils (the fraction of 
arsenic released from the soil into solution in the gastro-intestinal 
tract in a form that can potentially be absorbed into the 
bloodstream).21 The bioaccessible fraction in urban domains was 19-
28% compared to 5-9% in rural domains which are dominated by 
naturally occurring arsenic. Another explanation could be that urban 
environments have higher arsenic concentrations than rural 
environments due to anthropogenic contamination. Another study, 
however, has clearly shown that naturally occurring arsenic derived 
from geogenic mineralisation and from underlying ironstone 
formations found in rural locations were typically an order of 
magnitude higher than those found in the urban domain.161 
The most significant relationship with BCC risk was found in urban 
residents with arsenic exposures of 70 mg/kg and above. Our findings 
indicate that potential exposures are may be important risk factors, 
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and must be taken to under consideration in the investigation of 
cancer aetiology. These results warrant further investigations, but 
nevertheless, it is important to minimise human exposure to arsenic, 
especially for those emerging from lithological sources such as topsoil. 
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5 Summary 
Lung cancer is one of the deadliest forms of malignancies in the UK. It 
is the third most common type of cancer in the UK. Lung cancer has a 
plethora of risk factors – an individual’s risk of developing the 
malignancy depends mostly on the advancement of age, genetics and 
family history of cancer. However, avoidable lifestyle factors such as 
smoking, certain occupational exposures and ionising radiation are the 
biggest causes of lung cancer in the UK. Metallic elements such as 
arsenic, chromium and aluminium, as well as radioactive elements 
such uranium and radon have been linked to lung cancer. These are 
typical examples of elements that are naturally occurring in soils and 
remain ubiquitous in our environment; however, little is known of the 
health impacts of such soil exposure to most of these elements on 
lung cancer incidence in the UK.  
The goal of this chapter is address this gap in knowledge by using a 
two-stage process to conduct the following: (1) using data mining to 
determine which group of soil metals are the best predictors of lung 
cancer, and (2) using a population-based cohort design for quantifying 
the effect size for lung cancer risk for individuals living in a 
residential area with high concentration levels for the selected soil 
elements. 
All patients with a first diagnosis of lung cancer between 1-January-
2004 and 31-December-2014, including their X-ray fluorescence 
spectroscopic measurements for total concentration levels of all soil 
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elements in THIN-GBASE were extracted. The correlation-based filter 
selection was the chosen data mining method to determine which 
restricted group of soil elements were highly corrected with lung 
cancer. Two multivariable Cox regression models were used to 
determine the association between the subset of selected elements 
and lung cancer. Model one, termed as mutually adjusted model, 
consists of only subset of elements found from the data mining 
analysis. Model two is the corrected version which includes 
confounding variables such as age, gender, smoking status and 
socioeconomic deprivation. Additionally, a stratified analysis was 
carried out to assess the impact by type of residential setting (urban, 
suburban and rural). 
1,823,312 participants with complete soil concentration estimates for 
all 15 elements were extracted for THIN-GBASE database. Of these 
10,740 (0.6%) participants developed lung cancer (median survival 
time 4.8 years, IQR: 2.4 – 7.3 years). The correlation-based filter 
selection data mining identified aluminium [median 51,400 mg/kg, 
IQR: 40,500-59,300mg/kg (max = 116,700 mg/kg)], lead [median 72.0 
mg/kg, IQR: 47.0-158.0 mg/kg (max = 3,045 mg/kg)] and uranium 
[median 1.98 mg/kg, IQR: 1.58-2.40 mg/kg (max = 61.7 mg/kg)] as the 
most appropriate subset of soil elements to be modelled as risk 
factors for lung cancer with an error rate of selection = 1.47%. 
The mutually adjusted model has shown that the risk of developing 
lung cancer was significantly among individuals living in areas with 
 117 
 
elevated soil concentrations for aluminium (47,200-54,700 mg/kg: HR 
1.21, 95% CI: 1.13-1.29; 54,700-61,600 mg/kg: HR 1.19, 95% CI: 1.11-
1.28; and ≥ 61,600 mg/kg: HR 1.18, 95% CI: 1.09-1.27), lead (60.0-
95.0: HR 1.12, 95% CI: 1.06-1.20; 95.0-184.0 mg/kg: HR 1.11, 95% CI: 
1.04-1.18) and uranium (≥ 2.50 mg/kg: HR 1.13, 95% CI: 1.05-1.21). 
For the corrected model, the patterns of association were maintained 
for medium exposure groups for aluminium (47,200-54,700 mg/kg: HR 
1.09, 95% CI: 1.02-1.17; and 54,700-61,600 mg/kg: HR 1.10, 95% CI: 
1.02-1.18) while there were marginal reductions in risk for lead (60.0-
95.0: HR 1.12, 95% CI: 1.06-1.19; 95.0-184.0 mg/kg: HR 1.08, 95% CI: 
1.01-1.15). However, the observed risks (i.e. initial model) were 
abrogated for those living in areas with highest concentrations of 
aluminium (≥ 61,600 mg/kg: HR 1.06, 95% CI: 0.98-1.15) and uranium 
(≥ 2.50 mg/kg: HR 1.05, 95% CI: 0.97-1.13). The risk of lung cancer 
was only isolated to urban residents on residential soil with aluminium 
concentrations above 47,200 mg/kg. 
Conclusion: There was not enough evidence to conclude that soil 
uranium and lead were associated with lung cancer due to the 
ambiguous patterns found in both mutually adjusted and corrected 
model. However, this study suggests that residents living on soil with 
aluminium greater than 47,200 mg/kg have a higher risk of developing 
lung cancer, and such risks are confined to urban residential areas. 
Further research is required to firmly establish this apparent 
association.   
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5.1 Background 
Lung cancer in humans refers to a group of malignant neoplasms that 
develop within the air passages (trachea, bronchi or bronchial 
branches) of the respiratory tract and internal regions of the right 
lung (upper, middle & lower lobe) or left lung (upper or middle lobe, 
and lingula).171–173 Lung cancer is classified according to the type of 
cells in which the tumour originates: small cell lung carcinoma (SCLC) 
and non-small cell lung carcinoma (NSCLC). SCLCs are miniature 
tumours with growth patterns of a sporadic nature, which can 
potentially to spread to other vital organs giving rise to secondary 
tumours. NSCLCs usually grow into a single large and dense tumour 
which can potentially create blockages limiting gaseous exchange. The 
common types of NSCLCs are squamous cell carcinoma (SCC), 
adenocarcinoma and large cell carcinoma (LCC).171–173  
Lung cancer is a global health problem; where approximately 1.82 
million lung cancers were diagnosed globally in 2012.174–176 
Additionally, lung cancers are the most prevalent type of solid cancer 
(12.9% of all solid cancers), possibly due to it being caused by several 
risk factors which work together in a multifactorial manner. Globally, 
lung cancer has higher mortality rates than any other solid cancer 
equating approximately 1.6 million per year in 2012; the high 
mortality rate is due to it being difficult to treat, and the majority of 
patients are often diagnosed late.174–176 
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The innate aetiological factors which increase the risk of developing 
lung cancer include the advancement of age, heredity and biological 
factors at cellular levels typically influenced by the functional decline 
of the lungs.171,174,176 However, the biggest risk factor for lung cancer 
is lifestyle-related - the most significant is the inhalation of tobacco 
smoke (chiefly from cigarettes, but also pipes and cigars).171,174,176 The 
most established environmental factor is attributed to long-term 
exposure to high levels of environmental radon that have emerged for 
soil and diffused to indoor environments177–180 - the World Health 
Organisation (WHO) have labelled radon as the second most important 
cause of lung cancer after smoking.181 
In the context of environmental exposure to soil metallic elements – 
there are limited studies directly examining potential association 
between metallic elements (including arsenic, chromium, nickel, 
uranium, lead and zinc) that emerge from soil and lung cancer, 
particularly in relation to exposure of low-dose or low-level soil 
metallic elements. The purpose of this chapter is to establish a 
plausible explanation for the attribution of soil metals and how they 
may cause lung cancer, before carrying out a two-stage approach 
using data mining and a population-based cohort study to explore 
their association.      
5.2 Soil elements and lung cancer incidence in the UK 
The most important and likely exposure route to consider is the 
inhalation of soil particulates through the respiratory system. The vast 
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majority of particulates that are airborne are composed of elemental 
constituents, and while there are various sources, the significant 
amount of particulates that are ambient originate from soil through 
diffusion, wind erosion and soil disturbances due to anthropogenic 
processes.4 Pollution-based studies have quantified the mass 
contributions of various sources that give rise to airborne particulates 
and have analysed their constituents,182–184 while a few 
epidemiological studies have identified associations between lung 
cancer and concentrations of inhalable particulate matter. The former 
had shown that soils were the largest contributor to most particulates 
that were ambient compared to other mediums (traffic, motor 
vehicles and industries). The latter have established that elevated 
concentration levels of ambient particulates (with their elemental 
constituents) have a modest association with increased incidence of 
lung cancer.185,186 
Thus, this establishes a plausible mechanistic framework for linking 
soils with lung cancer, by showing how soils, air particulates and 
cancer are states related to one another (Figure 5.1). 
  
1
2
1
 
 
Figure 5.1: Diagram depicting a plausible mechanistic framework for causal pathway for lung cancer in relation soil 
elements 
Proxy 
measure 
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Lung cancer in the UK is currently a pressing public health issue. It is 
the second most common type of malignancy diagnosed in the primary 
health care followed after breast cancer.187 A recent study using the 
THIN database had indicated that the overall incidence of lung cancer 
was estimated as 41.4 per 100,000 person-years.188 It has suggested 
that the incidence of lung cancer in the UK will increase by 4.0% for 
every three-year periods.188 According to Cancer Research UK 89.0% of 
lung cancer cases occurring in the UK are strongly related to major 
modifiable lifestyle factors – mainly smoking – while they are 
convinced that 11.0% of the remaining cases are caused by 
environmental and occupational factors such as exposure to arsenic 
(and inorganic arsenic compounds); production of aluminium, iron and 
steel; chromium (VI) compounds; and outdoor air pollution (& 
particulate matter).187 In the context of soil metal exposure in 
relation to lung cancer - the literature is limited. 
Currently, there have been two studies that strictly considered 
examining the associations between low-level exposure to soil metals 
and risk of lung cancer. The first study was conducted in Taiwan 
which found that elevated chromium concentrations in soil were 
associated with increased incidence of SCC;157 while nickel and zinc 
were found to be positively associated with both adenocarcinoma and 
SCC.157 The other study was performed in Northern Ireland, which has 
shown that elevated levels for the total arsenic content in soil has a 
positive correlation with lung cancer incidence – estimated at a ward-
level.189 However, what these two studies have in common is that 
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their study design utilises an ecological framework. By virtue of the 
fact that the soil exposure in these studies were aggregated at a 
ward-level (or geographical unit) makes them prone to ecological 
fallacy. Thus, the individual-level association and the relative 
contribution of concentration levels of soil elements on lung cancer 
remain unclear.            
Therefore, the purpose of this chapter is to address this research gap. 
By using the THIN-GBASE database, we used series of epidemiological 
analysis using a two-stage approach to assess the impact of soil 
metallic elements on lung cancer risk. 
5.3 Methods 
5.3.1 Study design 
A 2-stage process was used to determine which of the 15 soil elements 
within the linked database were associated with lung cancer. The 
initial process involved the usage of data mining techniques as an 
exploratory exercise to find which of the element(s) (or best subset of 
elements) were predictive of lung cancer. The next stage used a 
population-based cohort design for the purpose of quantifying the 
effect size for lung cancer risk for individuals living in a residential 
area with high concentration levels for the selected soil elements. 
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5.3.2 Study population 
5.3.2.1 Case definition for lung cancer 
The case definition for lung cancer patients was any form of malignant 
neoplasm found in the internal sites of the respiratory tract (i.e. 
trachea, bronchi and lung). In THIN, lung-related neoplasms are coded 
mainly as site-specific cancers rather than cell-specific (i.e. SCLCs or 
NSCLCs). Clinical experts in respiratory medicine at the University of 
Nottingham were consulted with to determine which of lung cancer 
Read Codes were the most appropriate to be used. Patients with 
malignant neoplasms of the lung were identified using Read Codes 
under the following hierarchies: malignant neoplasms of trachea, 
bronchus and lung B22..00; carcinoma in situ of the respiratory tract 
B81..00; respiratory tract adenomas and adenocarcinomas BB5S.00; 
and any lung-related malignant neoplasm otherwise specified By…00, 
were extracted from the Medical and AHD records of the THIN-GBASE 
database. 
Patients found with any rare lung-related genetic syndrome or 
disease, neoplasms of the respiratory tract exhibiting uncertain 
behaviours or mesotheliomas were excluded. Patients coded with lung 
cancers located on the walls of the thoracic or chest cavity were also 
excluded from the analysis. 
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5.3.2.2 Inclusion and exclusion criteria 
Eligible participants were those aged 18+ years, which were registered 
at their GP practice and contributing data for at least one year before 
the study start date (1-January-2004). Participants were excluded if 
they had a lung cancer diagnosis before the start date of the study or 
did not have complete exposure data on the 15 soil elements. Patients 
were only included if the practice at which they were registered had 
an acceptable mortality recording (AMR) date before the start of the 
study. The end date for the study was 31-December-2013. 
Participants diagnosed with lung cancer during the course of the study 
(i.e. between 1-January-2004 and 31-December-2013) were right-
censored at the date of their first lung cancer recording. Participants 
with a death record within the duration of the study were right-
censored at the date they were recorded to have died. Participants 
with no lung cancer event throughout the duration of the study were 
automatically right-censored on 31-December-2013. 
5.3.2.3 Exposure and confounding variables 
Exposures for all 15 soil elements were classified into four groups 
using the CS4L, where soil levels up to half the CS4L were classified as 
the lowest exposure (Group I, referent group); soil levels between half 
& up to the C4SL were group II, soil levels with 1-2 times the C4SL 
were group III, and soil levels 2 times above the C4SL were the highest 
exposure (group IV). Where a soil guideline value was not available, or 
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if the guideline value was out of range of our data (i.e. not found 
between lowest and highest observation for specific element), or 
using the above method produced a category containing no cases; we 
used quintiles to categorise the exposure. 
Age, gender, smoking status, and socioeconomic deprivation were 
considered as confounding variables, due to their association with 
both the outcome and potential exposures of interest. Age was 
categorised as below 40, 41-50, 51-60, 61-70, 71-80 and 81+ years. 
Smoking status before the start of the study was extracted from the 
database using validated Read Codes,190 and categorised as never 
smoked, non-smoker, ever-smoked or unknown. Quintiles of Townsend 
indices of deprivation were used to measure socioeconomic 
deprivation. We also extracted data on the type of residential 
settings, which were categorised as urban, suburban and rural. 
5.3.3 Statistical analyses 
5.3.3.1 Filter method for feature selection (Stage 1) 
We have applied feature selection data mining techniques to our 
database to generate new hypothesis that may aid in determining the 
relationship between soil elements from GBASE and clinical outcomes 
in THIN. Feature selection is a very useful data mining tool which has 
a suite of wrapper, filter and embedded methods for searching 
potential exposures used for optimising risk predictions of certain 
outcome variables in a large database.191,192 The filter methods are 
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especially useful in determining which exposure, or subset of 
exposures that are relevant for building a predictive model. When 
applying filter methods to a large database, they act as filters for 
identifying relevant exposures needed for building and optimising risk 
models, whilst, at the same time removing any exposures that are 
redundant and do not contribute to the accuracy of the predictive 
model.191,192 This technique is certainly helpful in building our own risk 
models because there is paucity in literature that establish any direct 
relationships between specific soil elements and lung cancer. 
Contemporary studies that have shown associations between soil 
elements and lung cancer have conflicting results,157,189 and so it 
would be inappropriate to rely on their results to build our predictive 
models for risk of lung cancer. We therefore relied on these filter-
based methods to select the relevant soil elements. The technique 
optimises risk prediction of lung cancer based on the selected group 
of soil element and thus do not guarantee any statistical significance 
thereby limiting the potential of a type-I error occur in our results.        
The correlation-based filter selection (CFS) method was chosen as the 
most appropriate data mining method to use for this study because it 
generates a restricted group of potential soil exposures which were 
highly correlated with the outcome. The advantages are it can analyse 
continuous or categorical variables, and during the selection process it 
takes into account the collinearity between the subgroup of chosen 
elements and other elements that are least correlated to the 
outcome. 191,192,193 The default search algorithm used for CFS was the 
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forward (or backwards) greedy stepwise technique whereby exposures 
were progressively incorporated in a successive order of importance to 
form larger and larger subsets. The search process ends once the 
generated subset of exposures was reached, which produces a 
summary statistic known as the merit score. This information shows 
the overall strength of error in adding attributes into the subset – a 
summary score of 15% and below is usually preferred. 191,192,193 Note 
that the CFS algorithm does not guarantee model estimates for 
exposure categories in selected attributes to be statistically 
significant; rather, it ensures that the model constructed is fully 
optimised by returning the best log-likelihood score. All data mining 
analyses were performed in Weka 3.7.12 (University of Waikato, 
Hamilton & Tauranga, New Zealand). 
5.3.3.2 Multivariable Cox regression modelling (Stage 2) 
Multivariable Cox regression analysis was used to model the 
association between the subset of selected soil elements (derived 
from data mining) and lung cancer, allowing for confounding variables 
(section 5.3.2.3). Our initial analysis comprised of a mutual adjusted 
model containing only the subset of elements derived from the data 
mining in stage 1. Afterwards, a corrected model was fitted which 
contained both subset of elements from stage 1, and potential 
confounding variables. A stratified analysis was carried out to assess 
the impact by type of residential setting (urban, suburban and rural). 
Results are presented as Hazard Ratios (HR) with 95% confidence 
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intervals (95% CI), where statistical significance was deemed if 95% CI 
excluded the null value of 1.  
A trend test using orthogonal polynomial contrasts was carried out to 
assess whether lung cancer hazard increased linearly with higher 
exposure categories for the subset of elements, whereby a p-value < 
0.05 indicates that the increase hazard ratios across increasing 
exposure categories adequately (or crudely) follows a linear 
pattern.194  
We assessed whether the hazards of exposures and confounding 
variables were proportional using a test based on the Schoenfeld’s 
residuals, which provides p-values to determine non-proportionality in 
the overall model and exposure group (vs. referent group).195,196 
Where violation of the assumption was identified (p-values less than 
0.05) Aalen plots were used as a diagnostic tool to identify the time 
points where the hazard function changed significantly.168 Variables 
were then created on the cut points of where there is an obvious 
change in the pattern of the hazard function, and re-fitted into the 
multivariable regression model. This procedure eliminates the time-
varying effect that is present in the exposure.  
All statistical modelling was conducted in Stata 12.0 MP for Windows 
7.0 (Stata Corporation, Station College, Texas, USA). 
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5.4 Results 
5.4.1 Demographic characteristics  
A complete cohort of up to 2.3 million patients was identified before 
1-January-2004.  Of these, 20.7% (n = 144,307) of patients were 
excluded from the study because they did not meet the inclusion 
criteria. Those excluded from the analysis were patients with partial 
or completely missing soil data (69.0%, n = 99,575), those registered 
at a GP practice with an AMR date after 1-January-2004 (18.2%, n = 
26,202) and those with ages below 18 years (8.1%, n = 11,705). The 
final extract contained a sample of 1,823,312 participants (Figure 
5.2). 
During the study, 10,740 (0.6%) participants developed lung cancer. 
The overall median survival time for these participants was 4.8 years 
(Interquartile range (IQR): 2.4-7.3 years). Participants who developed 
lung cancer were more likely to be older (51-60 years: 19.5%; 61-70 
years: 31.5% and 71-80 years: 31.8%), a male (57.3%) current smoker 
(48.0%) from the south of England (36.2%), and from the deprived 
groups (group IV: 21.2%) (Table 5.1).
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Figure 5.2: Schematic diagram representing how participants were included or 
excluded from cohort study 
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Table 5.1: Baseline demographic characteristics of participants for lung cancer study, using THIN-GBASE database from 01-Jan-2004 to 
31-Dec-2013 
Characteristics  Without lung cancer  With lung cancer  Total 
 N %  N %  N % 
Sex         
  Male 892,740 49.3  6,155 57.3  898,895 49.3 
  Female 919,832 50.7  4,585 42.7  924,417 50.7 
Age group 
  
 
  
 
  
  ≤ 40 670,191 37  117 1.1  670,308 36.8 
  41-50 338,083 18.7  566 5.3  338,649 18.6 
  51-60 312,896 17.3  2,099 19.5  314,995 17.3 
  61-70 224,962 12.4  3,385 31.5  228,347 12.5 
  71-80 167,256 9.2  3,420 31.8  170,676 9.4 
  81+ 99,184 5.0  1,153 10.8  100,337 6.0 
Smoking status 
  
 
  
 
  
  Never 568,821 31.4  978 9.1  569,799 31.3 
  Non 284,919 15.7  773 7.2  285,692 15.7 
  Ex-smoker 250,403 13.8  3,006 28  253,409 13.9 
  Current smoker 383,965 21.2  5,102 47.5  389,067 21.3 
  Unknown 324,464 17.9  881 8.2  325,345 17.8 
Socioeconomic deprivation 
  
 
  
 
  
  Group I  518,606 28.6  2,291 21.3  520,897 28.6 
  Group II 402,128 22.2  2,157 20.1  404,285 22.2 
  Group III 365,795 20.2  2,238 20.8  368,033 20.2 
  Group IV 311,153 17.2  2,282 21.2  313,435 17.2 
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  Group V  200,108 11  1,719 16  201,827 11.1 
  Unknown 14,782 0.8  53 0.5  14,835 0.8 
Residential classification 
  
 
  
 
  
  Urban 1,438,529 79.4  8,702 81  1,447,231 79.4 
  Suburban 217,767 12  1,317 12.3  219,084 12 
  Rural 142,280 7.8  680 6.3  142,960 7.8 
  Unknown 13,996 0.8  41 0.4  14,037 0.8 
Health authority 
  
 
  
 
  
  London 233,028 12.9  1,099 10.2  234,127 12.8 
  East Midland 59,182 3.3  379 3.5  59,561 3.3 
  East of England 138,380 7.6  758 7.1  139,138 7.6 
  West Midlands 205,309 11.3  1,092 10.2  206,401 11.3 
  North East 61,494 3.4  528 4.9  62,022 3.4 
  North West  220,919 12.2  1,713 15.9  222,632 12.2 
  Yorkshire & Humber 40,326 2.2  298 2.8  40,624 2.2 
  South Central 294,553 16.3  1,531 14.3  296,084 16.2 
  South East 228,556 12.6  1,165 10.8  229,721 12.6 
  South West 198,389 10.9  1,191 11.1  199,580 10.9 
  Wales 132,436 7.3  986 9.2  133,422 7.3 
 134 
 
5.4.2 Exploratory analysis of geochemical data in THIN-GBASE 
The greedy stepwise search algorithm for CFS found the following 
metals to be the most appropriate subset for modelling the risk of 
lung cancer: aluminium, lead and uranium. The soil elements were 
selected in successive order of importance – the result indicated that 
aluminium was the most important attribute present in the subset, 
followed by uranium, and then lead – which was the attribute flagged 
as being the lowest important variable. The overall merit score for the 
chosen subset of attributes was 0.0147 (or 1.47%) which signed that 
the error rate for selecting, and including attributes in the subset for 
model construction was low. The remaining elements not included 
were arsenic, calcium, chromium, copper, iron, nickel, manganese, 
phosphorus, selenium, silicon, vanadium and zinc (Table 5.2). 
The overall median concentrations for the selected soil heavy metals 
were: aluminium 51,400 mg/kg (IQR: 40,500-59,300mg/kg with 
highest value = 116,700 mg/kg); lead 72.0 mg/kg (IQR: 47.0-158.0 
mg/kg with highest value = 3,045 mg/kg); and uranium 1.98 mg/kg 
(IQR: 1.58-2.40 mg/kg with highest value = 61.7 mg/kg). By visual 
inspection of the observed distribution for soil concentration levels of 
aluminium (Figure 5.3), lead (Figure 5.4) and uranium (Figure 5.5) 
among those with, and without lung cancer – the outputs indicate that 
the unadjusted association in terms of soil exposure do not substantial 
differ by outcome.
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Table 5.2: Showing the sequence in which soil elements were selected for model construction of lung cancer risk, subsets 
were generated using the Correlation-based Filter Selection (CFS) method 
Sequence   Order of selected 
attribute 
 Subset generated   
  Start set:  -  [start] 
1  Aluminium  {Aluminium}   
2  Uranium  {Aluminium, Uranium}   
3  Lead  {Aluminium, Uranium, Lead}  [End] 
       
    Overall merit score (i.e. error rate) = 0.0147   
       
  Excluded attributes:  Arsenic, Cadmium, Chromium, Copper, Iron, Nickel, Manganese, Selenium, 
Phosphorus, Silicon, Vanadium and Zinc 
  
  
 
1
3
6
 
 
Figure 5.3: Joint histograms plotted on the same axes to show the observed distribution (proportion) of participants registered to practices contributing to THIN-
GBASE their soil aluminium concentration levels. Upper-light grey histogram corresponds to lung cancer patients; lower-dark grey histogram corresponds to controls 
(without lung cancer). Each black vertical line corresponds to soil aluminium value that falls on quintile to create categories: <37,100, 37,100-47,200, 47,200-
54,700, 54,700-61,600 and ≥61,600
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Figure 5.4: Joint histograms plotted on the same axes to show the observed distribution (proportion) of participants registered to practices contributing to THIN-
GBASE their soil lead concentration levels. Upper-light grey histogram corresponds to lung cancer patients; lower-dark grey histogram corresponds to controls 
(without lung cancer). Each black vertical line corresponds to soil lead value that falls on quintile to create categories: 44.0, 44.0-60.0, 60.0-95.0, 95.0-184.0 and 
≥184.0 
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Figure 5.5: Joint histograms plotted on the same axes to show the observed distribution (proportion) of participants registered to practices contributing to THIN-
GBASE their soil uranium concentration levels. Upper-light grey histogram corresponds to lung cancer patients; lower-dark grey histogram corresponds to controls 
(without lung cancer). Each black vertical line corresponds to soil uranium value that falls on quintile to create categories: <1.49, 1.49-1.83, 1.83-2.16, 2.16-2.50 
and ≥2.50
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5.4.3 Cox regression model 
5.4.3.1 Mutually adjusted Cox multivariable regression 
model 
A pre-diagnostic test using the Schoenfeld’s residuals was used for 
checking the proportional-hazards assumption before reporting the 
any hazard ratios derived for the subset of soil elements. In the 
mutually adjusted model (without adjustment for confounding 
factors), our test found no evidence that our model specification for 
aluminium, lead and uranium violated the proportional-hazards 
assumption (global test: p-value = 0.60), and p-values for each 
category were non-significant (Table 5.3). 
The mutually adjusted model indicated that the risk of developing 
lung cancer was confined to individuals who lived in areas with higher 
soil aluminium concentrations above 47,200 mg/kg (Table 5.4). Our 
test seems to indicate a significant linear trends relationship for 
increased exposure of aluminium and risk of lung cancer (p < 0.001) 
(Figure 5.6). However, the patterns of risk for lung cancer in relation 
to aluminium show a plateau effect which are unclear. 
There was an increased risk of lung cancer for participants living in 
areas with medium soil concentration levels of lead (Group III: HR 1.12 
95% CI: 1.06-1.29; Group IV: HR 1.11 95% CI: 1.04-1.18) (Table 5.4). 
However, the pattern of association for lead remains unclear as there 
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is an apparent ambiguity in the order of direction for the hazard ratios 
across exposure categories, as well as statistically non-significant 
linear trend (p = 0.54). 
There was no association with lung cancer for uranium exposure 
between groups I to IV. However, there was a significant increase in 
risk for those with the highest uranium exposure (group V: HR 1.13 
95% CI: 1.05-1.21) (Table 5.4). Although the result indicated a 
significant linear trend across the exposure groups (p = 0.01); 
however, visual inspection showed that the patterns across exposure 
categories crudely captures a linear trend (Figure 5.6). 
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Table 5.3: Test of proportional-hazards assumption for mutually adjusted model for assessing risk of lung cancer with the selected 
group of soil metals using the Schoenfeld’s residual test 
Soil element  Aluminium1  Lead2  Uranium3 
 Exposure groups  p-value  p-value  p-value 
  Group I  -  -  - 
  Group II  0.61  0.28  0.70 
  Group III  0.39  0.62  0.25 
  Group IV  0.62  0.77  0.28 
  Group V  0.73  0.91  0.88 
1 
 
2 
 
3 
 
4 
Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 
54,700), group IV (54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600)  
Soil lead [Pb] (mg/kg) was categorised as quintiles: group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group 
IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0) 
Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III (1.83 ≤ U < 2.16), group 
IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50) 
Global test: p-value = 0.60 
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Table 5.4: Using mutually adjusted multivariable Cox regression model to estimate hazard ratios (HR) for lung cancer in association 
with aluminium, lead and uranium, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013 
Soil element  Aluminium1,3  Lead1,4  Uranium1,5 
 Exposure groups  HR (95% CI)2  HR (95% CI)  HR (95% CI) 
  Group I  1.00  1.00  1.00 
  Group II  1.01 (0.94-1.08)  0.95 (0.89-1.01)  1.08 (0.94-1.07) 
  Group III  1.21 (1.13-1.29)  1.12 (1.06-1.20)  0.98 (0.92-1.06) 
  Group IV  1.19 (1.11-1.28)  1.11 (1.04-1.18)  1.06 (0.98-1.14) 
  Group V  1.18 (1.09-1.27)  0.94 (0.88-1.01)  1.13 (1.05-1.21) 
       
1 
2 
3 
 
4 
 
5 
Cox model contains aluminium, lead and uranium only 
Hazard ratio (HR); 95% confidence interval (95% CI) 
Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 
54,700), group IV (54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600)  
Soil lead [Pb] (mg/kg) was categorised as quintiles: group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group 
IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0) 
Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III (1.83 ≤ U < 2.16), group 
IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50)              
  
 
1
4
3
 
 
Figure 5.6: Modified scatter plot with range capped spikes showing patterns of hazard ratio as seen from our mutually adjusted model in table 5.4. 
P-value for trends test was used to determine if hazard ratios increased linearly across increasing exposure groups for each element. 
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5.4.3.2 Corrected Cox multivariable regression model 
The Schoenfeld’s residuals test and Aalen plots were carried out as 
pre-diagnostic test for examining the proportional hazards assumption 
after correcting for potential confounding through including age, sex, 
smoking status and socioeconomic deprivation in the corrected model. 
Overall, we found significant evidence that the assumption of the 
proportional-hazards was violated (i.e. global test: p-value < 0.0001). 
The test showed significant evidence of non-proportional hazards and 
time dependent effects for categories in the following covariates: 
gender (female), age groups (71-80 and +81 years) and smoking status 
(unknown) (Table 5.5). 
We identified the form of the time-varying effects for each category 
affected by non-proportional hazards through generating Aalen plots 
to show the patterns of the estimated cumulative hazards regression 
coefficients so as to enable visual interpretation of the 
parameterisation of the time-varying effects found for these 
categories. These were used to identify the important cut-points 
where the patterns for the cumulative regression hazard function 
changed significantly. Based on the cut-points – interval-specific 
covariates for the affected categories were generated (Figure 5.7-
5.10). 
The original categories were replaced with the time-based interval-
specific covariates generated in Aalen analyses (Figure 5.7-5.10), and 
were refitted into the corrected model to ensure that the 
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proportional-hazards assumptions have been met, as well as the 
removal of any time-varying effects. After Aalen diagnostic testing, 
the re-analyses using Schoenfeld’s residuals shows all p-values that 
were significant previously for problematic categories have been 
abrogated successfully (Table 5.6). 
The inclusion of confounders, along with time-based interval-specific 
variable derived from the Aalen plots resulted in marginal reductions 
in the estimated hazard ratios for all subset of soil elements (Table 
5.7). The significant risk derived from the mutually model for those 
living in areas with the highest soil concentrations levels for 
aluminium (≥ 61,600 mg/kg) and uranium (≥ 2.50 mg/kg) was 
abrogated. Furthermore, the patterns of association for the subset of 
soil elements in terms of significant trends differed from the previous 
analysis, where aluminium was the only element that retained its 
significant linear trend pattern (p = 0.01) as opposed to lead and 
uranium whereby their patterns appeared to be abrogated after 
including confounding variables (Figure 5.11).       
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Table 5.5: Test of proportional-hazards assumption for the corrected model which includes confounding factors for assessing the risk 
of lung cancer with the selected group soil elements using Schoenfeld’s residuals 
Confounding variables Proportional-hazards assumption test 
Sex p-value 
  Male (referent) - 
  Female < 0.0001 
Age group (years)  
  ≤40 (referent) - 
  41-50 0.54 
  51-60 0.38 
  61-70 0.07 
  71-80 <0.0005 
  +81 <0.0001 
Smoking status  
  Never (referent) - 
  Non-smoker 0.37 
  Ever-smoked 0.25 
  Unknown <0.0001 
Socioeconomic deprivation  
  Group I (referent) - 
  Group II 0.32 
  Group III 0.49 
  Group IV 0.07 
  Group V 0.14 
  Unknown 0.12 
Global test: p-value < 0.0001 
P-values for aluminium, lead and uranium were not significant (p>0.05) (data not included)  
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Figure 5.7: Aalen plot showing the estimated cumulative regression coefficients for lung cancer patients (with 95% confidence interval) who were 
women (versus men). The vertical dashed lines are cut-points at 1.2 & 5.8 which show the change in slope of the cumulative hazard function. The 
following three time-based interval-specific effects for the female category were generated using the above cut-points: Early effects (t ≤ 1.2), 
Middle effects (1.2 < t ≤ 5.8) and late effects (t > 5.8)
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Figure 5.8: Aalen plot showing the estimated cumulative regression coefficients for lung cancer patients (with 95% confidence interval) whose 
smoking status was unknown (versus those who had never smoked). The vertical dashed line at the cut-point 4 is the change in the slope’s direction 
of the cumulative hazard function. Only two time-based interval-specific effects for the unknown smoking status category was generated using the 
above cut-point: Early effects (t ≤ 4) & late effects (t > 4) 
  
 
1
4
9
 
 
Figure 5.9: Aalen plot showing the estimated cumulative regression coefficients for lung cancer patients (with 95% confidence interval) who were 71-80 years of age 
(versus age groups ≤ 40 years). The changes in the hazard function in the above output were inconspicuous therefore cut-points were specified at a set interval of 
2.5 years to eliminate the time-varying effects. The following four time-based interval-specific effects for the age group were generated using the proposed cut-
points: Early effects (t ≤ 2.5), early-middle effects (2.5 < t ≤ 5.0), middle-late effects (5.0 < t ≤ 7.5) and late effects (> 7.5)
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Figure 5.10: Aalen plot showing the estimated cumulative regression coefficients for lung cancer patients (with 95% confidence interval) who were 
71-80 years of age (versus age groups ≤ 40 years). The changes in the hazard function in the above output were inconspicuous therefore cut-points 
were specified at a set interval of 2.5 years to eliminate the time-varying effects. The following four time-based interval-specific effects for the age 
group were generated using the proposed cut-points: Early effects (t ≤ 2.5), early-middle effects (2.5 < t ≤ 5.0), middle-late effects (5.0 < t ≤ 7.5) 
and late effects (> 7.5)
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Table 5.6: Test of proportional-hazards assumption for confounding factors in 
the corrected multivariable Cox regression model using Schoenfeld’s residuals 
after using Aalen plots to remove time-varying effects for sex, age group and 
smoking status 
Confounding variables Proportional-hazards assumption test 
Sex p-value 
  Male (referent) - 
  *Female  
     Early 0.91 
     Mid    0.79 
     Late 0.73 
Age group (years)  
  ≤40 (referent) - 
  41-50 0.55 
  51-60 0.38 
  61-70 0.08 
  *71-80  
      Early 0.42 
      Early to mid 0.58 
      Mid to late 0.48 
      Late 0.48 
  *+81  
      Early 0.45 
      Early to mid 0.51 
      Mid to late 0.37 
      Late 0.35 
Smoking status  
  Never (referent) - 
  Non-smoker 0.38 
  Ever-smoked 0.25 
  *Unknown  
      Early 0.37 
      Late 0.34 
Socioeconomic deprivation  
  Group I (referent) - 
  Group II 0.31 
  Group III 0.43 
  Group IV 0.08 
  Group V 0.12 
  Unknown 0.12 
Global test: p-value = 0.761 
P-values for aluminium, lead and uranium were not significant. Data not included 
in table 
*Category with reformatted to interval-specific variables as suggested by the 
Aalen plots   
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Table 5.7: Using a corrected multivariable Cox regression model to estimate hazard ratios (HR) for lung cancer in association with 
aluminium, lead and uranium, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013 
Soil element  Aluminium1,3  Lead1,4  Uranium1,5 
 Exposure groups  HR (95% CI)2  HR (95% CI)  HR (95% CI) 
  Group I  1.00  1.00  1.00 
  Group II  0.99 (0.92-1.06)  1.00 (0.93-1.06)  1.01 (0.94-1.07) 
  Group III  1.09 (1.02-1.17)  1.12 (1.06-1.19)  0.94 (0.88-1.01) 
  Group IV  1.10 (1.02-1.18)  1.08 (1.01-1.15)  1.00 (0.93-1.08) 
  Group V  1.06 (0.98-1.15)  0.97 (0.91-1.04)  1.05 (0.97-1.13) 
       
1 
 
 
2 
3 
 
4 
 
5 
Cox model contains aluminium, lead and uranium corrected for confounding variables: gender, age group, smoking status and 
socioeconomic deprivation. As suggested by the Aalen plots the following categories were fitted as time-based interval-specific 
variables: female, unknown smoking status, age groups 71-80 & +81 years.  
Hazard ratio (HR); 95% confidence interval (95% CI) 
Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 
54,700), group IV (54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600)  
Soil lead [Pb] (mg/kg) was categorised as quintiles: group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group 
IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0) 
Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III (1.83 ≤ U < 2.16), group 
IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50)              
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Figure 5.11: Modified scatter plot with range capped spikes showing patterns of hazard ratio as seen from our corrected model in table 5.7. P-value 
for trends test was used to determine if hazard ratios increased linearly across increasing exposure groups for each element.
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5.4.3.3 Stratified analysis based on residential settings 
The patterns of lung cancer risk in relation to soil aluminium, lead and 
uranium differed across different types of residential environment. 
Aluminium appeared to be the only element which significantly 
increased the risk of lung cancer among urban residents only (Figure 
5.12). The patterns seem mimic those seen in the mutual adjusted 
model; however, the stratified model suggests that the increased risks 
for lung cancer were between 12-16% for urban residents with soil 
aluminium concentrations above 47,200 mg/kg. It appears that there 
was a significant dose-response pattern within the urban residential 
areas, whereby the risks increased non-linearly between aluminium 
exposure groups I to III, and then the effects plateau from group III 
onwards (p < 0.001). The remaining exposure groups for all other 
elements – lead (Figure 5.13) and uranium (Figure 5.14) - were non-
significant in all different environmental settings, with unclear 
patterns. 
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Figure 5.12: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between BCC risk and soil aluminium, using THIN-GBASE database 01-01-2004 to 31-12-
2013. The stratified model included other primary exposures - soil lead and uranium, and were adjusted for sex, age group, smoking status, 
socioeconomic deprivation and categories fitted as time-based interval-specified covariates derived from earlier Aalen plots 
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Figure 5.13: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between BCC risk and soil lead, using THIN-GBASE database 01-01-2004 to 31-12-2013. 
The stratified model included other primary exposures - soil aluminium and uranium, and were adjusted for sex, age group, smoking status, 
socioeconomic deprivation and categories fitted as time-based interval-specified covariates derived from earlier Aalen plots 
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Figure 5.14: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between BCC risk and soil uranium, using THIN-GBASE database 01-01-2004 to 31-12-
2013. The stratified model included other primary exposures - soil aluminium and lead, and were adjusted for sex, age group, smoking status, 
socioeconomic deprivation and categories fitted as time-based interval-specified covariates derived from earlier Aalen plots 
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5.5 Discussion 
This is the first study to use a 2-stage approach to evaluate the 
association between environmental soil elements and lung cancer in 
the UK. Our data mining approach identified soil aluminium, lead and 
uranium as the most important subset of metals for lung cancer risk 
prediction. Our initial findings showed a modest increase in hazards 
for lung cancer in participants residing in areas with high 
concentrations for aluminium and uranium, and medium levels for soil 
lead. However, after controlling for confounding, the modest effects 
can only be seen for potential exposure to aluminium (i.e. above 
47,200 mg/kg). The risk of lung cancer appeared to be pronounced in 
urban residential areas. 
One of the key advantages of using the CFS method was that it 
allowed us to approach the THIN-GBASE database without any prior 
hypotheses, and to discover which restricted group of soil elements 
may potentially be related to lung cancer. The main purpose of using 
such filter-based search method was to ensure that the selected group 
of soil elements were the most relevant variables for model 
construction, yielding a model that would optimally predict lung 
cancer risk. However, there is the potential for this approach to 
create subsets which could include elements which were not 
biologically plausible to be associated with the risk of lung cancer. 
Lead and uranium are established agents known to be carcinogenic in 
humans.11,46,197,198 
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Uranium is widely treated as a proxy for radon, which, in turn, is 
strongly associated with cancer.177–181 The assertion that uranium 
being a proxy radon was derived from previous geological studies 
which showed soil concentrations with the most abundance of uranium 
were positively associated with higher levels of radon emissions into 
the air.199,200 While radon’s radioactive gas is produced from a series 
of decays; its lithological origin stems from radium which in turn is 
derived from uranium-enriched soil and rocks.199,201 The World Health 
Organisation (WHO) have estimated that life-long inhalation of low-
level radon is the second most important cause of lung cancer and 
have concluded that exposure to uranium-enriched soil can potentially 
be a contributing factor to lung cancer incidence, as it is responsible 
for radon emissions.181 Aluminium was the least expected to appear 
among the list of variables relevant for lung cancer prediction due to 
the IARC having not classified aluminium as a human carcinogen due 
to the limited amount of data;202 however, the IARC have 
acknowledged that exposure occurring within aluminium refinery (or 
reduction) industry is a major risk factor for lung and bladder 
cancer.46,202  
The results in the second stage of our analysis showed that potential 
exposure to medium to high concentrations of aluminium may be 
associated with lung cancer. A possible explanation for this finding 
can be drawn from previous occupational-based studies that have 
reported an increased risk of lung203 and bladder204 cancer among 
workers in the aluminium industry;43 however, most of these studies 
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asserted that the risks were attributed to exposure to other dangerous 
substances (polycyclic aromatic hydrocarbons, sulphur dioxide, 
fluorides etc.) involved with aluminium refinery.202–204 Despite this 
notion, these studies have acknowledged that long-term exposure to 
aluminium can impair the normal functioning of the respiratory tract, 
which, in turn, may lead to lung carcinogenesis.202,204–207 In the 
context of our study, particulate matter emitted from soil represents 
an important contribution to air quality in the UK. Aluminium has the 
largest abundance in UK top soil in terms of it having the highest 
concentration levels,53 it may be plausible that aluminium-bound 
particulates (or dust) emerging from soil and may remain airborne – 
and the general population may come into long-term contact through 
inhaling it. 
This study was unable to establish soil lead as significant risk factor 
for lung cancer. To the best of our knowledge no study within the 
domain of environmental exposures have found an association 
between increased exposure to soil concentrations of lead and risk of 
lung cancer. However, past studies found an association between lead 
and lung cancer208,209 however, these studies have later been 
contradicted by recent research. These studies were conducted within 
the industrial-occupational settings, and were focused on workers 
within the lead smelters and lead battery industry11,19,33   
Our study found that individuals living in areas with the highest levels 
of soil uranium concentration above 2.50 mg/kg have an increased risk 
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of developing lung cancer; however, this result did not persist 
following adjustment for potential confounding factors. Several 
studies have shown sites with localised soil uranium concentrations 
are associated with some of the highest levels of indoor radon. 
Uranium is ubiquitous in soils and rock which serves as a source for 
radon emission outdoors199,201,210 in a residential environment were 
uranium-enriched soil are in abundance leads to radon diffusing from 
an outdoor environment where radon particles are of higher 
concentration, to an indoor environment where concentrations are 
lower potentially leading to accumulation in houses (especially in 
basements).28,199,210,211  Long-term exposure to radon through 
inhalation leads to severe cellular DNA damage within the respiratory 
tract resulting in lung cancer. Several epidemiological studies have 
shown that environmental levels of radon were associated to lung and 
GIT cancer,177,178,197–199,212 and that concentrations of soil uranium 
were key contributor to indoor air contamination with radon. 
By using a retrospective cohort design for our lung cancer study, we 
believe that we managed to reduce the possibility of selection bias. 
This study uses incident records of lung cancer that were recorded in 
THIN by the time this study was being conducted. Similar to the 
studies in chapter 4, selection bias is not a major concern as we 
attempted to use the entire cohort of eligible patients in the THIN-
GBASE, we have provided a clear definition for our inclusion and 
exclusion criteria that limits our population of interests to adults 
(aged 18 years and above) registered at a GP practice at least 1-year 
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before start date of study (i.e. January 1st, 2004). One source of 
selection bias may occur from the dates we chose to begin the study 
which only captures incident cases of lung cancer after 2004, with a 
short study period limited to ten years (i.e. 2004-2014). However, we 
chose this date because of its significance because it marks the 
introduction of the QOF encouraging GPs to report new cases of lung 
cancers as soon as they are diagnosed. Prior to 2004, recordings of 
lung and other cancers were much lower in THIN than expected when 
compared on the national cancer registry data.188,213 Therefore, to 
avoid any inconsistencies in the recording rates of lung cancer that 
occurred before, and after 2004, we therefore limited the analysis to 
events that occur after 2004.  
In terms of completeness, the THIN-GBASE are reliable source of lung 
cancer data. Recent studies have shown that the recording of lung 
cancer in the THIN database consistent, especially after the 
introduction of QOF whereby the recording rates had increased to 
approximately 80.0%.188,213 Validation studies have indicated that lung 
cancer data from THIN captures most cases from other cancer 
registries, and therefore its complete and representative.188 One 
problem that was beyond our ability to resolve was the differences in 
lung cancer ascertainment rates at a GP-level across England and 
Wales. If case ascertainment rates at a practice-level is associated 
with geographical variation in exposures to the selected group soil 
element, then are our risk estimates for lung cancer was be biased.169 
We attempted to control for this by making adjustments with the SHA 
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variable; however, a better approach would have been the inclusion 
of some performance indicator at a practice-level that could be 
treated as a proxy for measuring how well practices tend to record 
clinical outcomes.  
We have incorporate data-driven approaches to determine initially 
which soil elements are likely predictors of lung cancer with data 
mining,193 before deriving detailed hazard estimates using Cox survival 
regression analysis, where we were able to remove any time-varying 
effects through using the Aalen additive survival model.168  
One of the major shortcomings was our inability to incorporate into 
our analyses the exact location of where a patient lived, and the 
spatial point of where soil samples were measured. The inability to 
display spatially by means of usage of high resolution maps could have 
potentially provided a convincing picture as to whether these soil 
elements (where they are highly concentrated at) are linked to large 
clusters of incident lung cancer cases. Furthermore, by incorporating 
that spatial component into the analysis would have reduced any error 
(spatial variability) that exists between samples measured. Another 
limitation was that although we were able to make adjustments for 
meaningful confounding variables, we unable to include other 
potentially important confounders; for example, the type of industrial 
occupation of a patient (i.e. in aluminium production), ambient levels 
of heavy metal particulates, and environmental levels of radon, which 
are highly correlated with soil levels of uranium, and may serve as a 
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better effect modifier (i.e. for stratification) for lung cancer than 
urban vs. rural. In addition, we cannot be certain that residential soil 
element levels as measured by the THIN-GBASE link directly translate 
into increased exposure and/or bioavailability at individual level. 
Just like our previous study for arsenic and BCC, another shortcoming 
for this study was our inability to use the following data: 1.) 
Information related to a patient’s addresses; 2.) the location of 
general practices he/she attended; and 3.) the georeferenced 
sampling points for the soil samples that were collected at different 
densities. We mentioned these limitations were due ethical and legal 
implications outlined by THIN. The geospatial details of lung cancer 
patients were anonymised, and therefore, we could not utilise this 
resource to directly ascertain the distribution of those that fall within 
a sampling point; let alone, determine the distribution of those that 
lived on soils classified as either a G-BASE urban or rural terrain, or 
BGS reanalysed NSI(XRFS) areas. If this information were available, we 
could have stratified the population at risk of lung cancer in 
accordance to these three areas. Our approach to this issue of 
differentiating participants that lived on urban and rural terrain (i.e. 
G-BASE urban, rural and NSI(XRFS)) by using a stratified Cox regression 
analyses was based on the type of residential setting indicators 
recorded in THIN (i.e. urban, suburban and rural), so as to reduce the 
possibility of any information bias that may affect our risk estimates 
for lung cancer because of systematic differences in exposure in soil 
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aluminium, lead and uranium as a result of samples being collected at 
densities. 
For aluminium, specifically, our results show a positive trend which 
indicates that there could be a potential dose-response relationship 
between the increased exposure groups for aluminium and lung cancer 
incidence. This has implications for the priority with which element 
should be monitored by environmental or geological agencies. Other 
sources of aluminium that contribute to soil and atmospheric 
contamination, especially within urban residential areas, should be 
monitored. Further research is required to conclusively establish 
whether soil elements in general are linked to lung cancer. 
In conclusion, the current study suggests that those living in areas 
with soil aluminium levels above 47,200 mg/kg may have a greater 
risk of developing lung cancer. The result suggests that aluminium 
exposure among urban residents may be the cause of lung cancer for 
this group. While, the results indicate statistical significance, they 
need to be interpreted with caution due to the limitations that are 
present for this study. Further studies will be needed to validate the 
findings made in this investigation. 
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6 Summary 
In the past (1950-80s), there has been much epidemiological research 
into the influence of exposure to soil metals on the risk of various GIT-
related cancers; however, these studies are historical and outdated, 
because they were conducted at a time period where soils were highly 
contaminated due to the many mining activities that took place. 
There is a need to update the evidence in relation to the modern 
environment. Therefore, we aim to examine the relationships 
between low-level soil contaminants and risk GIT cancers. 
A three-stage process was used to conduct the following: (1) using 
data mining to determine which group of soil metals are the best 
predictors of GIT cancer; (2) using a population-based cohort design 
for quantifying the effect size for GIT cancer risk for individuals living 
in a residential area with high concentration levels for the selected 
soil elements; and (3) multivariate analysis using competing risks 
survival models were applied to determine the association between 
the subset of selected elements and the risk of developing following 
cancers: a. upper GIT cancers, b. stomach cancer, and c. colorectal 
cancer. 
Our data mining model identified the following soil elements as 
appropriate predictors for overall GIT cancers: aluminium, calcium, 
lead, phosphorus, manganese, uranium and zinc. In stage 2, our 
mutually adjusted model had initially shown residents living on soils 
with elevated levels of aluminium, phosphorus and uranium had an 
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increased risk of developing GIT cancers, while soil levels for zinc 
were protective effect against GIT cancers. Only soil phosphorus 
remained significantly associated with overall GIT cancer while all 
remaining elements were rendered non-significant after making 
adjustments for confounding variables. In stage 3, our competing risk 
models had not shown any meaningful relationship for any of the 
selected group of elements while taking into account of potential 
competing events. 
The results for soil phosphorus authentically remained consist 
throughout the regression analysis, when compared to elements used 
for this analysis. Therefore, we concluded that increased exposure to 
low-levels of phosphorus may have an impact on overall GIT cancer 
incidence in the UK.   
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6.1 Background 
Gastrointestinal tract (GIT) cancer mainly refers to a group of internal 
malignant neoplasms occurring on primary organs actively involved 
with digestive processes – mouth, oesophagus, stomach, ileum (or 
small intestine), colon (or large intestine), rectum and anal canal. GIT 
cancers may also include the appearance of solid tumours on 
secondary or accessory glands such as the liver, bile, gallbladder and 
pancreas, which provide aid to the digestive organs.214,215 Primary 
organs of the GIT can be classified into three major groups: (1) the 
mouth and oesophagus comprise the upper GITs, (2) the stomach 
(standalone term); and (3) the duodenum, ileum, colon, rectum and 
anal canal comprise of the bowel (or colorectal area).  
GIT cancers are among the most frequently diagnosed cancers in the 
world176. There is significant geographical variability in the incidence 
of GIT cancers, especially by site and cell-type, with North America, 
Western Europe, Australia and Japan documented as having the 
highest occurrence of oesophageal and colorectal 
cancer175,214,216.whereas Africa and Asia (especially India and Iran) 
have the highest relative prevalence of stomach cancer relatively the 
highest prevalence of stomach cancers175,214,215, possibly due to high 
incidences of infectious diseases. 
There are multiple risk factors that contribute to the aetiology of 
most GIT cancers. Non-modifiable risk factors include the 
advancement of age, gender, genetics and heredity. Modifiable 
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factors are typically lifestyle-related: smoking, alcohol consumption, 
physical inactivity and dietary habits (i.e. minimum consumption or 
low intake of fibre-foods, fruit and vegetables)217–219. 
It has been strongly implied that exposure to environmental metals 
that emerge from soil may be risk factor for GIT cancer in humans. 
However, the few prior studies have directly addressed this 
possibility. Most of the contemporary studies exploring this aspect of 
research were conducted in countries such as Turkey,220 Iran,221,222 
Taiwan49 and China223,224, where areas of severe contamination are 
widespread than elsewhere in the world. The method for quantifying 
exposure to soil elements were restricted to only surrogate measures 
of levels in soils through using either biomarkers levels in blood49,220 
(or urine) or levels of in locally grown foods.220,223,224 In the UK, 
studies exploring this issue were carried out between the late 1950s 
and 1980s (and may not, therefore, reflect current risks), but were 
reliant on ecological study designs, limiting their value in assessing 
the likelihood of causation.99–103,225–229  
Therefore, the purpose of this chapter is to establish a plausible 
explanation for the attribution of soil metals and how they may lead 
towards GIT cancer. A contemporary approach carried out in three 
stages will use (1) data mining, (2) population-based cohort design 
and (3) multivariate analysis using competing risk modelling to assess 
the associations between GIT cancer and residential levels of soil 
metals in UK.    
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6.2 Potential mechanism for gastrointestinal tract cancers in 
relation to soil elements 
In previous chapters, we have shown a conceptual framework for how 
soil metals may be related to BCC and lung cancer, and shown the 
important pathways for exposure were through dermal absorption and 
inhalation via respiratory tract, respectively. In terms of GIT cancer, 
the largest pathway of concern is through the digestive tract. There 
are multiple means by which ingestion of soil particulates containing 
contaminants may occur. In particular, ingestion of airborne soil 
particulates in a form of household dust, ingestion of soil particulates 
that are attached to consumable plants, and the consumption of 
contaminated foods grown or raised on soil polluted with toxic metals. 
These are examples that can be integrated into our food chain 
indirectly. 
6.2.1 Upper gastrointestinal tract   
The biological mechanism for metallic elements that may trigger a 
carcinogenic effect differs depending on the type of organ associated 
with digestion. For instance, the effect of metallic elements on upper 
GIT organs responsible for ingestion [i.e. oral cavity (mouth) and 
oesophagus] may differ entirely from those of the stomach and 
colorectal tract involved with digestion and absorption, respectively. 
For example, recent studies conducted in Taiwan have shown that 
elevated concentrations of soil arsenic and nickel in farm soils may be 
associated with increased incidence of oral cancer,230,231 with 
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associations being attributed to the fact that residents were 
consuming locally grown produce from soils with high concentrations 
of arsenic and nickel.87,220,232 A study from Eastern Turkey,220 where 
GIT cancers are endemic, have shown that oesophageal cancers were 
common among residents that consumed foods grown on soil highly 
contaminated with cadmium, lead, copper and cobalt.220 It indicated 
that study population were consuming foods grown on soils with 
concentrations of cadmium, lead, copper and cobalt being 50, 6, 4 
and 2-fold, respectively, greater than the standard soil guideline 
levels outlined in Turkey.220 It has been hypothesised that the 
potential mechanism for soil metals to have carcinogenic effects on 
such tissues would require the lodging of contaminated material in the 
crevices of the oral cavity and oesophagus during ingestion.142-144 
6.2.2 Stomach cancer 
The carcinogenic effects of metallic elements are not limited to 
tissues of the upper GIT. For instance, past studies using tissues 
specimens extracted from the autopsied patients who had stomach or 
other cancers have demonstrated that long-term trace amount of 
exposure to environmental metals from air, water and soil leads to 
accumulation of elements inside tissues.77–82 Studies based on 
analysing trace metals build-up in tissues have support the notion of 
accumulation of elements in stomach tissues may potentially induce 
cancer.77–82 Health studies conducted in Iran and China have added to 
some degree of a possible link between elevated concentration levels 
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of metals in farm soil and stomach cancer by showing areas endemic 
to stomach cancer are typically situated at locations with farm land 
containing excessive concentrations of arsenic, chromium, cadmium, 
lead and selenium.221,223 The authors acknowledged that higher 
concentrations of soil elements in farm soil play a key role in gastric 
cancer development, and that this problem has led to certain areas 
being endemic with stomach cancer. 
6.2.3 Bowel cancer 
The potential mechanism for bowel (or colorectal) cancer in relation 
to soil elements may involve one of the following processes: (1) the 
long-term lodging of a carcinogen in the fissures of the intestinal wall 
during absorption in the small or large intestine,233–235 or (2) direct 
absorption of a carcinogen into the tissues of the intestine where upon 
they will remain and accumulate over time.77–82 This was proven by 
few clinical studies that have observed trace levels of harmful 
elements present in intestinal tissue samples from autopsied patients 
affected with colorectal polyps or tumour growth.233–235 It has been 
hypothesised that such mechanisms, if indeed, are occurring over a 
long period of time may be sufficient enough to trigger the 
development of tumour at the target organ. In general direct 
epidemiological research concerning the relationship between specific 
soil elements and bowel cancers are limited to studies (notably in 
China, Iran and Turkey) reporting general GIT cancers in rural areas 
where farming and soil cultivation are common practice. They usually 
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report GIT cancers area endemic to farm lands with soil containing 
excessive amount of toxic metals;220,222,224,236 however, they do not 
report whether there is an association. The authors acknowledge this 
due to the limitation and lack of data, and therefore mention that 
further research must be warranted to establish a clear association.   
6.3 Soil metallic elements and potential risk of 
gastrointestinal tract cancer in the United Kingdom 
GIT cancers are among the most common malignancies reported in the 
UK.237–239 In particular, bowel cancers are the fourth most diagnosed 
cancer following after breast, lung and prostate cancer.240–242 
According to Cancer Research UK, bowel cancer account for ~13% 
(41,581) of all incident cases reported in UK (2011) with an overall 
incidence rate of ~66 cases per 100,000 person year. Oesophageal, 
oral and stomach cancers are less common than large bowel cancers, 
being ranked 13th, 15th and 16th among UKs top 20 cancers by site, 
respectively.237–239 
Like most industrialised countries - the incidence of GIT cancers in the 
UK is heavily influenced by modifiable factors such as physical 
inactivity, smoking, dietary regime and alcohol consumption.214,215,217–
219 The current literature pertaining to GIT cancers is therefore 
strongly focused on these risk factors as they are deemed to be the 
most readily addressable in public health terms. While there is also a 
considerable body of research exploring the relationship of GIT 
cancers and environmental carcinogens, most studies are focused on 
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occupational populations. The UK studies published to date on 
exposure to metallic elements from soil in relation to GIT cancers are 
limited, and are predominately over thirty years old.99–103,225–229     
Studies assessing links between soil metals and GIT cancers were 
mostly carried out during the early 1950s to late-1980s, with an 
emphasis on finding the health impacts of trace elements – especially 
for cadmium, chromium, cobalt, nickel and lead102,243–247. At the time, 
investigations were performed in the North West (Cheshire) and 
Southwest of England (Somerset & Devonshire), as well as Northern 
Wales (Anglesey & Montgomeryshire) - due to rapid increase in cancer 
mortality and stomach cancers observed in these areas, as well as the 
known contamination present in soils of those areas. The increased 
incidence was a matter of huge public health concern that attracted 
considerable attention from the research community, and the 
subsequent search for potential environmental risk factors included 
several studies investigating the health impacts of soil elements102,243–
247.  
A series of ecological studies were conducted, whereby investigators 
hypothesised that the nature of soil had a potential health impact, as 
well as the possibility of residents living in areas reported to have the 
greatest incidence of stomach cancer were more likely to be exposed 
to excessive concentrations of trace elements at their soil location. 
These studies indicated that the high incidence of stomach cancers 
were mainly observed in areas with soils that were peaty in texture243, 
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which contained large excessive amounts of chromium, cobalt, 
copper, and zinc102,244. 
From 1978, until the late-80s, cadmium became a focus of public 
health concern in England which received much attention due to high 
concentrations of cadmium detected in soils throughout the Shipham 
Parish (South West England)104,248–250. The possibility of a health 
impact could not be ignored and so an array of exposure, risk 
assessment and epidemiologic studies similar to those performed in 
Northern Wales and parts of England during the early 50s were carried 
out. Substantial evidence of cadmium toxicity was found in a pilot 
study which that residents of Shipham whose garden soils contained 
between 60.0 and 998.0 mg/kg of cadmium had elevated blood-
cadmium levels. The observed health consequences included 
hypertension, renal tubular damage and cancer of the colon in some 
patients248; however, this association was refuted in subsequent 
studies which only showed a small but nonetheless statistically 
significant risk for ovarian carcinoma only and not with GITs cancers – 
and thus concluded that risks of other health outcomes were unlikely 
to be explained by soil cadmium exposure104,249–251. 
The latest UK study aimed at elucidating local relationships between 
various metallic elements and twelve different cancer types was 
carried out in Northern Ireland. McKinley et al. (2013) used a spatial 
and ecological study design which demonstrated that the incidence of 
stomach cancer (at a ward-level) was correlated with arsenic levels in 
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soil. In addition, the strongest association for stomach cancer in the 
study was observed for wards linked to soil data having arsenic soil 
levels greater than 43.7 mg/kg (above UK the national safety value of 
32 mg/kg).189 However, the one of the major limitations of this study 
were that soil samples were aggregated at a geographical ward-level 
in Northern Ireland. This means that is ecological bias and any risk 
quantified cannot be related to a single individual due to exposure 
being measured on a geographical scale. 
The linkage of THIN-GBASE removes this limitation by providing soil 
data on a postcode-level which can be utilised to quantify cancer risk 
at an individual-level. Therefore, the purpose of this chapter is to 
address this research gap. By using the THIN-GBASE database, we used 
series of epidemiological analysis that adopts a three-stage approach 
to assess the impact of soil metallic elements on GIT cancer risk. 
6.4 Methods 
A three stage process was used to determine which of the 15 soil 
elements in the linked database were associated with GIT cancers. 
The initial process involved the usage of data mining techniques as an 
exploratory exercise to find which of the element(s) (or best subset of 
elements) were predictive of GIT cancer. The next stage used a 
population-based cohort design for the purpose of quantifying the 
effect size for overall GIT cancer risk for individuals living in a 
residential area with high concentration levels for the selected soil 
elements. The third stage, multivariate analysis using competing risks 
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survival models were applied to determine the association between 
exposure to the subset of elements and the risk of developing cancer 
at certain region of the GIT [upper gastrointestinal cancer (includes 
oral & oesophagus), stomach cancer, and small (ileum) & large bowel 
cancer (colon, rectum & anal canal)]. 
6.4.1 Study population 
6.4.1.1 Case definition for gastrointestinal tract cancer 
The case definition for GIT cancers were patients typically recorded 
with any type of malignant neoplasm found in accessory organs 
actively involved with food digestion (mouth, oesophagus, stomach, 
ileum, colon, rectum and anal canal) - in THIN, GIT-related neoplasms 
are coded as site-specific cancers. Clinical gastrointestinal experts at 
the University of Nottingham were consulted with to determine which 
of the GIT cancer Read Codes were the most appropriate to be used 
for this analysis.  
Patients with malignant neoplasms were identified using Read Codes 
under the following hierarchies: malignant neoplasms of lip, oral 
cavity and pharynx B0…00; malignant neoplasm of oesophagus 
B10…00; malignant neoplasm of stomach B11…00; malignant neoplasm 
of small intestines (ileum) B12…00; malignant neoplasm of colon 
B13…00; and malignant neoplasm of rectum, rectosigmoid junction & 
anus B14…00. The group of Read Codes with the above hierarchies 
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were extracted from the THIN-GBASE databases’ patient medical and 
AHD records. 
Patients found with any rare genetic-related GIT illness, or neoplasms 
located on the walls of the peritonum [or in any section of the intra-
abdominal cavity rather than on the digestive organs themselves] 
were excluded from the analysis. Only malignant neoplasms appearing 
on organs that are actively involved with food digestion were 
considered; although the liver, pancreas, and biliary tract play an 
important role in digestion, their role is to store or secrete of fluids 
that break down food particles for absorption in the small and large 
intestine. Since they do not normally come into direct contact with 
ingested matter, they were excluded from the analysis. 
In stages 1 and 2 the main outcome variable was treated as a binary 
indicator; as the presence or absence any GIT cancer. However, in 
stage 3 the study adopted a multivariate framework, whereby 
outcomes were generated separately for each site-specific GIT cancer 
(upper GIT, stomach and bowel cancer) as a three-category 
(polychotomous) indicator in which a category coded with 0 means 
complete absence of cancer outcome. The value 1 represented the 
main outcome of interest, while the third category (coded as 2) was 
classed as the group competing with main outcome. For example, the 
multivariate outcome or indictor for upper GIT cancers - the absence 
of any cancer would be coded as 0. The main outcome, diagnosis with 
upper GIT (mouth or oesophageal) cancer during the study period was 
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coded as 1. Lastly, the third category which was the competing risk 
group representing any GITs (i.e. stomach or bowel) other than upper 
GIT cancers were coded as 2. The definitions for upper GITs, stomach 
and bowel cancers are as follows: (1) Upper GIT cancers are any oral 
and oesophageal malignant neoplasms, (2) stomach cancers including 
any form of gastric-related neoplasms, and (3) bowel (or colorectal) 
cancers having Read Codes that refer to malignant neoplasms of the 
duodenum, ileum, colon, rectum and anal canal.  
6.4.1.2 Inclusion criteria 
The specification for inclusion was similar to that outlined in Chapter 
5 (see section 5.3.2.2). Eligible participants were those aged 18+ 
years, which were registered at their GP practice and contributing 
data for at least one year before the study start date (1-January-
2004). Participants were excluded if they had a GIT cancer diagnosis 
before the start date of the study or did not have complete exposure 
data on the 15 soil elements. Patients were only included if the 
practice at which they were registered had an acceptable mortality 
recording (AMR) date before the start of the study. The end date for 
the study was 31-December-2013. 
Participants diagnosed with a GIT cancer during the course of the 
study (i.e. between 1-January-2004 and 31-December-2013) were 
right-censored at the date of their first GIT cancer recording. 
Secondly, participants with a death record within the duration of the 
study were right-censored at the date they were recorded to have 
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died. Lastly, participants with no event throughout the duration of the 
study were automatically right-censored on 31-December-2013. 
6.4.1.3 Exposure and confounding variables 
The methodologies used for categorising all 15 soil elements were 
similar to those applied in Chapter 5 (see section 5.3.2.3). Non-
modifable risk factors treated as potential confounding variables 
included age, gender, and socioeconomic deprivation. Age was 
categorised as below 40, 41-50, 51-60, 61-70, 71-80 and 81+ years. 
Quintiles of Townsend indices of deprivation were used to measure 
socioeconomic deprivation. 
Modifiable or lifestyle-related confounding variables were smoking 
status, body mass index (BMI) and alcohol consumption. An 
individual’s smoking status and the amount of alcohol consumed per 
week before the start date of study was extracted from the AHD files 
using validated Read Codes. Smoking status of participants were 
categorised as never smoked, non-smoker, ever-smoked or unknown if 
information about the patient’s smoking status was unavailable.190 A 
participant’s alcohol consumption level (per week) was categorised in 
accordance with the UK sensible drinking guideline as moderate (men: 
<21 units per week; or women: <14 units per week), hazardous (men: 
21-50 units per week; or women: 14-35 units per week), harmful 
(men: 50+ unit per week; or women: 35+ units per week) or unknown 
if information about regarding the patient’s drinking patterns was 
unavailable. BMI of participants were directly extracted from the AHD 
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files in THIN-GBASE. The BMI was directly estimated using the height 
(in m) and mass (in kg) of a participant as an alternative approach 
when he/she had missing information. BMI was categories in 
accordance with WHO guideline for adults – underweight: <18.5 BMI; 
acceptable: 18.5-24.9 BMI; pre-obesity: 25.0-29.9 BMI; Obesity (class 
I-III): 30+ BMI. 
The type of residential setting (or living environment the patient 
resided in) was extracted and classified as urban (>10,000 buildings), 
suburban (town or fringe) and rural (village, hamlet or isolated 
village). In stage 2 – the categories were treated as strata (for 
subsequent stratification analysis) rather than confounders, so as to 
test the effects of each soil metal on GIT cancers in each geographic 
setting. 
6.4.2 Statistical analysis 
6.4.2.1 Filter method for feature selection (Stage 1) 
The CFS method was used to determine which restricted group of soil 
metals were highly correlated with overall GIT cancer outcome. The 
default search algorithm used for CFS was the forward greedy 
stepwise technique to select elements in a successive order of 
importance (from highest importance to lowest) to form larger and 
larger subsets.  
The CFS algorithm was applied using the greedy stepwise technique 
whereby exposures were procedurally generated in successive order of 
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importance to form a larger subset. The search process ends once it 
reaches the optimal subset of exposures. The algorithm produces a 
summary statistic called the merit score which determines the overall 
strength of error in adding attributes into the subset – a summary 
score of 15% and below is usually preferred. Note that the CFS 
algorithm does not guarantee model estimates for exposure categories 
in selected attributes to be statistically significant; rather, it ensures 
that the model constructed is fully optimised by returning the best 
log-likelihood score. All data mining analyses in stage one were 
performed in Weka 3.7.12 (University of Waikato, Hamilton & 
Tauranga, New Zealand). All elements derived from this stage are 
used throughout subsequent stages. 
6.4.2.2 Multivariable Cox regression modelling (Stage 2) 
Multivariable Cox regression models were used to determine the 
association between the selected group of soil elements derived from 
stage 1 and GIT cancers. Our initial model comprised of a mutual 
adjusted model containing only the selected set of soil metals. 
Subsequently, a corrected model was fitted with both soil elements 
and confounding variables. A stratified analysis was also carried out to 
assess the impacts within a type of residential setting (urban, 
suburban and rural). Results from the mutually adjusted and fully 
corrected models were presented in tables as Hazard Ratios (HR) with 
95% confidence intervals (95% CI), where statistical significance was 
accepted if 95% CI excluded the null value of 1. Results from stratified 
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analyses were presented graphically through the use of modified 
scatter plots to display HRs added with range plot with capped spikes 
to show 95% CI.  
The diagnostics involved a trend test using orthogonal polynomial 
contrasts to assess whether the hazards for GIT cancer increased 
linearly with exposure categories going higher for each soil metal. P-
values were generated whereby a value < 0.05 indicates that the 
increase in hazard ratios across increasing exposure categories 
adequately (or crudely) follows a linear pattern194. In addition, we 
assessed whether the hazards of exposures and confounding variables 
were proportional using a test based on the Schoenfeld’s residuals, 
which provides p-values to determine non-proportionality overall or 
per exposure category195,196. Where violation of the assumption was 
identified (p-values less than 0.05) - Aalen plots in a form spline were 
generated to identify the time points where the hazard function 
changed significantly168. Indicator variables were then created on the 
cut points where there is an obvious change in the pattern of the 
hazard function, and re-fitted into the multivariable regression model. 
This procedure eliminates any time-varying effect that is present in 
the exposure. 
For stage 2, all statistical analyses were performed in Stata 12.0 MP 
for Windows 7.0 (Stata Corporation, Station College, Texas, USA). 
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6.4.2.3 Sensitivity analysis using multivariate competing 
risk models (Stage 3) 
We carried out a sensitivity analysis to see if the patterns of risk 
detected in our previous models differed according to the type of 
cancer (upper GIT vs. stomach vs. colorectal cancer). In order to 
obtain site-specific estimates, we used competing risk survival models 
(as described by Fine and Gray252,253). As noted previously, our case 
definition required a first ever cancer as it is difficult to distinguish 
between subsequent primary diagnoses, metastases, and follow up 
visits for the first cancer. When considering specific sites, it is 
necessary to censor patients who develop a cancer at another site on 
the date of this diagnosis, as they can no longer develop a first ever 
cancer in the specific site of interest. This competing risk may 
artificially diminish the observed hazard ratio at the site of interest. 
Competing risks models attempt to remove this bias by estimating the 
sub-hazard ratio in the site of interest alone. 
For each site, the outcome was categorised as described in section 
6.4.1.1 (no outcome, outcome at site of interest, outcome at other 
site – treated as competing risk). The results presented for this 
analysis were sub-hazard ratios (SHR) with 95% confidence intervals 
and an overall p-value for trend for each soil metal. All models were 
adjusted for the same confounding variables as shown in the previous 
corrected Cox models. Note that SHRs are not directly comparable to 
the HRs from stage 2 as they are derived from a subgroup of 
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outcomes. Furthermore, SHRs are not directly comparable between 
models (e.g. SHRs for upper GIT cancers will inhabit a different scale 
from those for stomach or bowel cancers); they can only be compared 
within a single model. The main estimates of interest were therefore 
the p-values for trend, which can be compared with those derived 
from the corrected model. For stage 3, all statistical analyses were 
performed in Stata 12.0 MP for Windows 7.0 (Stata Corporation, 
Station College, Texas, USA). 
6.5 Results 
6.5.1 Demographic characteristics 
The study was based on a prospective UK cohort of 1,812,477 
individuals in the English and Welsh areas. The total time for follow-
up in our study population between 2004 and 2013 was 17.3 million 
years. Among the participants, 17,477 developed a GIT cancer – these 
have an average duration of follow-up time of 4.89 years (SE: 0.021, 
IQR: 2.45–7.31). Out of 17,477 individuals who developed GIT cancer, 
malignant neoplasms of the large intestine (colon) were commonly 
recorded in THIN (7,461, 42.8%); followed by cancer of the rectum 
and anal canal (3,862, 22.2%); oesophageal cancer (2,867, 16.4%); 
stomach cancer (1,675, 9.6%); oral cancer (1,406, 8.1%); and cancer 
of the small intestine (ileum) (166, 0.95%). 
The overall demographic characteristics of the study population in 
relation GIT cancer are presented in (Table 6.1). It indicates that 
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proportion of those diagnosed with GIT cancers was greater in men 
(58.7%) than women (41.3%). It also shows that participants 
developing GITs were more likely to be in the older age groups (≥61 
years), from the least deprived groups (group I: 28.1%; group II: 
23.7%), whose a current drinker (moderate & hazardous: 52.8%) and 
some whose ever-smoked (current & ex-smoker: 45.0%).
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Table 6.1: Baseline demographic characteristics of participants for GIT cancer study, using THIN-GBASE database from 01-
Jan-2004 to 31-Dec-2013 
Characteristics   Without GIT cancer (1,800,040)  With GIT cancer (17,477)  Total (1,817,477) 
    N %  N %  N % 
Sex          
  Male  885,737 49.2  10,227 58.7  895,964 49.3 
  Female  914,303 50.8  7,210 41.3  921,513 50.7 
Agegroup          
  ≤40  670,099 37.2  406 2.3  670,505 36.9 
  41-50  336,678 18.7  1,366 7.8  338,044 18.6 
  51-60  310,924 17.3  3,471 19.9  314,395 17.3 
  61-70  222,079 12.3  5,130 29.4  227,209 12.5 
  71-80  163,577 9.1  5,040 28.9  168,617 9.3 
  81+  96,683 5.4  2,024 11.6  98,707 5.4 
BMI          
  <18.5  46,205 2.6  334 1.9  46,539 2.6 
  18.5-24.9  605,418 33.6  5,167 29.6  610,585 33.6 
  25-29.9  463,488 25.7  5,907 33.9  469,395 25.8 
  30+  261,709 14.5  3,217 18.4  264,926 14.6 
  Unknown  423,220 23.5  2,812 16.1  426,032 23.4 
Alcohol drinking patterns          
  Never  224,903 12.5  2,372 13.6  227,275 12.5 
  Ex-drinker  20,428 1.1  293 1.7  20,721 1.1 
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  Moderate  766,496 42.6  7,661 43.9  774,157 42.6 
  Hazardous  123,493 6.9  1,552 8.9  125,045 6.9 
  Harmful  18,081 1  339 1.9  18,420 1 
  Unknown  646,639 35.9  5,220 29.9  651,859 35.9 
Smoking status          
  Never  562,733 31.3  4,983 28.6  567,716 31.2 
  Non  281,787 15.7  2,726 15.6  284,513 15.7 
  Ex-smoker  247,682 13.8  4,408 25.3  252,090 13.9 
  Current  385,027 21.4  3,429 19.7  388,456 21.4 
  Unknown  322,811 17.9  1,891 10.8  324,702 17.9 
Socioeconomic deprivation          
  1st  514,246 28.6  4,903 28.1  519,149 28.6 
  2nd  398,736 22.2  4,141 23.7  402,877 22.2 
  3rd  363,350 20.2  3,466 19.9  366,816 20.2 
  4th  309,415 17.2  3,047 17.5  312,462 17.2 
  5th  199,567 11.1  1,788 10.3  201,355 11.1 
  Unknown  14,726 0.8  92 0.5  14,818 0.8 
Residential setting          
  Urban  1,429,290 79.4  13,515 77.5  1,442,805 79.4 
  Suburban  215,818 12  2,406 13.8  218,224 12 
  Rural  140,981 7.8  1,449 8.3  142,430 7.8 
  Unknown  13,951 0.8  67 0.4  14,018 0.8 
Health authorities          
  London  231,889 12.9  1,693 9.7  233,582 12.9 
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  East Midlands  58,761 3.3  600 3.4  59,361 3.3 
  East of England  137,463 7.6  1,312 7.5  138,775 7.6 
  West Midlands  203,723 11.3  1,933 11.1  205,656 11.3 
  North East  61,121 3.4  677 3.9  61,798 3.4 
  North West  219,452 12.2  2,470 14.2  221,922 12.2 
  Yorkshire & Humber  40,051 2.2  438 2.5  40,489 2.2 
  South Central  292,507 16.3  2,677 15.4  295,184 16.2 
  South East Coast  226,854 12.6  2,079 11.9  228,933 12.6 
  South West  196,679 10.9  2,144 12.3  198,823 10.9 
  Wales   131,540 7.3  1,414 8.1  132,954 7.3 
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6.5.2 Exploratory analysis for soil elements 
The greedy stepwise search algorithm for CFS found the following 
metals to be the most appropriate subset for modelling the risk of GIT 
cancer: aluminium, calcium, lead, manganese, phosphorus, uranium 
and zinc. Being that the elements were selected in successive order of 
importance – the result indicated that aluminium was the most 
important attribute present in the subset, followed by phosphorus, 
and zinc as the third. The attribute with the lowest importance was 
lead. The overall merit score was 0.0234 (or 2.34%) which indicated 
the error rate for selecting, and including attributes in a subset for 
model construction was low. The remaining elements not included 
were arsenic, chromium, copper, iron, nickel, selenium, silicon and 
vanadium (Table 6.2). 
The median concentrations for the selected soil metals among cases 
with GIT cancer (n = 17,477) were as follows: aluminium (median: 
52,300 mg/kg, IQR: 41,700-60,000 mg/kg); calcium (median: 5,600 
mg/kg, IQR: 3,200-13,200 mg/kg); lead (median: 69.0 mg/kg, IQR: 
46.0-137.0 mg/kg); manganese (median: 499.0 mg/kg, IQR: 373.0-
790.0 mg/kg); phosphorus (median: 960.0 mg/kg, IQR: 724.0-1,301.0 
mg/kg); uranium (median: 2.04 mg/kg, IQR: 1.63-2.45 mg/kg); and 
zinc (median: 94.0 mg/kg, IQR: 65.0-148.0 mg/kg) (Table 6.3). When 
comparing the soil concentration levels for elements that may 
potentially be harmful (or carcinogenic) – it was observed that the 
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median soil concentration levels for aluminium and uranium only were 
higher in cases than in controls. 
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Table 6.2: Show the soils elements selected for model construction and the order of sequence in which the subset were 
generated using the Correlation-based Filter Selection method 
Sequence  Order of selected attribute  Subset generated  
  Start set: no attribute  - [Start] 
1  Aluminium  {Aluminium}  
2  Phosphorus  {Aluminium, Phosphorus}  
3  Zinc  {Aluminium, Phosphorus, Zinc}  
4  Uranium  {Aluminium, Phosphorus, Zinc, Uranium}  
5  Calcium  {Aluminium, Phosphorus, Zinc, Uranium, Calcium}  
6  Manganese  {Aluminium, Phosphorus, Zinc, Uranium, Calcium, Manganese}  
7  Lead  {Aluminium, Phosphorus, Zinc, Uranium, Calcium, Manganese, Lead} [End] 
     
Overall merit score (i.e. error rate) 0.0234 
 
      
  Excluded attributes:  Arsenic, Chromium, Copper, Iron, Nickel, Selenium, Silicon, Vanadium  
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Table 6.3: Showing the residential soil’s average (arithmetic mean) and median (with interquartile ranges) concentration 
levels for selected metallic elements among study population from THIN-GBASE data 
Soil metallic element  Without GIT cancer  With GIT cancer 
  Mean (SE) Median (IQR)  Mean (SE) Median (IQR) 
Aluminium [mg/kg]  49,981.5 (12.1) 51,400.0 (40,500-59,300)  50,959.3 (121.2) 52,300.0 (41,700-60,000) 
Calcium [mg/kg]  15,369.4 (20.9) 6,600.0 (3,300-14,300)  14,987.4 (214.2) 5,600.0 (3,200-13,200) 
Lead [mg/kg]  126.2 (0.11) 72.0 (47-158)  114.4 (0.93) 69.0 (46-137) 
Manganese [mg/kg]  613.4 (0.29) 492.0 (380-765)  623.8 (3.11) 499.0 (373-790) 
Phosphorus [mg/kg]  1084.5 (0.40) 986.0 (729-1352)  1057.8 (3.98) 960.0 (724-1301) 
Uranium [mg/kg]  2.10 (0.00048) 1.98 (1.58-2.40)  2.06 (0.00493) 2.04 (1.63-2.45) 
Zinc [mg/kg]  132.7 (0.099) 99.0 (67-164)  124.4 (0.927) 94.0 (65-148) 
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6.5.3 Results for overall gastrointestinal cancers 
6.5.3.1 Mutually adjusted Cox multivariable regression 
model 
Before deriving the hazard ratios for the soil exposure categories for 
each of the selected elements, we carried out a diagnostic test based 
on the Schoenfeld’s residuals to assess the proportional-hazards 
assumption. It shows no evidence that the model specification for the 
subset of selected elements (aluminium, calcium, lead, manganese, 
phosphorus and zinc) violates the proportional-hazards assumption 
(global test: p-value = 0.40). In addition, all p-values for each 
category for the individual soil elements were non-significant (p > 
0.05) (Table 6.4). 
Our mutually adjusted model containing the subset of soil metals only 
suggested that there was no evidence of increased, nor a decreased 
risk of GIT cancer for participants living in areas with soil containing 
calcium, lead and manganese (Table 6.5). However, it was observed 
that participants living on residential soil with elevated 
concentrations of uranium were likely to have an increased risk of 
developing GIT cancer (Group II: HR 1.10, 95% CI: 1.05-1.17; Group III: 
HR 1.11, 95% CI: 1.06-1.18; Group IV: HR 1.09, 95% CI: 1.03-1.16; 
Group V: HR 1.15, 95% CI: 1.08-1.22). Especially, those with the 
highest exposure (Group V: 2.5-61.2 uranium mg/kg of topsoil) were 
at a 15% increased risk of developing the malignancy compared to 
those in the lowest exposure (Group I: < 1.49 uranium mg/kg of 
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topsoil). The trends test indicates that the pattern of increase in risk 
of GIT cancer. Although, the patterns were increasing non-linear, the 
risk patterns appeared to be significant for elevated exposure groups 
for soil uranium (p < 0.001) (Table 6.5). 
There was an increased risk of GIT cancer for participants living in 
areas with medium to highest soil concentration levels of aluminium 
(Group III: HR 1.07, 95% CI: 1.01-1.14; Group IV: HR 1.09, 95 CI%: 
1.03-1.17; Group V: HR 1.07, 95% CI: 1.01-1.15). The inspection of HRs 
shows that the increased risk of GIT cancer in groups III to V remains 
stationary between 7.0-9.0%. The overall pattern in terms of 
increased risk was significant (p < 0.001); such pattern was probably 
captured in the apparent increase that occurs between exposure 
group II and IV (Table 6.5). 
Evidence of an increased risk of GIT cancer was seen for soil 
phosphorus, whereby the apparent risks appeared to be confined to 
residents living on soil with medium concentration levels (Group II: HR 
1.09, 95% CI: 1.04-1.15; Group III: HR 1.12, 95% CI: 1.07-1.19; Group 
III: HR 1.08, 95% CI: 1.02-1.15). However, due the inverted U-shape 
seen for the exposure categories for phosphorus and such trends in 
elevated risk of GIT cancer were rendered non-significant (p = 0.36) 
(Table 6.5). 
Participants in areas with elevated soil concentrations of zinc were at 
a significantly reduced risk of developing GIT cancer (Group II: HR 
0.91, 95% CI: 0.85-0.96; Group III: HR 0.83, 95% CI: 0.78-0.85; Group 
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IV: HR 0.85, 95% CI: 0.79-0.92; Group V: HR 0.83, 95% CI: 0.76-0.90). 
With the exception of group II exposures (60.0-85.0 zinc mg/kg of 
topsoil), it is apparent that the reduced effect of soil zinc on GIT 
cancer risk remain stationary between 15.0-17.0% across exposure 
groups III to V. Although the patterns in HRs seem to appear non-linear 
between groups I-III, and plateaued after zinc concentrations of above 
85.0 mg/kg; the overall reduction in risk patterns was significant (p < 
0.001) (Table 6.5). 
 
  
1
9
8
 
Table 6.4: Test of proportional-hazards assumption for mutually adjusted model for assessing risk of gastrointestinal tract 
cancer with the selected group of soil metals using the Schoenfeld’s residual test 
Soil element  Al1  Ca2  Pb3  Mn4  P5  U6  Zn7 
    p-value  p-value  p-value  p-value  p-value  p-value  p-value 
  Exposure groups               
    Group I  -  -  -  -  -  -  - 
    Group II  0.44  0.33  0.41  0.22  0.16  0.51  0.97 
    Group III  0.18  0.39  0.93  0.32  0.23  0.32  0.47 
    Group IV  0.75  0.70  0.71  0.80  0.66  0.79  0.94 
    Group V  0.39  0.71  0.42  0.77  0.41  0.18  0.23 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) – for completeness – its left in 
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Table 6.5: Using mutually adjusted multivariable Cox regression model to estimate hazard ratios (HR) for gastrointestinal tract (GIT) 
cancer in association with aluminium, calcium, lead, manganese, phosphorus, uranium and zinc, using THIN-GBASE database from 01-
Jan-2004 to 31-Dec-2013 
Soil element Al1 Ca2 Pb3 Mn4 P5 U6 Zn7 
 HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Exposure groups        
 Group I 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 Group II 0.93 (0.88-1.00) 1.02 (0.97-1.08) 0.95 (0.91-1.00) 0.92 (0.87-0.97) 1.09 (1.04-1.15) 1.10 (1.05-1.17) 0.91 (0.85-0.96) 
 Group III 1.07 (1.01-1.14) 0.98 (0.94-1.04) 1.04 (0.98-1.09) 0.95 (0.90-1.01) 1.12 (1.07-1.19) 1.11 (1.06-1.18) 0.83 (0.78-0.89) 
 Group IV 1.09 (1.03-1.17) 0.94 (0.88-1.00) 1.01 (0.95-1.07) 0.99 (0.93-1.04) 1.08 (1.02-1.15) 1.09 (1.03-1.16) 0.85 (0.79-0.92) 
 Group V 1.07 (1.01-1.15) 0.99 (0.94-1.05) 0.94 (0.87-1.01) 1.01 (0.95-1.07) 1.04 (0.97-1.11) 1.15 (1.08-1.22) 0.83 (0.76-0.90) 
        
Trend test p < 0.001 p = 0.14 p = 0.39 p = 0.18 p = 0.36 p < 0.001 p < 0.001 
Hazard ratio (HR); 95% Confidence Interval (95% CI) 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) 
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6.5.3.2 Corrected Cox multivariable regression model 
Testing of the proportional-hazards assumption was performed to 
ensure that the proportional-hazards assumption remained valid when 
assessing the hazard ratios for the selected soil elements with the 
inclusion of confounding factors - including age, gender, BMI, drinking 
status, smoking status and socioeconomic deprivation.  
There was an overall violation of the model assumptions (global test: 
p < 0.001) caused by the following categories in BMI (i.e. category I: 
<18.5; category III: 25-29.9; and category IV: 30+) and ages (i.e. group 
IV: 61-70; group V: 71-80; and group VI: 80+ years) (Table 6.6; Table 
6.7). With the exception of BMI and age groups, the model 
specification for the main soil exposure, and remaining confounding 
factors did not violate the proportional-hazard assumptions, and 
therefore, further diagnostic test using the Aalen plots were carried 
out on the identified variables to remove the time-varying effects. 
As performed in previous sections (see 5.4.3.2), the time-varying 
effects for each category affected by non-proportional hazards were 
identified through Aalen plots to examine the patterns of the 
estimated cumulative hazards regression coefficients. Visual 
inspection of the Aalen plots enables parameterisation and removal of 
time-vary effects through the creation of time-based interval-specific 
covariates based on the affected categories (Figure 6.1-6.6).
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Table 6.6: Test of proportional-hazards assumption for the corrected model which includes confounding factors for assessing the risk 
of gastrointestinal tract cancer with the selected group soil elements using Schoenfeld’s residuals (part one) 
Soil element  Al1  Ca2  Pb3  Mn4  P5  U6  Zn7 
    p-value  p-value  p-value  p-value  p-value  p-value  p-value 
  Exposure groups               
    Group I  -  -  -  -  -  -  - 
    Group II  0.40  0.23  0.52  0.22  0.10  0.35  0.73 
    Group III  0.15  0.36  0.91  0.27  0.17  0.39  0.73 
    Group IV  0.66  0.53  0.83  0.77  0.57  0.90  0.86 
    Group V  0.30  0.81  0.52  0.73  0.47  0.20  0.27 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0); 8 Global test; p-value < 0.001 
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Table 6.7: Test of proportional-hazards assumption for the corrected 
model which includes confounding factors for assessing the risk of GIT 
cancer with the selected group soil elements using Schoenfeld’s residuals 
(part two) 
Confounding variables  Schoenfeld test 
  p-value 
Sex   
  Male (referent)  - 
  Female  0.06 
Age group (years)   
  ≤ 40 (referent)  - 
  41-50  0.73 
  51-60  0.06 
  61-70  < 0.001 
  71-80  < 0.001 
  +81  < 0.001 
Body mass index (BMI)   
  <18.5  0.002 
  18.5-24.9 (referent)  - 
  25.0-29.9  0.001 
  +30  < 0.001 
  Unknown  0.12 
Smoking status   
  Never smoked (referent)  - 
  Non-smoker  0.69 
  Ex-smoker  0.83 
  Current smoker  0.26 
  Unknown  0.57 
Drinking status   
  Never (referent)  - 
  Ex-drinker  0.44 
  Moderate  0.23 
  Hazardous  0.21 
  Harmful  0.28 
  Unknown  0.59 
Socioeconomic deprivation   
  Group I (referent)  - 
  Group II  0.85 
  Group III  0.30 
  Group IV  0.15 
  Group V  0.11 
  Unknown  0.72 
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Figure 6.1: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
with BMI value < 18.5 (versus those with a BMI between 18.5-24.9). The vertical dashed lines are cut-points at 1.5 & 4.5 which show 
the change in slope of the cumulative hazard function. The following three time-based interval-specific effects for the BMI category 
were generated using the above cut-points: Early effects (t ≤ 1.5), Middle effects (1.5 < t ≤ 4.5) and late effects (t > 4.5)       
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Figure 6.2: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
with BMI value between 25-29.9 (versus those with a BMI between 18.5-24.9). The vertical dashed lines are cut-points at 1.2, 2.0 & 
4.5 which show the change in slope of the cumulative hazard function. The following four time-based interval-specific effects for the 
BMI category were generated using the above cut-points: Early effects (t ≤ 1.2), early-to-middle effects (1.2 < t ≤ 2.0), middle-late 
effects (2.0 < t ≤ 4.5) and late effects (>4.5)  
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Figure 6.3: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
with BMI value 30+ (versus those with a BMI between 18.5-24.9). The vertical dashed lines are cut-points at 1.2, 2.0 & 4.5 which show 
the change in slope of the cumulative hazard function. The following four time-based interval-specific effects for the BMI category 
were generated using the above cut-points: Early effects (t ≤ 1.2), early-to-middle effects (1.2 < t ≤ 2.0), middle-late effects (2.0 < t ≤ 
6.0) and late effects (>6.0) 
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Figure 6.4: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
who were 61-70 years of age (versus those with ages ≤ 40 years). The changes in the hazard function in the above output were 
inconspicuous therefore cut-points were specified at a set interval of 2.5 years to eliminate the time-varying effects. The following 
four time-based interval-specific effects for the age group were generated using the proposed cut-points: Early effects (t ≤ 2.5), early-
middle effects (2.5 < t ≤ 5.0), middle-late effects (5.0 < t ≤ 7.5) and late effects (> 7.5) 
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Figure 6.5: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
who were 71-80 years of age (versus those with ages ≤ 40 years). The changes in the hazard function in the above output were 
inconspicuous therefore cut-points were specified at a set interval of 2.5 years to eliminate the time-varying effects. The following 
four time-based interval-specific effects for the age group were generated using the proposed cut-points: Early effects (t ≤ 2.5), early-
middle effects (2.5 < t ≤ 5.0), middle-late effects (5.0 < t ≤ 7.5) and late effects (> 7.5) 
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Figure 6.6: Aalen plot showing the estimated cumulative regression coefficients for GIT cancer patients (with 95% confidence interval) 
who were 81+ years of age (versus those with ages ≤ 40 years). The changes in the hazard function in the above output were 
inconspicuous therefore cut-points were specified at a set interval of 2.5 years to eliminate the time-varying effects. The following 
four time-based interval-specific effects for the age group were generated using the proposed cut-points: Early effects (t ≤ 2.5), early-
middle effects (2.5 < t ≤ 5.0), middle-late effects (5.0 < t ≤ 7.5) and late effects (> 7.5)
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The original categories were replaced and refitted in the corrected 
models using their time-based interval-specific counterparts to ensure 
successful removal of any time-varying effects (all variables with p > 
0.05) (Table 6.8). After adjusting for confounding factors in the 
corrected model, this lead to marginal reductions in the estimated 
hazard ratios of the selection of soil elements (Table 6.9). With the 
exception of soil phosphorus which retained it statistical significance 
for its exposure groups (Group III: HR 1.08, 95% CI: 1.02-1.14; Group 
IV: HR 1.07, 95% CI: 1.01-1.13; Group V: HR 1.07, 95% CI: 1.01-1.13); 
soil aluminium, uranium and zinc estimates were rendered non-
significant after inclusion of confounding variables. All other 
exposures for the remaining elements were not statistically 
significant. In terms of trends, the important patterns of association 
that we examined for aluminium and phosphorus did not differ from 
previous results found in our mutually adjusted model (p < 0.05). In 
contrast, previous patterns that were found to be significant for soil 
uranium and zinc were negated after including confounding factors (p 
> 0.05) (Table 6.9). 
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Table 6.8: Test of proportional-hazards assumption for confounding factors in the 
corrected multivariable Cox regression model using Schoenfeld’s residuals after using 
Aalen plots to remove time-varying effects for age groups and BMI 
Confounding variables  P-value 
Sex   
  Male (referent)  - 
  Female  0.06 
Age group (years)   
  ≤ 40 (referent)  - 
  41-50  0.73 
  51-60  0.06 
  61-70  < 0.001 
    (1) early effect t = [0.0, 2.5) 0.08 
    (2) early-to-middle effect t = [2.5, 5.0) 0.24 
    (3) mid to late effect t = [5.0, 7.5) 0.25 
    (4) late effect               t = [7.5, 10) 0.34 
  71-80  < 0.001 
    (1) early effect  t = [0.0, 2.5) 0.20 
    (2) early to mid effect t = [2.5, 5.0) 0.19 
    (3) mid to late effect t = [5.0, 7.5) 0.21 
    (4) late effect t = [7.5, 10) 0.24 
  +81  < 0.001 
    (1) early effect  t = [0.0, 2.5) 0.17 
    (2) early to mid effect t = [2.5, 5.0) 0.18 
    (3) mid to late effect t = [5.0, 7.5) 0.29 
    (4) late effect t = [7.5, 10) 0.28 
Body mass index (BMI)   
  <18.5 (category 1)   
    (1) early effect  t = [0.0, 1.5) 0.98 
    (2) mid effect  t = [1.5, 4.5) 0.99 
    (3) late effect t = [4.5, 10) 0.61 
  18.5-24.9 (referent)  - 
  25.0-29.9 (category 3)   
    (1) early effect  t = [0.0, 1.5) 0.45 
    (2) early to mid effect t = [1.5, 2.0) 0.79 
    (3) mid to late effect t = [2.0, 4.5) 0.56 
    (4) late effect t = [4.5, 10) 0.41 
  +30 (category 4)   
    (1) early effect   t = [0.0, 1.5) 0.58 
    (2) early to mid effect t = [1.5, 2.0) 0.78 
    (3) mid to late effect t = [2.0, 6.0) 0.71 
    (4) late effect t = [6.0, 10) 0.28 
  Unknown (category 5)  0.12 
Smoking status   
  Never smoked (referent)  - 
  Non-smoker  0.80 
  Ex-smoker  0.86 
  Current smoker  0.25 
  Unknown  0.60 
Drinking status   
  Never (referent)  - 
  Ex-drinker  0.41 
  Moderate  0.21 
  Hazardous  0.19 
  Harmful  0.27 
  Unknown  0.53 
Socioeconomic deprivation   
  Group I (referent)  - 
  Group II  0.85 
  Group III  0.34 
  Group IV  0.12 
  Group V  0.06 
  Unknown  0.86 
Global test: p-value = 0.89 
 
  
 
2
1
1
 
Table 6.9: Using a corrected multivariable Cox regression model to estimate hazard ratios (HR) for GIT cancer in association with aluminium, 
calcium, lead, manganese, phosphorus, uranium and zinc, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013 
Soil element Al1 Ca2 Pb3 Mn4 P5 U6 Zn7 
 HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Exposure groups        
 Group I 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 Group II 0.94 (0.89-1.00) 0.96 (0.91-1.01) 0.99 (0.95-1.04) 0.97 (0.92-1.03) 1.03 (0.98-1.09) 0.99 (0.95-1.05) 0.98 (0.93-1.05) 
 Group III 1.04 (0.98-1.10) 0.95 (0.91-1.01) 1.08 (1.03-1.14) 0.99 (0.93-1.05) 1.08 (1.03-1.14) 1.00 (0.95-1.06) 0.92 (0.86-0.98) 
 Group IV 1.07 (1.02-1.14) 0.91 (0.86-0.97) 1.02 (0.96-1.08) 0.96 (0.91-1.02) 1.06 (1.01-1.13) 0.98 (0.92-1.04) 0.94 (0.87-1.01) 
 Group V 1.06 (0.99-1.13) 0.94 (0.89-1.00) 0.97 (0.90-1.05) 1.01 (0.95-1.06) 1.07 (1.01-1.14) 1.02 (0.97-1.09) 0.93 (0.86-1.02) 
        
Trend test p = 0.001 p = 0.01 p = 0.81 p = 0.99 p = 0.04 p = 0.63 p = 0.08 
Hazard ratio (HR); 95% Confidence Interval (95% CI) 
Adjustments include age groups (post-Aalen diagnostics), gender, smoking status, BMI (post-Aalen diagnostics), drinking behaviour and socioeconomic 
deprivation  
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) 
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6.5.3.3 Stratified analysis based on residential settings 
The patterns of GIT cancer risk in relation to soil aluminium, calcium, 
phosphorus and uranium differed depending on the types of 
residential environment. Aluminium appeared to be the only element 
which significantly increased the risk of GIT cancer among suburban 
residents only - whereby the increased risks of GIT in suburban areas 
appeared to be between 21.0 and 24.0% for exposure groups III, IV & V 
(p = 0.011) (Figure 6.7). For calcium, there was a significant dose-
response pattern of a linear nature within the urban residential areas, 
whereby the risks decreased significantly with increasing 
concentration levels of soil calcium between exposure groups II-IV (p = 
0.014) (Figure 6.8). For soil phosphorus, the risks were confined to 
urban residents where the risk GIT cancer increases as elevated 
concentration levels for phosphorus reaches up to 1,127 mg/kg, and 
the risks of GIT cancer appears to plateau ranging between 9.0-12.0% 
(p-value = 0.034) (Figure 6.11). Finally, there was a significant 
increase in risk for those living in urban areas with the highest soil 
concentrations of soil uranium (group V: HR 1.08 95% CI: 1.01-1.17); 
however, there are no clear risk patterns shown for uranium in other 
residential settings (p = 0.07) (Figure 6.12).  
The remaining exposure groups for all other elements – lead (Figure 
6.9), manganese (Figure 6.10) and zinc (Figure 6.13) - were non-
significant in all different environmental settings, with unclear 
patterns (p > 0.05). 
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Figure 6.7: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil aluminium, using THIN-GBASE database 01-01-2004 to 
31-12-2013. The stratified model included other primary exposures - soil calcium, lead, manganese, phosphorus, uranium and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots 
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Figure 6.8: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil calcium, using THIN-GBASE database 01-01-2004 to 31-
12-2013. The stratified model included other primary exposures - soil aluminium, lead, manganese, phosphorus, uranium and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots
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Figure 6.9: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil lead, using THIN-GBASE database 01-01-2004 to 31-12-
2013. The stratified model included other primary exposures - soil aluminium, calcium, manganese, phosphorus, uranium and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots 
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Figure 6.10: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil manganese, using THIN-GBASE database 01-01-2004 to 
31-12-2013. The stratified model included other primary exposures - soil aluminium, calcium, lead, phosphorus, uranium and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots
  
2
1
7
 
 
Figure 6.11: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil phosphorus, using THIN-GBASE database 01-01-2004 to 
31-12-2013. The stratified model included other primary exposures - soil aluminium, calcium, lead, manganese, uranium and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots
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Figure 6.12: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil uranium, using THIN-GBASE database 01-01-2004 to 31-
12-2013. The stratified model included other primary exposures - soil aluminium, calcium, lead, manganese, phosphorus and zinc, and were 
adjusted for sex, age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-
specified covariates derived from earlier Aalen plots
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Figure 6.13: Modified scatter plot with range capped spikes were used to represent HR estimates derived from a stratified Cox regression model 
based on residential classification to show the association between GIT cancer risk and soil zinc, using THIN-GBASE database 01-01-2004 to 31-12-
2013. The stratified model included other primary exposures - soil aluminium, calcium, lead, manganese and uranium, and were adjusted for sex, 
age group, BMI, drinking alcohol status, smoking status, socioeconomic deprivation and categories fitted as time-based interval-specified covariates 
derived from earlier Aalen plots 
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6.5.3.4 Sensitivity analyses using competing risk models 
When comparing trend p-values derived from competing risk models 
we found that the direction and patterns of risk for certain elements 
were more pronounced for particular sub outcomes. For upper GIT 
cancers, the relationship for soil calcium shows an overall downwards 
pattern indicating a significant reduction in risk of upper GIT cancer 
with increased concentrations of soil calcium (p = 0.03). This pattern 
appeared to be consistent with those found in the mutually adjusted 
model. However, it appears the trends’ p-value for aluminium and 
phosphorus was sensitive to the stratification of outcomes, their 
previous trend patterns of an increased risk were rendered non-
significant for upper GIT cancer (p= 0.05 & 0.08, respectively) when 
negating the competing effects of stomach and bowel cancers.  
However, the patterns of risk for aluminium appeared to be non-
sensitive when stomach cancer was the primary outcome (vs. upper 
GIT & bowel cancer). Similar to the correct model, it retains its 
significant positive association, indicating that increased exposure to 
soil aluminium may specifically be linked to stomach cancer (p=0.02). 
The trend patterns for the remaining elements were not significant in 
all models despite the attempt to negate the effects of competing 
outcomes. 
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Table 6.10: Using an adjusted multivariate competing risk model to estimate sub-hazard ratios (SHR) for upper GIT cancers in 
association with selected soil elements, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013 
Soil element Al1 Ca2 Pb3 Mn4 P5 U6 Zn7 
 SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) 
Exposure groups        
 Group I 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 Group II 1.02 (0.91-1.14) 0.98 (0.89-1.09) 1.00 (0.91-1.12) 0.89 (0.80-1.00) 1.02 (0.92-1.13) 1.05 (0.94-1.16) 1.01 (0.89-1.12) 
 Group III 1.14 (1.02-1.28) 0.93 (0.83-1.03) 1.08 (0.97-1.20) 0.95 (0.85-1.06) 1.04 (0.94-1.17) 1.00 (0.89-1.13) 0.95 (0.84-1.08) 
 Group IV 1.15 (1.02-1.30) 0.81 (0.72-0.92) 1.06 (0.94-1.19) 0.88 (0.79-0.98) 1.05 (0.93-1.18) 1.01 (0.89-1.13) 0.93 (0.79-1.07) 
 Group V 1.08 (0.94-1.23) 0.95 (0.85-1.06) 1.03 (0.88-1.20) 0.91 (0.81-1.01) 1.07 (0.93-1.22) 1.05 (0.92-1.18) 0.95 (0.80-1.13) 
        
Trend test p = 0.08 p = 0.03* p = 0.55 p = 0.12 p = 0.34 p = 0.74 p = 0.38 
Sub-hazard ratio (SHRs); 95% Confidence Interval (95% CI) 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) 
* p-value for trend < 0.05 
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Table 6.11: Using an adjusted multivariate competing risk model to estimate sub-hazard ratios (SHR) for stomach cancers in 
association with selected soil elements, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013 
Soil element Al1 Ca2 Pb3 Mn4 P5 U6 Zn7 
 SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) 
Exposure groups        
 Group I 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 Group II 0.84 (0.72-1.01) 0.98 (0.84-1.16) 1.04 (0.86-1.23) 0.95 (0.81-1.14) 0.99 (0.99-1.14) 0.98 (0.91-1.04) 0.89 (0.73-1.08) 
 Group III 0.98 (0.84-1.20) 0.98 (0.82-1.17) 1.27 (1.07-1.52) 0.90 (0.76-1.10) 1.05 (1.05-1.18) 0.99 (0.93-1.08) 0.99 (0.80-1.22) 
 Group IV 1.04 (0.87-1.28) 0.90 (0.76-1.10) 1.20 (0.99-1.45) 0.98 (0.83-1.18) 0.99 (0.99-1.16) 0.96 (0.89-1.03) 0.97 (0.76-1.24) 
 Group V 1.17 (0.98-1.47) 0.95 (0.80-1.14) 1.22 (0.95-1.56) 0.90 (0.75-1.10) 0.99 (0.99-1.27) 0.99 (0.93-1.08) 0.86 (0.64-1.13) 
        
Trend test p < 0.001 p = 0.14 p = 0.39 p = 0.18 p = 0.36 p < 0.001 p < 0.001 
Sub-Hazard ratio (HR); 95% Confidence Interval (95% CI) 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) 
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Table 6.12: Using an adjusted multivariate competing risk model to estimate sub-hazard ratios (SHR) for colorectal cancers in 
association with selected soil elements, using THIN-GBASE database from 01-Jan-2004 to 31-Dec-2013  
Soil element Al1 Ca2 Pb3 Mn4 P5 U6 Zn7 
 SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) 
Exposure groups        
 Group I 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 Group II 0.93 (0.88-0.99) 0.96 (0.89-1.02) 0.99 (0.93-1.05) 1.02 (0.85-1.08) 1.05 (0.99-1.12) 0.98 (0.91-1.04) 0.99 (0.92-1.06) 
 Group III 1.01 (0.95-1.08) 0.98 (0.90-1.03) 1.16 (0.99-1.13) 1.03 (0.96-1.10) 1.11 (1.05-1.18) 0.99 (0.93-1.07) 0.89 (0.82-0.96) 
 Group IV 1.06 (0.98-1.14) 0.96 (0.88-1.03) 0.99 (0.91-1.06) 1.00 (0.94-1.07) 1.07 (0.99-1.15) 0.96 (0.89-1.03) 0.94 (0.85-1.02) 
 Group V 1.03 (0.96-1.12) 0.95 (0.88-1.00) 0.92 (0.85-1.02) 1.07 (0.99-1.04) 1.08 (0.99-1.16) 0.99 (0.93-1.07) 0.94 (0.84-1.05) 
        
Trend test p < 0.001 p = 0.14 p = 0.39 p = 0.18 p = 0.36 p < 0.001 p < 0.001 
Sub-Hazard ratio (SHR); 95% Confidence Interval (95% CI) 
1 Soil aluminium [Al] (mg/kg) was categorised as quintiles: group I (Al < 37,100), group II (37,100 ≤ Al < 47,200), group III (47,200 ≤ Al < 54,700), group IV 
(54,700 ≤ Al < 61,600) and group V (Al ≥ 61,600); 2 Soil calcium [Ca] (mg/kg) was categorised as quintiles: group I (Ca < 3,000), group II (3,000 ≤ Ca < 
4,700), group III (4,700 ≤ Ca < 8,800), group IV (8,800 ≤ Ca < 17,100) and group V (Ca ≥ 17,100); 3 Soil lead [Pb] (mg/kg) was categorised as quintiles: 
group I (Pb < 44.0), group II (44.0 ≤ Pb < 60.0), group III (60.0 ≤ Pb < 95.0), group IV (95.0 ≤ Pb < 184.0) and group V (Pb ≥ 184.0); 4 Soil manganese [Mn] 
(mg/kg) was categorised as quintiles: group I (Mn < 345), group II (345 ≤ Mn < 444), group III (444 ≤ Mn < 572), group IV (572 ≤ Mn < 867) and group V (Mn 
≥ 867); 5 Soil phosphorus [P] (mg/kg) was categorised as quintiles: group I (P < 680), group II (680 ≤ P < 873), group III (873 ≤ P < 1,127), group IV (1,127 
≤ P < 1,456) and group V (P ≥ 1,456); 6 Soil uranium [U] (mg/kg) was categorised as quintiles: group I (U < 1.49), group II (1.49 ≤ U < 1.83), group III 
(1.83 ≤ U < 2.16), group IV (2.16 ≤ U < 2.50) and group V (U ≥ 2.50); 7 Soil zinc [Zn] (mg/kg) was categorised as quintiles: group I (Zn < 60.0), group II 
(60.0 ≤ Zn < 85.0), group III (85.0 ≤ Zn < 115.0), group IV (115.0 ≤ Zn < 186.0) and group V (Zn ≥ 186.0) 
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6.6 Discussion 
This study uses a unique three-stage approach in an attempt to show 
the association between the risk of developing various GIT cancers 
and with elevated concentrations of metallic elements present in 
residential soil.  
In stage one; aluminium, calcium, lead, manganese, phosphorus, 
uranium and zinc were identified as the set of important exposures for 
modelling GIT cancer risk. In stage two; a mutually adjusted model 
showed evidence of an increased risk of GIT cancer for participants 
residing in areas with higher concentrations for soil aluminium, 
phosphorus and uranium. It also showed a reduction in risk of GIT 
cancer for participants living on residential soil containing elevated 
levels soil zinc. However, these findings from the initial model 
disappeared after taking into account of age, gender, alcohol 
consumption, smoking status, BMI and levels of socioeconomic 
deprivation. The only exposure group that retained its statistical 
significance after adjustments for confounding was soil phosphorus. 
Further analysis in stage 2 included the usage of stratified models. It 
showed that the marginal risks appeared to be confined to residents 
living in urban and suburban areas, whereby they had the highest 
exposure for soil phosphorus (>1,127 mg/kg) and uranium (> 2.5 
mg/kg); and a weak positive dose-relationship for soil aluminium, 
respectively. Finally, in stage three, our competing risk models had 
shown a possible association for the following: (1) a trends reduction 
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in risk of upper GIT cancer in relation to soil calcium; and (2) an 
increased risk of stomach cancer in association with soil aluminium. 
There were no meaningful relationships for any of the remaining 
elements with the sub outcomes when attempting to negate the 
effects of competing events. 
One of the key advantage for using the CFS method was that it 
provided an analytical, and yet, an objective approach for 
determining which set of soil metallic elements were appropriate for 
model construction that would optimally predict GIT cancer risk. The 
algorithm for this analysis had accurately selected meaningful 
elements that, in some way, have a plausible relationship with various 
GIT cancers. For instance, recent studies have shown evidence of the 
beneficial effects for dietary calcium, manganese and zinc; they have 
indicated that higher levels and intake of these trace elements in food 
(or in supplements) were associated with a reduced risk of developing 
colon cancers.254–259  Also, the IARC have ranked lead and uranium as 
carcinogenic agents with the potential to cause a wide spectrum of 
cancers in humans.46,197,198 In contrast, aluminium and phosphorous 
are yet to be recognised by the IARC as carcinogenic agents46. 
For aluminium, an initial positive association was found with GIT 
cancer after mutually adjusted for other elements. However, this 
positive relationship disappeared after correcting for confounding 
factors. The results derived from the corrected model takes 
precedence over the mutually adjusted model since it takes into 
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account confounding; therefore, we found no consistent evidence of 
any links between soil aluminium and overall risk of developing GIT 
cancer. In addition, our model detected an increasing trend for risk of 
stomach cancers only. Due to the limitations of this epidemiological 
research (i.e. residual confounding and bias), further studies are 
needed to confirm or refute our findings. According to some research, 
the amounts of aluminium derived from soil and absorbed via GIT 
tract are considered negligible to cause toxicity.202,205,260 This 
assertion is based on empirical studies that have derived oral 
bioavailability indexes for aluminium based on data that has been 
theoretically assumed for humans, which have shown that aluminium 
is derived largely from particulate matter and contaminated drinking 
water. These study have shown that the oral bioavailability for 
aluminium from foods were estimated to be between 0.05-0.1%; 
whereas from ambient air and drinking water, they were >0.1-0.2% 
and ~0.3%, respectively.202,205,260 At present, there is no current data 
showing the uptake of soil aluminium in animals. 
A similar observation was found for uranium. The initial model had 
shown a positive association with GIT cancer with increased exposure 
of uranium. However, the association disappeared after correcting for 
other risk factors. The results derived from the corrected model takes 
precedence over the mutually adjusted model; therefore, we were 
unable to identify an overall association for GIT cancers with soil 
uranium. In addition, our sensitivity analyses were unable to pick up 
any significant trends despite negating the effects of competing 
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outcomes. The carcinogenic nature of uranium has been established in 
previous studies;197,261 however, most studies relating uranium 
exposures are focused of drinking water. For instance, a study used an 
ecological design and observed that elevated concentrations of 
uranium in wells use local residents in rural areas of South Carolina 
(US) had an increased risk of colorectal, breast, kidney and prostate 
cancer.197 Furthermore, past studies in Pennsylvania (US) and New 
Mexico (US) have shown that the incidence of stomach cancers were in 
correlation with elevated levels of uranium and radon in both drinking 
water and soil. 251 This was the first study to explore the potential 
relationship between soil uranium and risk of GIT cancers in the UK. 
Overall, this study suggests that there is no consistent or strong 
association which is a reassuring result because currently the presence 
of uranium in major areas of South West England and Southern Wales 
is of a huge concern, where elevated levels and decay of top soil 
uranium that gives significant rise to radon. It is emitted as radon in a 
form of radioactive gas typically at low-levels. The nature of this gas 
is that it has the properties of permeating through built environments 
in which it accumulates leading to increased levels of indoor radon in 
air.199,200  Long-term exposure through inhalation or ingestion of 
indoor radon contributes significantly to the risk of developing lung 
and GIT cancer.181 197,261 This may possibly explain the observed risk 
found among urban residents with the highest exposure of soil 
uranium ranging from levels of 2.5 mg/kg and above who had a 
modest increase in risk of GI cancer (Figure 6.12); however, this result 
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should be interpreted with caution due to the limitations of other 
residual confounding in this study.  
The observed relationship between elevated concentrations of soil 
phosphorus and GIT cancer (overall) remained consistent throughout 
both models. It showed that there was general increased risk of GIT 
cancers for residents living on soil phosphorus that have 
concentrations above 873.0 mg/kg, and that, such increased risk 
ranged between 6-8%. Our results are similar to findings of a previous 
study which quantified cancer risks using serum levels of inorganic 
phosphate as a proxy for environmental exposure.262 Laboratory-based 
studies using rodents have shown elevated serum levels of inorganic 
phosphate causes a modification in their gene expression and protein 
translation, which, in turn, affects the rate of cell proliferation in 
vitro. In addition, the entry of large amounts of inorganic phosphate 
in diet has been indicated to increase the development of lung and 
cutaneous cancers in rodents. It is through these observations that the 
potential link with carcinogenesis was extrapolated on to humans. In 
addition, soil phosphorous concentrations are usually high in 
residential areas mostly due to urban development; the frequent 
contact with environmental phosphorus in urban areas could be a 
possible explanation for finding a weak positive dose-response 
relationship between elevated levels of soil phosphorus and GIT 
cancer. 
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For zinc, our initial model had shown that elevated soil levels were 
associated with a risk reduction of developing GIT cancer. Although 
the direction in the patterns of risk remained in the corrected model; 
however, the findings were no longer significant after including 
confounding variables. In addition, we could not find any plausible 
link with the sub outcomes. Zinc is among the elements considered to 
be essential to humans.5  Zinc deficiency commonly leads to growth 
retardation, cell-mediated immune dysfunctions and cognitive 
impairment.257,259 The most important property of zinc is that it 
functions as an antioxidant and anti-inflammatory agent which are 
two key mechanisms that prevent oxidative stress and chronic 
inflammation (i.e. two mechanisms that triggers the development of 
cancer), respectively.257,259 Experimental studies have suggested that 
zinc supplements may be efficacious in the prevention (and 
treatment) of cancers of the head, neck, upper GIT, pancreas and 
colon,257,259 to which, in some way are agreement with reduced risk 
patterns observed in our results. The authors of this areas stated that 
further studies in the preventative properties of zinc are needed to 
confirm it usage in management and chemoprevention of cancer. 
257,259 If the efficacious nature of zinc is true, then the likely 
explanation of the patterns observed in our study may be due to the 
fact that it is an abundant metal in soil, whereby the general 
population commonly derives its zinc supplements through the food 
chain (i.e. soil-plant-human or soil-plant-animal-human). However, 
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this result should be interpreted with caution due to the limitations of 
other residual confounding in this study. 
For this research, we believe that we managed to minimise any 
potential selection bias in terms of selecting GIT cases and non-cases. 
Like chapters 4 and 5, this study uses incident cases of GIT cancer 
that were recorded in THIN before the time this study was conducted. 
Selection bias is not a major concern as we attempted to use the 
entire cohort in the THIN-GBASE. We have provided a clear definition 
in our inclusion and exclusion criteria that limits our population of 
interests to adults (aged 18 years and above) registered at a GP 
practice at least 1-year before start date of study (i.e. January 1st, 
2004) with linked soil data. One source of selection bias may arise 
from the dates we have chosen to initiate our study - by setting the 
start date from 2004, we are only capturing incident cases of GIT 
cancer after this year and assessing the risks at a much shorter time 
window (i.e. 2004-2014). However, we chose this date because of it 
was the year that the QOF scheme was introduced to encourage GPs in 
report new cases of GIT cancers when they are observed.  
The recording of GIT cancers in THIN appear to be relatively 
complete, a recent study has shown that specific recording of these 
solid cancers has increased over time after 2004,213 and indicated that 
with increasing expertise with Vision software these records are now 
close to that expected based on cancer registry data.213 There are 
differences in the case ascertainment rates for GIT cancers at a GP-
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level across England and Wales, if ascertainment rates across GP 
practices are associated with the geographical variation in exposures 
for the selected group soil elements - it would mean that our risk 
estimates derived for GIT cancer are biased.169 We attempted to 
making corrections for these by including SHA in our models; however, 
the study would have benefitted if we were able to include a better 
indicator such as practice-level performance variable which accounts 
for how well practices tend to record clinical outcomes. 
Finally, a robust statistical approach was adopted to objectively 
determine which selection soil elements are appropriate predictors of 
GIT cancer through data mining, before deriving detailed hazard 
estimates using Cox survival regression analysis, where we removed 
any time-varying effects through using a recognised diagnostic tool 
(the Aalen additive survival model).168,193  
One of the main limitations was our inability to incorporate into our 
analyses the exact location of where a patient lived, and the spatial 
point of where soil samples were measured. The inability to display 
spatially by means of usage of high resolution maps could have 
potentially provided a convincing picture as to whether these soil 
elements (where they are highly concentrated at) are linked to large 
clusters of incident GIT cancer cases. Furthermore, by incorporating 
that spatial component into the analysis would have reduced any error 
(spatial variability) that exists between samples measured. Another 
limitation was that although we were able to make adjustments for 
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meaningful confounding variables, we unable to include other 
potentially important confounders; for example: the dietary records; 
217–219 biomarkers for exposure includes finger nail (or toenail)27,30,31 
and household source of drinking water and levels of elements 
measured.159 At present, this study is the only nationwide UK study to 
analyse the potential relationship between soil elements and GIT 
cancer at an individual-level; therefore, we recommend further 
research in this aspect and propose that much of limitations should be 
incorporated in future studies. 
Similar to previous chapters, we are unable to provide a descriptive 
account on the spatial characteristics related to: 1.) a patient’s 
address; 2.) the location of general practices he/she attends; and 3.) 
whether exposures fall within G-BASE rural, urban or NSI(XRFS) 
settings. These limitations were due to ethical implications outlined 
by THIN. The geospatial details of GIT cancer patients were 
anonymised, and therefore, we could not utilise this resource to 
directly ascertain the distribution of those that fall within (or close 
to) a sampling location; let alone, quantify the distribution of those 
that lived on soils classified as either a G-BASE urban or rural terrain, 
or NSI(XRFS) areas. If this information was made available in the 
linked database, we could have stratified the population at risk of GIT 
cancer in accordance to these three types of sampling locations. 
However, we used the THIN-derived residential setting indicators as a 
proxy to differentiate participants that lived on an urban or rural 
terrain, and incorporated them in our stratified Cox regression model 
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in attempting to minimise potential information biases that may 
affect our risk estimates for GIT cancer due to the systematic 
differences in exposure caused by the locations of sampling points, as 
well as the different densities through which the soil samples were 
collected.  
In conclusion, this study suggests that there may be evidence of an 
increased risk of general GIT cancers for residents living areas with 
high levels of phosphorus. This study also indicates the possibility of a 
modest risk of GIT cancers in general, where there are elevated levels 
of soil aluminium and uranium in urban and suburban environments. 
However, when we account for confounding, the increased risk for GIT 
cancer disappears, which is reassuring. Our competing risk models 
indicated that the trend in risk reduction for upper GIT cancers were 
more pronounced for calcium, while the trends in an increased risk of 
stomach cancer were linked to elevated soil levels of aluminium only. 
Overall, it is difficult to conclude whether these metals can genuinely 
be carcinogenic due to the ambiguous results observed from this 
study. Further investigation is warranted to establish a clear 
association.    
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7.1 Commentary on findings 
7.1.1 For basal cell carcinoma 
In chapter two, the primary aims were to produce contemporary 
incidence rates of BCC throughout the UK, and to determine whether 
elevated concentrations levels of soil arsenic in residential areas was 
an aetiological factor for the development BCC. We were able to 
achieve our first aim through a large population-based ecological 
study using the THIN-GBASE database to obtain regional breakdowns 
of the incidence rates of BCC in the UK, and an updated coverage for 
country and regional incidence of BCC. We have also presented novel 
estimates for stratified incidence of BCC for levels of socioeconomic 
deprivation in the UK.  
The work pertaining to this section has shown that at the country-
level, Wales has the largest incidence of BCC than England, Scotland 
and Northern Ireland. At a regional-level (i.e. the 10 SHAs in England, 
Wales, Northern Ireland and Scotland), the South East Coast has 
England’s highest incidence of BCC. Levels of socioeconomic 
deprivation was major contributing factor to the increased incidence 
rates of BCC whereby those in the least deprived group were at a 
higher risk of developing BCC. This study provided novel findings in 
terms of informing which regions of UK had higher rates of BCC, as 
well as which socioeconomic groups were at a higher risk of BCC. The 
second objective which sought to use the UK soil guideline values to 
assess whether arsenic levels in residential soils were linked to the 
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development of BCC were also achieved through a population-based 
cohort study. The work presented in this thesis has shown that soil 
arsenic present at low-levels have the potential to contribute towards 
the BCC burden in UK. We quantified residential exposure levels for 
soil arsenic based on the C4SL value of 35.0 mg/kg. By definition, the 
C4SL system deems that the level of health risk soil arsenic 
concentrations below the value of 35.0 mg/kg to low; while, areas 
with soil arsenic above this threshold are typically considered to be 
contaminated lands with the possibility of causing harmful effects to 
humans. Our study population for this study had approximately 5.0% of 
participants contributing to the THIN-GBASE database that lived in 
areas with residential soils contaminated with arsenic (i.e. > 35.0 
mg/kg). Compared with the remaining 95.0% of participants that 
resided on lands with acceptable levels of arsenic that were below 
35.0 mg/kg; those living on residential soil with levels exceeding this 
criterion were at 8.0-17.0% increased risk of developing BCC [(1) 35.0-
70.0 mg/kg: HR 1.08, 95% CI: 1.02-1.14; (2) ≥70.0 mg/kg: HR 1.17, 
95% CI: 1.09-1.28], and urban residents with the highest exposure 
were significantly at the greatest risk of developing BCC (≥ 70.0 
mg/kg: HR 1.18, 95% CI: 1.06-1.36). 
7.1.2 For lung cancer 
In chapter five, we sought to use a two-stage process to first 
determine which group of soil elements were best suited as predictors 
for modelling lung cancer risk. Before using a population-based cohort 
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study to incorporate the selected group of elements into a statistical 
model in order to quantify the effect size for lung cancer risk for 
individuals living in a residential area with high concentration levels 
for the selected group of soil elements. 
The first objective was achieved by using data mining techniques i.e. 
correlation-based filter selection method which identified aluminium, 
lead and uranium as the most appropriate subset of soil elements to 
be modelled as risk factors for lung cancer. The selection of these 
elements are plausible variables modelling risk of lung cancer since 
they are among the group agents ranked as carcinogenic due to their 
toxic properties for inducing cell-mediated immune dysfunctions, 
oxidative stress, cell proliferation and genetic alterations, which are 
known mechanisms for triggering cancer. We were able to determine 
such associated risks between the selected group of metals and lung 
cancer. Our mutually adjusted model have shown that the risk of 
developing lung cancer was significantly higher among individuals 
living in areas with elevated soil concentrations for aluminium, lead 
and uranium; however, these risk patterns were only retained for 
aluminium after correction of confounding factors. We also observed 
that the risk of lung cancer was only isolated to urban residents on 
residential soil with aluminium concentrations above 47,200 mg/kg. 
7.1.3 For GI tract cancers 
In chapter 6, we sought to use a three-stage process to determine the 
following: (1) using data mining to find which restricted group of soil 
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elements were appropriate modelling GIT cancer risk, (2) using a 
population-based cohort design for quantifying the effect size for GIT 
cancer risk with the elements found in the first stage, and (3) further 
analysis of multiple GIT cancer outcomes using competing risk models. 
The data mining model identified the following seven soil elements as 
appropriate predictors for GIT cancer: aluminium, calcium, lead, 
phosphorus, manganese, uranium and zinc. In stage 2, once the model 
was mutually fitted for all the selected elements, we found that 
residents in areas with elevated levels of aluminium, phosphorus and 
uranium had a significant increase in risk of GIT cancer. Further 
adjusts showed zinc to have a protective effect against GIT cancer, 
while soil phosphorus was the only element to have retained its 
significance throughout the analysis. In stage 3, once the model was 
adjusted for different GIT cancers as competing events, no consistent 
relationships were identified between any of the selected groups of 
elements and the GIT-specific cancer outcomes. 
7.2 Implications 
The THIN-GBASE database is an invaluable resource for studying the 
health impacts of geochemical soil contaminants in the UK. It is a 
huge resource that contains complete coverage on the soil 
contamination levels of fifteen soil elements in England and Wales. 
One of the main advantages of the resource is that the concentration 
levels of each contaminant has been individually linked to person 
contributing to THIN by postcode, and so exposure-levels of 
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individuals in the linkage are quantified at a fine resolution. Another 
of the main advantages of THIN-GBASE has made possible for this 
research to conduct a series of epidemiological studies on a national 
scale, and so the results presented in these studies are reliable and 
representative of the population residing on English and Welsh soil. 
Since several outcomes in THIN have been validated; however, the 
results cannot be generalised to neighbouring countries – Northern 
Ireland and Scotland, until full geochemical coverage is achieved in 
Northern Ireland and Scotland. Furthermore, this resource has enabled 
us to test a series of hypotheses to examine the health impact of low-
level concentrations of toxic soil elements on BCC, lung and GI tract 
cancer incidence in the England and Wales. 
7.2.1 Causality 
For BCC, the study has shown an indication of an increased hazard of 
BCC for residents living on soil with arsenic concentration above the 
UK national safety limits. We have incorporated UK arsenic C4SL as a 
tool for categorising residential exposure levels of soil arsenic, which 
have shown that the risk of BCC has a modest positive dose-
relationship with elevated concentrations of arsenic. The patterns of 
risk for BCC in association with soil arsenic concentration were 
unambiguous and remained consistent throughout the multiple stages 
of risk estimation in our analyses. Furthermore, our results have 
corroborated other studies with similar findings in India, Bangladesh, 
Taiwan and in the mainland of Europe.87,169,232,263,264 These studies 
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have provided a theoretical and plausible basis for environmental 
arsenic to be potential carcinogen for BCC. In light of the findings for 
soil arsenic and BCC, the viewpoint of this research stands in support 
that there is a possibility of cause and effect relation between 
potential exposures to soil arsenic and BCC. 
The same can be inferred for aluminium and phosphorus, these were 
the only soil metals that appeared to be associated with lung and GI 
tract cancer, respectively. The viewpoint of this research stands in 
favour of these metals may have a carcinogenic causal effect for lung 
and GI tract cancer. Uranium and the remaining 14 soil elements (i.e. 
lead, chromium, copper, iron…) had a very weak, or no effect for 
these outcomes. Although most of these metals have a plausible and 
theoretical basis for causing cancer, our result failed to establish any 
forms of a significant statistical association and dose-response 
pattern. The patterns of risk were ambiguous and not consistent 
throughout the modelling stages. By taking in to account of these 
results, the viewpoint of this PhD thesis stands in favour that these 
groups of metals have a non-causal effect which is a reassuring result. 
7.2.2 Public health implications 
The implications of these findings indicate that more studies are 
required to fully understand the causal nature between such potential 
exposures and cancer outcomes. As a public health implication in 
terms of minimising exposure to soil aluminium, arsenic and 
phosphorus; the following simple measures can be implemented: 1) 
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Garden owners growing their own produces should test their soils 
frequently for signs of any contamination using soil testing kits; 2) 
Protective clothing (i.e. face masks, aprons and gloves) should be 
worn by frequent garden users to avoid soil particulates entering the 
main exposure pathways (oral, inhalation and dermal absorption); 3) 
Builders and contractors establishing residential settlements should 
ensure that the safely soil levels are met before constructing a 
building; and 4) Environmental agencies should utilise electronic 
geochemical atlases that are updated frequently to monitor soil levels 
for contaminations, so as to take pre-emptive measures in preventing 
local areas from becoming heavily contaminated.        
7.2.3 Lessons 
A population-based prospective cohort study is the best approach for 
analysing the effects of environmental contaminants on cancer 
outcomes. For instance, we initially adopted a population-based case-
control study design to analyse the effects of soil arsenic and BCC 
whereby the cases were matched by age, sex and GP at a ratio of 1:5. 
The intentions were to have the cases and controls have similar 
demographic characteristics only. Unfortunately, the soil arsenic 
estimates between cases and controls were also similar – this was 
probably caused by a data artefact in G-BASE [i.e. soil estimates for 
elements in GBASE were spatially interpolated, and one of the key 
assumptions for interpolating the actual soil metal samples over 
continuous surface is spatial autocorrelation, which assumes that the 
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pixel point(s) of surface closest to the index sampling sites in GBASE 
must be approximately similar to one another, while those farthest 
away from an index sampling location may have a different value]. 
This data artefact was realised through matching patients registered 
to similar practices (i.e. within catchment of a radius of 250 meters) 
had yielded sub-groups having the same arsenic value. By revising the 
study design to a prospective cohort, we were able to negate the 
effects of spatial autocorrelation. 
We discovered that survival analyses using the Cox proportional 
hazard regression model was a much flexible approach for analysing 
geochemical data. By adopting this model, we were able to account 
for time dependency between soil exposure (at the start of the study) 
and outcome. Most importantly, we were able to incorporate advance 
diagnostic techniques such as the Aalen additive survival model to 
ensure a non-violation of the proportional hazards assumption. The 
Aalen additive survival model is an example of a spline-based 
diagnostic tool for detecting points of occurrences for time-varying 
effects. This robust approach enabled the removal of such time-
varying artefacts ensuring validity of our risk estimates. 
Finally, to optimise the predictive accuracy of our Cox models, we 
adopted a multi-disciplinary approach utilising data mining techniques 
such as correlation-based filter selection as a tool for generating a 
restricted group of soil exposures for modelling lung and GI tract 
cancer risk. Although, such technique does not guarantee the model 
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to churn out hazard ratios that will be statistically significant, its 
algorithm uses a robust approach in forwardly (or backwardly) 
selecting the significant attributes to help the investigator to further 
generate hypothesis in terms of biological plausibility, so that they 
can be modelled appropriately. 
7.3 Avenues for further research 
Despite the limitations outlined in prior chapters, the work presented 
has shown huge potential, and the usefulness of this unique THIN-
GBASE database for future medical geological and epidemiological 
research in cancer. Although, several potential confounders were 
measured and accounted for in our studies; however, in addition to 
the information that was provided in this work, we strongly urge to 
obtain additional variables to remove the possibility of residual 
confounding that was inherently present in our studies. 
The most important variables to include the following for future 
studies: (1) toxicological information such as biomarkers as an 
indicator for metal toxicity – this would include the collection of hair, 
toenail, urine and blood samples. More specifically, lung cancer 
induced by long-term metallic toxicity can be measured in exhaled 
breath and expelled mucus of the lung (i.e. sputum), and for GIT 
cancer induced by metal toxicity can also be measured through stool 
examination; (2) the inclusion of dietary information and nutritional 
status; (3) the GPS coordinates of the participant so as to map areas 
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using GIS showing high risk patients residing on soil with elevated 
levels of soil contaminants. 
7.3.1 Protocol for developing an exposure model for 
subsequent environmental epidemiologic analysis 
7.3.1.1 Introduction 
The methods presented in the chapters for this PhD provides a data-
driven and viable approach for making direct associations for a 
specific group of cancers in light of potential exposures to 
environmental levels of certain soil contaminants in England and 
Wales. The interesting aspect of this research was the adoption of a 
multi-disciplinary approach, using both statistical and data mining 
methodologies, to quantifying cancer risk in relation to a group of soil 
metals. To extend this research, we take the opportunity to explore 
these databases further. 
One of the advantages of this new and unique resource is that it 
provides an unprecedented population size with enough statistical 
power to research on the effects of geochemical soil metals on human 
health.119 The linkage of soil data with details documented in EMRs in 
THIN provides us with the ability to adjust for range of potential 
confounding factors – these typically include a range of additional 
health and lifestyle details (such as smoking, alcohol consumption and 
BMI), as well as area-level measurements (such as quintile estimates 
for socioeconomic deprivation and air pollution for certain 
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compounds).105,106,109,119 Finally, our recent validation study, which has 
just been accepted to a peer-review publication, has established that 
the observed soil exposure levels for each contaminant among THIN 
patients are similar to the wider population, and thus, studies utilising 
the linked resource are likely to produce generalizable results.119 
However, the greatest limitation of this resource – exposure estimates 
are measured at an environmental level and they by no means reflect 
in-vivo or internal exposures that occur within an individual, and so, 
studies using this resource may be subject to exposure bias. Due to 
geographic variations in concentrations for the soil metals, as well as 
paucity of GPS readings on THIN patients and soil sampling sites in the 
database - studies using this resource will be subject to geographic 
bias – unless, such information is made available and adjusted for in 
the analysis.        
One of the challenging aspects of assessing the environmental impacts 
of soil elements on cancer risk in the UK are due to some of the 
outlined limitations of this database, as well as the paucity of 
personal exposure data which is most often determined from 
biological specimens (e.g. fingernail and hair samples) and lack of 
spatial data. In this protocol, we proposal an exposure-based 
assessment study and provide a brief outline for how we can utilise 
the THIN-GBASE (and collaborating directly with GP practices using 
THIN) to develop an exposure model for estimating the amounts of soil 
contaminant ingested by an individual, which, in turn, can be used in 
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subsequent epidemiological cancer studies; and also, as an attempt to 
address some of the limitations outline in this thesis.  
7.3.1.2 Study area and population    
The intention is to carry out an exposure-based assessment study on a 
small-scale targeting family members in one of the major Boroughs in 
London. The determination of the area from which we will draw our 
sample will be dependent on the characteristics such as the 
population, surface area and total number of people within the 
Borough that have access to a GP practice. For instance, Ealing is the 
third largest in terms of population in London, and it also ranks as the 
eleventh borough with the largest surface area covering the north-
western parts of London.265 It has an estimated total land surface area 
of 55.53km2. The borough itself is sub-divided into 23 wards which has 
an estimated total population size of 345,038 (males ~ 174,423 
(50.6%)).265 There are currently 79 GP practices responsible for slightly 
over 400,000 people – the discrepancy that exist between the Ealing 
population and patients registered to Ealing GPs is not unusual 
because people other neighbouring Boroughs register to a practice. 
According to the maps we derived from GBASE (Figure 3.1), Ealing is a 
GBASE urban zone which might have full coverage of sampling points 
at a resolution of 1 sampling site per every 0.25km2. This is an 
example of the criteria selecting a potential study area. 
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7.3.1.3 Data collection 
A feasible approach for collecting biological samples from individuals 
will be through GP practices using THIN (and practices linked to 
GBASE). GP practices agreeing to participate will be the channel 
through which registered individuals at the participating practice will 
be contacted and sent a consent form. These consent forms will be 
distributed to the addresses of individuals registered at the practices 
that typically fall within 250m of their practice’s catchment area. 
Individuals who agree to provide a written consent will receive a 
package through the post which will contain a number of sealable 
plastic bags for submitting hair strands and fingernail clippings.  
For each participant, a questionnaire will be distributed to collect 
information about the food and dietary habits, residential histories 
(which includes the number of years of stay at the current address or 
previous addresses in the UK), type of household (i.e. a house, 
apartment, store building etc.) and ownership of a garden. 
Participants will be urged to also provide other additional health 
information such as their ages, gender, body weight, smoking status 
and frequency of hair product usage. The collected fingernail and hair 
samples from participants will be sent for laboratory analysis whereby 
total concentrations for elements such as arsenic, copper, lead, nickel 
and other elements present in the GBASE dataset will be determined 
using the appropriate chemical analysis. 
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7.3.1.4 Statistical analysis 
The estimated exposure doses via the ingestion route for an individual 
is the primary outcome of interest. For each soil metal, we will able 
to develop an exposure model to estimate the amount of soil (with 
the contaminants) ingested  using a set of dose-exposure 
mathematical equations outlined by the ATSDR guidelines.266  These 
set of equations are highly modifiable and can be tailored to estimate 
dose exposures at an individual-level. The predicted outcome is 
typically dependent on the elemental concentrations found in the soil 
at the residence of the individual, as well as their duration at their 
residence, age group (i.e. child or adulthood) and his/her body 
weight.266 After the derivation of these estimates, they can be 
implemented in regression models in subsequent epidemiologic studies 
for predicting cancer risk.  
7.3.2 Other suggestions for future studies and 
recommendation 
The suggestions for future research are below:  
1. Geostatistical prediction of the intensity of basal cell carcinoma 
risk in association with elevated arsenic concentrations in UK 
topsoil; 
Health information of patients contributing to the THIN is 
georeferenced at a SHA-level, which renders the spatial analysis 
between geochemical risk factors and cancer outcomes to be 
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limited. In order to use a geostatistical approach in predicting the 
intensity of BCC risk in association with elevated concentrations of 
soil arsenic over a continuous surface would require the 
investigator to be engaged with collecting data directly from 
consenting participants, as well as obtaining their health 
information directly from the GPs they are registered with (i.e. 
GPs whom have agreed to be involved with the project).  
Data collection would include a participant’s current address 
recorded as a postcode or geographical coordinate (i.e. latitude 
and longitude). Data on incident BCC occurrence can also be 
collected directly from participating practices in which the 
patients have registered with. This data, in turn, can be postcode 
linked to soil sample records in GBASE to facilitate the use of 
geostatistical modelling of BCC risk in relation soil arsenic. 
2. Implementing environmental, toxicological and dietary risk 
factors through linking UK Biobank with GBASE, to assess the 
effects of topsoil metal exposure and general cancers in the UK; 
The UK Biobank is a unique resource containing large range of 
biological samples obtained from over 500,000 individual 
volunteers in the UK. These include blood, saliva, urine, faecal, 
hair and finger and toenail samples submitted by participating 
volunteers contributing to the UK Biobank. The advantages of using 
UK Biobank database allow researchers to follow-up samples of 
volunteers to perform further biochemical analysis - e.g. detecting 
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levels of toxic elements stored in blood, urine, nail and hair 
samples to determine the extent of exposure. Furthermore, 
dietary information of volunteers contributing to the database is 
available in the UK Biobank. 
One of the major limitations of the investigations carried out in 
this PhD was our inability to include dietary information and 
biomarkers for exposures as confounding risk factors. By linking UK 
Biobank to GBASE, we will have environmental, toxicological and 
dietary information to increase the accuracy of predicting the risks 
of BCC, lung and GI tract cancers associated with soil metal 
exposure. 
3. Using the THIN-GBASE linkage and adopting risk-based approach 
in deriving UK exposure (or exceedance) limits for each the of 
the soil metal; 
The UK C4SLs are national safety limits or trigger values used to 
monitor and ensure that specific elements (or compounds) do not 
exceed certain concentration levels in soils that are typical 
considered to be in a residential, agricultural and industrial 
settings. One of the major problems encountered for this research 
were that the guideline values were limited to only arsenic, 
chromium, lead and selenium. There are currently no C4SLs for the 
remaining 12 elements in the THIN-GBASE database. Using 
mathematical modelling approach, the linkage can be exploited to 
determine for each metal the minimum environmental exposure 
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needed to have an incident recording of a cancer outcome in THIN-
GBASE; where C4SLs are currently limited to only arsenic, 
chromium and lead, this resource can also be utilised to derive 
other C4SLs for toxic metals such as aluminium, copper, nickel, 
phosphorous and uranium.  
7.4 Overall conclusions 
In conclusion, this thesis showed a modest relationship between BCC, 
lung and GIT cancers, and potential exposures to elevated 
concentrations of soil arsenic, aluminium and phosphorus, 
respectively. The series of investigations conducted for this research 
are one of the first, if not, contemporary UK-based study to present 
novel estimates for a group of ill-defined pollutants. This research 
demonstrates that linking geochemical data with electronic primary 
care medical records can be a valuable for the investigation of long-
term potential exposures to low-level soil contaminants may have a 
health consequence in the population. 
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8.3 BCC THIN Read codes 
Description Code 
Basal cell carcinoma B33..11 
Epithelioma B33..12 
Rodent Ulcer B33..13 
Epithelioma Basal cell B33..16 
Naevoid basal cell carcinoma B33z100 
[M]Basal cell neoplasms BB3..00 
[M]Basal cell tumour BB30.00 
[M]Basal cell carcinoma NOS BB31.00 
[M]Multicentric basal cell carcinoma BB32.00 
[M]Basal cell carcinoma (morphoea type) BB33.00 
[M]Basal cell carcinoma (fibroepithelial) BB34.00 
[M]Basal cell neoplasm NOS BB3z.00 
 
8.4 Lung cancer THIN Read codes 
Description Code 
Malignant neoplasm of trachea; bronchus and lung B22..00 
Malignant neoplasm of trachea B220.00 
Malignant neoplasm of mucosa of trachea B220100 
Malignant neoplasm of trachea NOS B220z00 
Malignant neoplasm of main bronchus B221.00 
Malignant neoplasm of carina of bronchus B221000 
Malignant neoplasm of hilus of lung B221100 
Malignant neoplasm of main bronchus NOS B221z00 
Malignant neoplasm of upper lobe; bronchus or lung B222.00 
Malignant neoplasm of upper lobe bronchus B222000 
Malignant neoplasm of upper lobe of lung B222100 
Pancoast's syndrome B222.11 
Malignant neoplasm of upper lobe; bronchus or lung NOS B222z00 
Malignant neoplasm of middle lobe; bronchus or lung B223.00 
Malignant neoplasm of middle lobe bronchus B223000 
Malignant neoplasm of middle lobe of lung B223100 
Malignant neoplasm of middle lobe; bronchus or lung NOS B223z00 
Malignant neoplasm of lower lobe; bronchus or lung B224.00 
Malignant neoplasm of lower lobe bronchus B224000 
Malignant neoplasm of lower lobe of lung B224100 
Malignant neoplasm of lower lobe; bronchus or lung NOS B224z00 
Malignant neoplasm of overlapping lesion of bronchus & lung B225.00 
Malignant neoplasm of other sites of bronchus or lung B22y.00 
Malignant neoplasm of bronchus or lung NOS B22z.00 
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Lung cancer B22z.11 
Carcinoma in situ of the respiratory tract B81..00 
respiratory tract adenomas and adenocarcinomas  BB5S.00 
any lung-related malignant neoplasms otherwise stated By…00 
 
8.5 GIT cancer THIN Read codes 
Description Code 
Malignant neoplasm of lip; oral cavity and pharynx B0...00 
Malignant neoplasm of lip B00..00 
Malignant neoplasm of upper lip; vermilion border B000.00 
Malignant neoplasm of upper lip; external B000000 
Malignant neoplasm of upper lip; lipstick area B000100 
Malignant neoplasm of upper lip; vermilion border NOS B000z00 
Malignant neoplasm of lower lip; vermilion border B001.00 
Malignant neoplasm of lower lip; external B001000 
Carcinoma of lip B00..11 
Malignant neoplasm of lower lip; lipstick area B001100 
Malignant neoplasm of lower lip; vermilion border NOS B001z00 
Malignant neoplasm of upper lip; inner aspect B002.00 
Malignant neoplasm of upper lip; frenulum B002100 
Malignant neoplasm of upper lip; mucosa B002200 
Malignant neoplasm of upper lip; oral aspect B002300 
Malignant neoplasm of upper lip; inner aspect NOS B002z00 
Malignant neoplasm of lower lip; inner aspect B003.00 
Malignant neoplasm of lower lip; buccal aspect B003000 
Malignant neoplasm of lower lip; frenulum B003100 
Malignant neoplasm of lower lip; mucosa B003200 
Malignant neoplasm of lower lip; oral aspect B003300 
Malignant neoplasm of lower lip; inner aspect NOS B003z00 
Malignant neoplasm of lip unspecified; inner aspect B004.00 
Malignant neoplasm of lip unspecified; buccal aspect B004000 
Malignant neoplasm of lip unspecified; mucosa B004200 
Malignant neoplasm of lip; oral aspect B004300 
Malignant neoplasm of commissure of lip B005.00 
Malignant neoplasm of overlapping lesion of lip B006.00 
Malignant neoplasm of lip; unspecified B007.00 
Malignant neoplasm of lip; unspecified; external B00z000 
Malignant neoplasm of lip; unspecified; lipstick area B00z100 
Malignant neoplasm of lip; vermilion border NOS B00zz00 
Malignant neoplasm of tongue B01..00 
Malignant neoplasm of base of tongue B010.00 
Malignant neoplasm of base of tongue dorsal surface B010000 
Malignant neoplasm of posterior third of tongue B010.11 
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Malignant neoplasm of fixed part of tongue NOS B010z00 
Carcinoma of lip; oral cavity and pharynx B0...11 
Malignant neoplasm of dorsal surface of tongue B011.00 
Malignant neoplasm of dorsum of tongue NOS B011z00 
Malignant neoplasm of tongue; tip and lateral border B012.00 
Malignant neoplasm of ventral surface of tongue B013.00 
Malignant neoplasm of anterior 2/3 of tongue ventral surface B013000 
Malignant neoplasm of frenulum linguae B013100 
Malignant neoplasm of ventral tongue surface NOS B013z00 
Malignant neoplasm of anterior 2/3 of tongue unspecified B014.00 
Malignant neoplasm of tongue; junctional zone B015.00 
Malignant neoplasm of lingual tonsil B016.00 
Malignant overlapping lesion of tongue B017.00 
Malignant neoplasm of other sites of tongue B01y.00 
Malignant neoplasm of tongue NOS B01z.00 
Malignant neoplasm of major salivary glands B02..00 
Malignant neoplasm of parotid gland B020.00 
Malignant neoplasm of submandibular gland B021.00 
Malignant neoplasm of sublingual gland B022.00 
Malignant neoplasm of other major salivary glands B02y.00 
Malignant neoplasm of major salivary gland NOS B02z.00 
Malignant neoplasm of gum B03..00 
Malignant neoplasm of upper gum B030.00 
Malignant neoplasm of lower gum B031.00 
Malignant neoplasm of other sites of gum B03y.00 
Malignant neoplasm of gum NOS B03z.00 
Malignant neoplasm of floor of mouth B04..00 
Malignant neoplasm of anterior portion of floor of mouth B040.00 
Malignant neoplasm of lateral portion of floor of mouth B041.00 
Malignant neoplasm; overlapping lesion of floor of mouth B042.00 
Malignant neoplasm of other sites of floor of mouth B04y.00 
Malignant neoplasm of floor of mouth NOS B04z.00 
Malignant neoplasm of other and unspecified parts of mouth B05..00 
Malignant neoplasm of cheek mucosa B050.00 
Malignant neoplasm of buccal mucosa B050.11 
Malignant neoplasm of vestibule of mouth B051.00 
Malignant neoplasm of upper buccal sulcus B051000 
Malignant neoplasm of lower buccal sulcus B051100 
Malignant neoplasm of hard palate B052.00 
Malignant neoplasm of soft palate B053.00 
Malignant neoplasm of uvula B054.00 
Malignant neoplasm of palate unspecified B055.00 
Malignant neoplasm of junction of hard and soft palate B055000 
Malignant neoplasm of roof of mouth B055100 
Malignant neoplasm of palate NOS B055z00 
Malignant neoplasm of retromolar area B056.00 
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Overlapping lesion of other and unspecified parts of mouth B057.00 
Malignant neoplasm of other specified mouth parts B05y.00 
Malignant neoplasm of mouth NOS B05z.00 
Kaposi's sarcoma of palate B05z000 
Malignant neoplasm of oropharynx B06..00 
Malignant neoplasm of tonsil B060.00 
Malignant neoplasm of faucial tonsil B060000 
Malignant neoplasm of palatine tonsil B060100 
Malignant neoplasm of overlapping lesion of tonsil B060200 
Malignant neoplasm tonsil NOS B060z00 
Malignant neoplasm of tonsillar fossa B061.00 
Malignant neoplasm of tonsillar pillar B062.00 
Malignant neoplasm of faucial pillar B062000 
Malignant neoplasm of glossopalatine fold B062100 
Malignant neoplasm of palatoglossal arch B062200 
Malignant neoplasm of palatopharyngeal arch B062300 
Malignant neoplasm of tonsillar fossa NOS B062z00 
Malignant neoplasm of vallecula B063.00 
Malignant neoplasm of anterior epiglottis B064.00 
Malignant neoplasm of epiglottis; free border B064000 
Malignant neoplasm of glossoepiglottic fold B064100 
Malignant neoplasm of anterior epiglottis NOS B064z00 
Malignant neoplasm of junctional region of epiglottis B065.00 
Malignant neoplasm of lateral wall of oropharynx B066.00 
Malignant neoplasm of posterior wall of oropharynx B067.00 
Malignant neoplasm of oropharynx; other specified sites B06y.00 
Malignant neoplasm of other specified site of oropharynx NOS B06yz00 
Malignant neoplasm of oropharynx NOS B06z.00 
Malignant neoplasm of nasopharynx B07..00 
Malignant neoplasm of roof of nasopharynx B070.00 
Malignant neoplasm of posterior wall of nasopharynx B071.00 
Malignant neoplasm of adenoid B071000 
Malignant neoplasm of pharyngeal tonsil B071100 
Malignant neoplasm of posterior wall of nasopharynx NOS B071z00 
Malignant neoplasm of lateral wall of nasopharynx B072.00 
Malignant neoplasm of pharyngeal recess B072000 
Malignant neoplasm of lateral wall of nasopharynx NOS B072z00 
Malignant neoplasm of anterior wall of nasopharynx B073.00 
Malignant neoplasm posterior margin nasal septum and choanae B073200 
Malignant neoplasm of anterior wall of nasopharynx NOS B073z00 
Malignant neoplasm; overlapping lesion of nasopharynx B074.00 
Malignant neoplasm of other specified site of nasopharynx B07y.00 
Malignant neoplasm of nasopharynx NOS B07z.00 
Malignant neoplasm of hypopharynx B08..00 
Malignant neoplasm of postcricoid region B080.00 
Malignant neoplasm of pyriform sinus B081.00 
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Malignant neoplasm aryepiglottic fold; hypopharyngeal aspect B082.00 
Malignant neoplasm of posterior pharynx B083.00 
Malignant neoplasm of other specified hypopharyngeal site B08y.00 
Malignant neoplasm of hypopharynx NOS B08z.00 
Malig neop other/ill-defined sites lip; oral cavity; pharynx B0z..00 
Malignant neoplasm of pharynx unspecified B0z0.00 
Malignant neoplasm of Waldeyer's ring B0z1.00 
Malignant neoplasm of laryngopharynx B0z2.00 
Malignant neoplasm of other sites lip; oral cavity; pharynx B0zy.00 
Malignant neoplasm of lip; oral cavity and pharynx NOS B0zz.00 
Malignant neoplasm of oesophagus B10..00 
Malignant neoplasm of cervical oesophagus B100.00 
Malignant neoplasm of thoracic oesophagus B101.00 
Malignant neoplasm of abdominal oesophagus B102.00 
Malignant neoplasm of upper third of oesophagus B103.00 
Malignant neoplasm of middle third of oesophagus B104.00 
Malignant neoplasm of lower third of oesophagus B105.00 
Malignant neoplasm; overlapping lesion of oesophagus B106.00 
Siewert type I adenocarcinoma B107.00 
Malignant neoplasm of other specified part of oesophagus B10y.00 
Malignant neoplasm of oesophagus NOS B10z.00 
Oesophageal cancer B10z.11 
Malignant neoplasm of stomach B11..00 
Malignant neoplasm of cardia of stomach B110.00 
Malignant neoplasm of cardiac orifice of stomach B110000 
Malignant neoplasm of cardio-oesophageal junction of stomach B110100 
Malignant neoplasm of gastro-oesophageal junction B110111 
Malignant neoplasm of cardia of stomach NOS B110z00 
Malignant neoplasm of pylorus of stomach B111.00 
Malignant neoplasm of prepylorus of stomach B111000 
Gastric neoplasm B11..11 
Malignant neoplasm of pyloric canal of stomach B111100 
Malignant neoplasm of pylorus of stomach NOS B111z00 
Malignant neoplasm of pyloric antrum of stomach B112.00 
Malignant neoplasm of fundus of stomach B113.00 
Malignant neoplasm of body of stomach B114.00 
Malignant neoplasm of lesser curve of stomach unspecified B115.00 
Malignant neoplasm of greater curve of stomach unspecified B116.00 
Malignant neoplasm; overlapping lesion of stomach B117.00 
Siewert type II adenocarcinoma B118.00 
Siewert type III adenocarcinoma B119.00 
Malignant neoplasm of other specified site of stomach B11y.00 
Malignant neoplasm of anterior wall of stomach NEC B11y000 
Malignant neoplasm of posterior wall of stomach NEC B11y100 
Malignant neoplasm of other specified site of stomach NOS B11yz00 
Malignant neoplasm of stomach NOS B11z.00 
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Malignant neoplasm of colon B13..00 
Malignant neoplasm of hepatic flexure of colon B130.00 
Malignant neoplasm of transverse colon B131.00 
Malignant neoplasm of descending colon B132.00 
Malignant neoplasm of sigmoid colon B133.00 
Malignant neoplasm of caecum B134.00 
Carcinoma of caecum B134.11 
Malignant neoplasm of appendix B135.00 
Malignant neoplasm of ascending colon B136.00 
Malignant neoplasm of splenic flexure of colon B137.00 
Malignant neoplasm; overlapping lesion of colon B138.00 
Hereditary nonpolyposis colon cancer B139.00 
Malignant neoplasm of other specified sites of colon B13y.00 
Malignant neoplasm of colon NOS B13z.00 
Colonic cancer B13z.11 
Malignant neoplasm of rectum B141.00 
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8.6 Examiner’s feedback and list of amendments 
8.6.1 Comments from Internal examiner 
 Internal examiner’s comments Responses and amendments Location of changes 
1. Abstract, Conclusion: Given the modest 
overall effect size and total number of soil 
elements evaluated I believe the statement 
that there is “strong evidence” overstates 
the findings 
Thank you for your comments. It has been change to:  
“Conclusion: There appears to be slight evidence of BCC, respiratory 
and GIT cancer risk with elevated exposure to soil arsenic, aluminium 
and phosphorus, respectively.” 
Abstract, page iv, lines 8-
10 
2. p. 32: At the start of section 2 at least one 
paragraph is needed describing exactly how 
the linkage was carried out as understanding 
this linkage is crucial to the understanding 
of the entire work. Saying this was carried 
out by “experts from University of 
Nottingham and BGS” is probably not 
sufficient. 
Thank you for your comments. A paragraph has been inserted to give a 
brief description of how the linkage was carried out. The added 
paragraph was:  
“G-BASE database contains geochemical information on the normal 
background concentrations for different trace elements in UK topsoil. 
Soil samples were collected throughout England and Wales from 
urban and rural soils within 1-2km of an individual’s home. Soil 
samples were analysed using the X-ray fluorescence spectroscopy to 
detect geochemical composition and concentrations levels for each 
element. The soil concentrations for fifteen elements were spatially 
interpolated over a continuous raster shapefile for England and Wales 
to produce point estimates at a pixel-level. Spatially referenced 
point estimates that overlapped the street postcode of patient 
registered to a general practice using the THIN were merged to 
produce the THIN-GBASE database.”  
Chapter 2, section 2, page 
32, lines 9-20 
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3. p. 36: The last sentence could be improved 
grammatically, also “at least 85,803,247 
person-years” is rather a strange statement. 
This seems quite an exact number 
Thank you for your comments. The last sentence has been formatted 
to:  
“The overall number of patients contributing computerised data in 
THIN is 85,803,247 person-years.” 
Chapter 3, section 3.1, 
page 36, lines 20-21 
4. p. 44: The thesis would really benefit from a 
table detailing the number and percentage 
of the overall cohort size of 6,825,382 
patients who had missing data for each of 
the 15 elements 
Thank you for your comments, this additional information would have 
been beneficial for this PhD. However, this change is not feasible. To 
provide results based on 6,825,382 patients, I would need to have 
complete access to the entire THIN database, which is not possible. 
The dataset provided for this PhD was limited to a cohort of up-to 2.3 
million patients who were alive, active at their recent GP practice 
which is within GBASE coverage. 
No changes made 
5. p. 44: The was signposted to ref no. 116 for 
important comparing the linked population 
with the general population. However, if 
this paper has not appeared in print, by the 
time a revised version of this thesis is 
submitted would it be possible to include 
the manuscript as an appendix? 
Thank you for your comments. The first author and I discussed 
copyright concerns and therefore I have refrained from adding the full 
manuscript to the appendix.  
However, a revised version of the article has recently been accepted 
to the Population Health Metric Journal. I have updated its citation in 
the bibliography, and added its information to my list of publications 
since I have co-authored it. You will find that I have provided the 
contact details of the first author who would be happy to distribute a 
copy of the manuscript for your perusal. 
Page v, lines 7-12  
6. p. 45: The median level of silicon was 
299,000 in the text (in line 12) but 29,900 in 
Table 3.2. The IQRs are also discrepant by 
the same order of magnitude. 
The errors for the median levels of silicon have been corrected. The 
median and IQR estimates for silicon in the text have been updated 
and are now consistent with the values shown in table 3.2. The 
sentence has been changed to the following:  
“Overall, the elements with highest median concentrations were 
aluminium (median: 51,000 mg/kg, IQR: 40,300-59,300 mg/kg) 
Chapter 3, section 3.3.4, 
page 48, lines 4-7 
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followed by silicon (median: 29,900 mg/kg, IQR: 26,500-32,900 
mg/kg)”. 
7. p. 45: Whilst description of the distribution 
of soil elements by sampling point is 
informative what will be even more helpful 
is a description of the number of linked 
THIN participants who have been assigned to 
each sampling point (i.e. exposure level). 
The minimum, maximum, median and IQR 
for this distribution would be informative. 
This could be done separately for G-BASE 
and NSI-XRFS sampling points 
Thank you for your comment, this piece of information would have 
been beneficial for this PhD. However, this change is not feasible. 
This is because of the limitations imposed by partners at THIN/EPIC. 
The linkage between databases were carried out in manner that 
censored any spatial details (postcode, address and geographic 
coordinates) of a soil sampling locations. In addition, sensitive 
information pertained to a patient’s home address, residential history 
and location of the GP were stripped from their medical records after 
the linkage. Therefore, the dataset provided for this research 
contained cohort of 2.3 million patient records that were anonymised.     
No changes made 
8. p. 46 (Table 3.2): Please clarify whether the 
total of 1,742,205 relates to the total 
number of sampling points rather than 
participants in the THIN dataset 
Thank you for your comment. The value of 1,742,205 corresponds to 
the total number of patients in the database who have soil data across 
all fifteen elements. The following information has been added to 
provide clarification:  
“Descriptive analyses were performed accordingly on 1,742,205 
patients in the THIN-GBASE who have soil data across all 15 elements. 
Table 3.2 provides the statistical summaries in a form of median, 
interquartile ranges (IQRs) and maximum value observed among the 
cohort of participants who are contributing data to the THIN-GBASE 
database. For instance, 1,664,155 (out of 1,742,205) (95.52%) 
participants have a concentration value for aluminium – among the 
participants the estimates typically ranged between 2,000 to 116,700 
mg/kg with a median of 51,000 mg/kg (IQR: 40,300-59,300 mg/kg). 
The remaining participants (4.48%) either had concentrations for 
aluminium that were deemed as estimates below detection limits 
Chapter 3, section 3.3.4, 
page 44, lines 10-21 
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(i.e. less than 2,000 mg/kg (coded as -1)) or not available (coded -
2).” 
9. Figure 3.3 to 3.16: For some elements (e.g. 
aluminium, calcium, silicon), the x-axis 
presents values as a percent and in mg/kg 
units we would expect. Is there a reason for 
this? 
Thank you for your comment. The concentrations (in mg/kg) for these 
elements were too high, and so, I have reported them as weight 
percentage (%) in the histograms: Weight percent (%) = soil metal 
concentration (in mg/kg) ÷ 10,000. Whereby, a 1.0% equivalent to 
10,000 parts-per million.  
Also, I have included the information below to the legends for Figure 
3.3, 3.5 and 3.14: “The concentrations for [aluminium, calcium or 
silicon] were converted to a weight percentage (mg/kg÷10,000), 
whereby 1.0% = 10,000 (of [aluminium, calcium or silicon]) parts-per 
million” 
Chapter 3, section 3.3.4, 
figure 3.3 (page 52, lines 
5-6); figure 3.5 (page 54, 
lines 5-6); and figure 3.14 
(page 63, lines 5-6) 
10. p. 74: I am not clear how the confidence 
intervals for each country were used to 
establish statistical significance. Statistical 
significance between the IRs of 2 countries 
can only be established from CI around the 
difference between the two IRs and not by 
whether or not they overlap 
Thank you for this comment. This statement has been removed and 
formatted to:  
“We observed the incidences are low, and similar for Scotland and 
Northern Ireland” 
Chapter 4, section 4.2.3.1, 
page 77, lines 5-6 
11.  p. 80: The final sentence is quite difficult to 
follow. I assume you mean the “IRRs for 
deprivation were higher in men than in 
women” not “the incidence rate was 
higher…”   
Thank you for your comments. This error has been corrected to: 
“…the IRRs for socioeconomic deprivation were higher in men than in 
women” 
Chapter 4, section 4.2.3.3, 
page 84, lines 1-2 
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12. p. 88: The justification for choosing arsenic 
for chapter 4 and not other soil elements 
needs to be stronger 
A paragraph has been inserted at the opening of the summary section 
of chapter four to reinforce the justification for conducting both 
incidence and soil arsenic-BCC study:  
“Basal cell carcinoma (BCC) is one of the most common types of non-
melanoma skin cancer in the UK. There is a well-established link 
between environmental arsenic exposure and the development of 
BCC, but at considerably higher levels of exposure than those likely 
to be observed in the UK. We therefore carried out a study to 
determine whether there is evidence that more modest levels of 
arsenic in soil increase the risk of BCC, as an example of testing a 
specific, evidence-informed hypothesis using the new data source 
(other elements were therefore not considered, except where there 
was concern they might modify the effect of arsenic). As little is 
known about how the incidence of BCC varies across the UK, we first 
took the opportunity to quantify the variation. Therefore, this 
chapter describes two studies:” 
Chapter 4, section 4, page 
68, lines 2-14 
13. p. 95: Given you have presented column 
percentages in table 4.5 (row percentages 
may be more intuitive) it would be correct 
to say “The proportion of men was greater 
among those with BCC than for those 
without”. Also, the % for group I with BCC is 
35.5 in the text but 35.2 in the table. 
The sentence has been corrected, and the percentage for group I with 
BCC has been updated (in accordance to what’s in table 4.5) to 
following:  
“The proportion of men was greater among those with BCC than for 
those without. Participants developing BCC were more likely to be in 
the older age groups and from the least deprived group (Group I: 
35.2%; Group II: 25.6%).” 
Chapter 4, section 4.3.3.1, 
page 98, lines 14-17 
14. p. 115-124: Please correct the page 
numbering and formatting errors (text in 
landscape rather than portrait) 
The corrections and formatting has been made.   
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15. p. 120: The filter method for feature 
selection algorithm needs a greater 
explanation and a reference which can be 
easily traced (journal article rather than a 
book section). How this corrects for the 
potential of a type I error needs to be 
explained with particular care. 
Thank you for your comments. The filter methods have been 
explained in greater details and references have been provided. The 
following information have been added: 
“We have applied feature selection data mining techniques to our 
database to generate new hypothesis that may aid in determining the 
relationship between soil elements from GBASE and clinical outcomes 
in THIN. Feature selection is a very useful data mining tool which has 
a suite of wrapper, filter and embedded methods for searching 
potential exposures used for optimising risk predictions of certain 
outcome variables in a large database.191,192 The filter methods are 
especially useful in determining which exposure, or subset of 
exposures that are relevant for building a predictive model. When 
applying filter methods to a large database, they act as filters for 
identifying relevant exposures needed for building and optimising risk 
models, whilst, at the same time removing any exposures that are 
redundant and do not contribute to the accuracy of the predictive 
model.191,192 This technique is certainly helpful in building our own 
risk models because there is paucity in literature that establish any 
direct relationships between specific soil elements and lung cancer. 
Contemporary studies that have shown associations between soil 
elements and lung cancer have conflicting results,157,189 and so it 
would be inappropriate to rely on their results to build our predictive 
models for risk of lung cancer. We therefore relied on these filter-
based methods to select the relevant soil elements. The technique 
optimises risk prediction of lung cancer based on the selected group 
of soil element and thus do not guarantee any statistical significance 
thereby limiting the potential of a type-I error to occur in our 
results.”        
Chapter 5, section 5.3.3.1, 
pages 126 (lines 17-23) 
and 127 (lines 1-17)  
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16. p. 123: “sample population”: I assume you 
mean either sample or population. 
The error has been corrected to:  
“The final extract contained a sample of 1,823,312 participants 
(Figure 5.2).” 
Chapter 5, section 5.4.1, 
page 130, lines 9-11  
17. p. 123: The statement that 35.1% of people 
developing lung cancer live in the South 
Eastern or Western region of England does 
not tally with the numbers in table 5.1 
The sentence has been corrected to:  
“Participants who developed lung cancer were more likely to be older 
(51-60 years: 19.5%; 61-70 years: 31.5% and 71-80 years: 31.8%), a 
male (57.3%) current smoker (48.0%) from the south of England 
(36.2%), and from the deprived groups (group IV: 21.2%).” 
Chapter 5, section 5.4.1, 
page 130, lines 14-18 
18. p. 133: Interpretation of figure 5.6: A test 
for “linear trend” is not the converse of a 
“test for non-linearity”. The test for linear 
trends states the probability of obtaining 
your results assuming that any true 
relationship is linear (and that the null 
hypothesis of no relationship is true). A 
plateau in effect sizes with increasing 
exposure can occur simply due to statistical 
error. A test for non-linearity compares 
nested models where in one instance group 
number (I to V) is fitted as a linear term and 
another where it is fitted as a category. 
The interpretation for the trends test for aluminium has been revised 
to:  
“Our test seems to indicate a significant linear trends relationship 
for increased exposure of aluminium and risk of lung cancer (p < 
0.001) (Figure 5.6). However, the patterns of risk for lung cancer in 
relation to aluminium show a plateau effect which are unclear.” 
Chapter 5, section 5.4.3.1, 
page 139, lines 14-18 
19. p. 138: Please rephrase “the proportional 
hazards assumption was highly significant”. I 
think you mean there is significant evidence 
that the assumptions of PH was violated  
The sentence has been rephrased to:  
“Overall, we found significant evidence that the assumption of the 
proportional-hazards was violated (i.e. global test: p-value < 
0.0001).” 
Chapter 5, section 5.4.3.2, 
page 144, Lines 6-7 
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20. Figures 5.7 to 5.10: These plots show the 
“cumulative regression coefficients” not the 
“cumulative hazard functions” as stated in 
the figure titles. Also, as written you have 
implied that the assumption of PH has been 
violated for females, 71-80 years, etc., but 
this actually relates to the comparison with 
the reference group (i.e. coefficient 
comparing women with men). The title of 
the figures should therefore be changed to 
reflect this. 
All changes to the figure titles have been made to reflect the 
following: 1.) the estimates plotted are cumulative regression 
coefficients, 2.) the reference groups for each of the variables used in 
the Aalen exercise are added to the figure titles. 
Chapter 5, section 5.4.3.2, 
pages 147-150  
21. p. 148: Some differences were highlighted 
between urban, suburban and rural areas, 
but were tests for interaction carried out? 
These could be chance findings and 
therefore the fairly strong conclusion on p. 
157 that such risks are limited to residential 
areas may be overstated. 
Thank you for this comment. No tests for interactions between the 
soil exposure groups and type residential environment were conducted 
for this research. The analysis was only limited to stratifications based 
on the type of residential environmental because: 1.) I wanted to 
know magnitude of risk for the cancers across the different, and 2.) 
this indicator was used as a proxy for G-BASE rural, G-BASE urban, and 
NSI(XRFS) areas, in attempt to account for differences caused by the 
sampling areas. The conclusions made have been modified to:  
“In conclusion, the current study suggests that those living in areas 
with soil aluminium levels above 47,200 mg/kg may have a greater 
risk of developing lung cancer. The result suggests that aluminium 
exposure among urban residents may be the cause of lung cancer for 
this group. While, the results indicate statistical significance, they 
need to be interpreted with caution due to the limitations that are 
present for this study. Further studies will be needed to validate the 
findings made in this investigation.”  
Chapter 5, section 5.5, 
page 165 (lines 20-24) and 
166 (lines 1-3) 
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22. p. 177: The approach to how competing 
risks were taken account needs to be 
explained more fully so that someone is able 
to clearly understand and appraise the 
approach used. As sub-hazards ratios are 
present, I assume the method of Fine and 
Gray was used. Could you therefore cite 
their paper if this is the case?  
Thank you for this comment. I have provided additional information 
regarding the competing risk models used in chapter 6:  
“In order to obtain site-specific estimates, we used competing risk 
survival models (as described by Fine and Gray252,253). As noted 
previously, our case definition required a first ever cancer as it is 
difficult to distinguish between subsequent primary diagnoses, 
metastases, and follow up visits for the first cancer. When 
considering specific sites, it is necessary to censor patients who 
develop a cancer at another site on the date of this diagnosis, as they 
can no longer develop a first ever cancer in the specific site of 
interest. This competing risk may artificially diminish the observed 
hazard ratio at the site of interest. Competing risks models attempt 
to remove this bias by estimating the sub-hazard ratio in the site of 
interest alone.” 
The methods used were based on the Fine and Gray – I have cited 
their paper which appears as reference number 250 in the 
bibliography. 
Chapter 6, section 6.4.2.3, 
page 186, lines 5-16 
23. p. 189: Table 6.4 is not especially 
informative. The main information that is 
contained in the footnote and this has been 
copied and pasted directly from other 
tables. I believe it will be simply to say okay 
in the text that tests for proportional 
hazards were non-significant for all seven 
elements (p > 0,05) 
Thank you for your comments. However, I wish to keep this table 
because it has the added value of contributing to the consistency 
within this section and across chapters, as in previous sections I 
included similar tables.  
No changes made 
24. p. 191 to 200: Please incorporate all the 
above suggestions re: presentation of results 
Thank you for your comments. All changes to the figure titles in figure 
6.1 to 6.6 have been applied to reflect the following changes: 1.) the 
estimates plotted are cumulative regression coefficients, 2.) the 
Chapter 6, section 6.5.3.2, 
pages 204-209 
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from the Aalen plots in the same way you 
have done for chapter 5. 
reference groups for each of the variables used in the Aalen exercise 
are added to the figure titles 
 Presentational aspects:   
25. Where typographical and grammatical errors 
occurred these tend to cluster in the same 
sections of the thesis, in particular the 
abstract, e.g. “much” rather than “many” 
(line 1), “utilise a new resource…” (line 15), 
“…the findings for the ecological study…” 
(p. ii, last line 4). Please could you correct 
these and check the thesis carefully for any 
further errors of this type before 
resubmitting.  
Thank you for your comments. All the errors that have been 
highlighted in the abstract have been corrected. The entire thesis has 
been carefully checked for any further errors of this sort.  
  
Abstract, page i (lines 2 
and 15) and ii (line 22) 
26. References: Several web links provided were 
broken (ref. 43-45, 52, 68, 71 and 72). Also, 
please make sure the date last accessed is 
provided for all internet references in some 
instances only the year is provided (ref. 69 
and 70) 
Thank you for your comments. I have checked all internet references, 
and most appear to be okay. The references that were broken are 
those numbered 68 – 72. These references are from the same source 
(the Department for Environment, Food and Rural Affairs (DEFRA)) and 
so I have amended their URLs by providing DEFRA’s parent webpage 
where the PDF documents for the soil elements can be downloaded.  
The dates at which an internet reference provided in this thesis was 
last accessed has also been provided.    
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8.6.2 Comments from External examiner 
 Comments and responses 
 
1. 1.1. External examiner: The report does not make entirely clear the extent to which the different sources of the “interpolated smooth surface over 
the map of England and Wales” mentioned on page 42, provided the main information on potential exposure in different geographic areas within the 
study area. 
 
Response: Thank you for your comments. To address the above statement, I have added a new section to chapter 3 (sections 3.3.1 page 38 (lines 
17-22) and page 39 (lines 1-15)) which provides a descriptive account about the 3 primary soil datasets used in the G-BASE project (G-BASE rural, 
G-BASE urban and NSI(XRFS)), and provided a breakdown on the number of sampling sites that were derived for G-BASE rural, G-BASE-urban and 
NSI(XRFS). Also, in section 3.3.3 (Page 44, lines 2-16) of chapter 3, I have formatted the text to make it a bit clear on how the spatial 
interpolation for each substance was carried out between sampling points.         
 
1.2. External examiner: Although section 3.2 on page 37 and following, explains the G-BASE is joint project with BGS re-analysis of the National Soil 
Inventory x-ray fluorescence spectrometry NSI(XRFS) samples, there was no consideration given to the differential error in epidemiology that could 
derive from systematic differences across the geochemistry from G-BASE data were completely absent from many parts of England and Wales (see map 
on page 40), and therefore the interpolation would have been supplemented on NSI(XRFS) data where G-BASE data were not available, but a THIN 
database derived postcode was available and required the corresponding geochemical area value. The validity of the interpolated smoothed surface 
would be correspondingly variable according to the different density of sampling points in predominantly G-BASE derived areas compared to 
predominantly NSI(XRFS) derived areas (average 1 every 25km2). In any case, the geochemical information would have been referring to actual 
geochemical samples representing geographical areas larger than most population-containing areas (postcodes) used for the linking of THIN 
information. It would be desirable to provide an overall tabulation of the percentages of population for whom the exposure model was derived mainly 
from G-BASE and those for whom it was derived mainly from NSI(XRFS). If this is not feasible, it would seem essential at least to add to the discussion a 
consideration of the potential information bias that might affect all cancer risk estimates due to systematic differences in exposure method between 
population groups across study areas, in Page 104 (i.e. discussion of BCC associations), Page 156, (discussions of lung cancer associations), Page 221, 
discussion of gastrointestinal cancer associations. 
 
Response: Thank you for your comments. To address the above comments regarding the potential for information bias that might have 
occurred due to the inability to control for the sampling areas defined as G-BASE urban, G-BASE rural and NSI(XRFS) - the following 
information have been added to the discussions for each chapter:  
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- In chapter 4, i.e. BCC (section 4.3.4, pages 110 (lines 19-25) and 111 (lines: 1-13))  
- In chapter 5, i.e. lung cancer (section 5.5, page 164 (lines 7-25) and 165 (lines 1-3)) 
- In chapter 6, i.e. GIT cancer (section 6.6, pages 232 (lines 10-25) and 233 (lines 1-5))  
 
Also, I agree that the fact that this thesis would have benefitted with the inclusion of a tabulation showing the percentages of the population 
(i.e. cases and non-cases) that were classified as G-BASE urban, rural or NSI(XRFS). However, this is addition is not feasible due the 
limitations of the dataset. The linkage between THIN and the G-BASE database was carried out in manner that censored any spatial details 
(i.e. postcode, address and geographic coordinates) relating to the soil sampling locations. In addition, any sensitive information pertained to 
a patient’s home address, residential history and location of the GP were stripped from their medical records after the linkage.  
 
1.3. External examiner: In addition, the title of overall dissertation would seem more appropriate as referring to BGS data, as in “Environmental 
Exposure to Metallic Soil Elements and Risk of Cancer in the UK Population, Using a Unique Linkage Between THIN and BGS Databases. 
 
Response: Thank you for your comments, the title has been changed to the above suggestion (see title page). 
 
1.4. External examiner: Another design aspects that would have been interesting to see discussed in more detail in same discussion sections, is 
regarding for differential ascertainment rates for cancers, completeness of cancer diagnosis reports based on histology available at GP level, within 
SHA areas, and the potential implications for selection bias in this study, given the pattern of spatial distribution of the main exposure of interest. 
 
Response: Thank you for your comments, in the discussion sections for each chapters 4, 5 and 6, I have included text discussing the 
completeness of the data, as well as potential for selection bias to occur due to certain aspects pertained to the selection of our case and 
non-case population. I have also discussed potential biases that my might arise if GP-level cancer ascertainment rates are associated with the 
geographical variations in the exposure for soil elements in THIN-GBASE. Please see the following sections: 
 
- In chapter 4, i.e. BCC (section 4.3.4, pages 107 (lines 11-24) and 108 (lines: 1-25))  
- In chapter 5, i.e. lung cancer (section 5.5, page 161 (lines 17-25), 162 (lines: all) and 163 (lines 1-4)) 
- In chapter 6, i.e. GIT cancer (section 6.6, pages 230 (lines 3-24) and 231 (lines 1-8))  
 
2. Comments on the exposure model 
 
2.1. External examiner: The building of a valid exposure model for the population studied is one of the most crucial tasks for an environmental 
epidemiology analysis. The challenges involved in addressing this task are such that a specific report on the population exposure model building and 
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results is often considered a requirement or certainly very helpful, before proceeding to estimation of disease risk based on exposure model. Although 
the exposure model developed and used by Anwar represents perhaps the main result included in his thesis, numerous aspects of such model did not 
benefit from as full a description as one would wish. 
 
Response: Thank you for your comments. However, I believe I have provided a full description and an account of the models used to quantify 
the risk for each type of cancer. In Chapter 5 and 6 includes a detailed description of the data mining methods used for determining which 
subset of soil metals before implementing them into my risk model (in sections under 5.3.3, and sections under 6.4.2).  
 
The comments raised in 2.1 are similar those in 2.4 - I have provided an in-depth response as to why this research did not include an exposure 
model for calculating lifetime dose (or intake).  
 
2.2. External examiner: The limitations of an exposure model to chemical elements that does not include a reference to validity of such exposure as 
could be confirmed by estimation of biomarkers was acknowledged in the thesis. In view of this, it would have helped to refer to “potential exposure” 
rather than simple “exposure” especially when discussing conclusions on causality of any associations identified  
 
Response: Thank you for your comments, where applicable in the discussions sections of chapter 4 (section 4.3.4), chapter 5 (section 5.5), 
chapter 6 (section 6.6) and chapter 7, the term “exposure” as has been replace with the terms “potential exposure(s)”. 
 
2.3. External examiner: It would have been desirable to include a descriptive account and tables on the number and variation in the number of 
individuals contained in the geographical areas that were used as units of observation would have helped, and so would have also a general coherent 
description of such spatial units in terms of their size and other characteristics potentially meaningful for the analysis, and the description for the 
overall cohort  population, and also perhaps separately for the two areas of geochemical sampling underlying the smooth surface, of each element 
median and range by quintile of its distribution.  
 
Response: Thank you for your comments. I agree with the above statement and the fact that this thesis would have benefitted with the 
inclusion of a descriptive table and a visual map showing the number or density of individuals (i.e. cases and non-cases), respectively, 
contained in the geographical study areas. The work would have also benefitted with a full description of the cohort population from THIN 
within these three sampling areas (i.e. G-BASE urban, rural or NSI(XRFS)). However, this addition is not feasible because the records were 
anonymised. These limitations have been acknowledged in the discussions in chapters 4, 5 and 6. But, in chapter 3, I do provide a description 
on the overall numbers of patients with soil measurements across all elements, as well as the distribution of patients with specific 
concentrations for each of the 15 elements provided in the linkage (see chapter 3, 3.3.4, table 3.2 (page 49) and figure 3.3-3.17 (pages 52-
66)).   
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2.4. External examiner: A further element of distribution of population exposure, as opposed to environmental concentration of an element, that 
would have helped, would be the accounting for estimated intake into the body by year of life, based on several assumptions required to be made 
mode explicit. This could have led to some approximate estimate of the lifetime of the study population represented by values in this exposure model, 
in terms of percentage, and to description of such exposure indicator and its variation by space and time.  
 
Response: Thank you for your comments. I agree with the above statement, the implementation of an exposure model to estimate the 
cumulative (i.e. lifetime) dose (or intake) of a contaminant via ingestion of soil would have been a useful exposure variable for this research. 
However, I refrained from using this approach for the following reasons: 1.) An exposure model is typically a function of the length of 
exposure an individual may experience at a source (i.e. postcode). Usually, the time spent living at a residence is a proxy for measuring 
length of exposure; however, I was unable to derive these dose exposure estimates because of the paucity of records in THIN pertained to a 
person’s residential history and the time spent at the address; 2.) The exposure model is also dependent on other environmental and dietary 
factors such as source of drinking water (i.e. name of water suppliers, boreholes, wells etc.) and type of food consumed (and their trace 
levels of elements from such food sources etc.) for which such information is not present in THIN; 3.) In absence of such data in THIN, the 
parameterisation of an exposure model will be problematic. One would have to rely on scientific and grey literature elsewhere to abstract 
values (which may not be generalizable or representative of the UK population) in order to parameterise the exposure model for calculating 
dose exposure (or intake) – which I believe is inappropriate as this will introduce certain bias in my risk estimates for BCC, lung and GIT 
cancer.  
 
2.5. External examiner: Similarly, several other population exposure indicators could have been defined more clearly, such as exposure indicators for 
period within the life of the exposed population, either the first 20 years or other period. In the absence of this information, the discussion sections in 
each of the cancer risk chapters may be supplemented by a paragraph commenting on the possible types of error in risk estimates due to measurement 
errors in population indices of potential exposure. 
 
Response:  Thank you for your comments. Please see the responses made for comments numbered as 1.4. 
 
2.6. External examiner: Also, I would like to comment on the selection of the chemical elements to be analysed, described on pages 42-44. The 
circumstance by which Anwar used a dataset linked by collaborators who had agreed this before he started his PhD work appears to indicate that he 
was not involved in choices made regarding the selection of chemical elements (15) analysed in his dissertation, compared to the total number actually 
available (48). Within his PhD work, Anwar adopted a “screening” procedure, described as “Stage 1”, for further selection of the elements to be 
analysed, which was essentially a data-driven approach. Alternative approaches could have been discussed on page 42 or in the relevant discussion 
section, such as a selection justified entirely based on literature evidence of recognised or potential harm to human health. 
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Response: Thank you for your comments. 15 of the elements (out of the 48) were selected for the linkage with the medical records in THIN 
for the following reasons: 1.) they are major elements with the greatest abundance in soil (aluminium, calcium and silicon); 2.) their 
influence in terms of mobility of trace elements in soil (e.g. iron’s influence on the mobility of arsenic); and 3.) interests due to known or 
suspected impacts (i.e. beneficial or adverse) on health human (arsenic, chromium, copper, lead, manganese, nickel, phosphorus, selenium, 
uranium, vanadium and zinc). The remaining element that were not included in the linkage were excluded because 75% of their samples were 
typically below detection limits. 
 
In response to comments made regarding the use of data mining – I have included a justification for using filter-based methods for the 
selection of potential exposure variables in chapter 5 (section 5.3.3.1, page 127, lines 7-14)  
 
3. Comment on confounders 
 
3.1. External examiner: It was good to see an attempt to control for the major known cause of BCC by inclusion of a proxy indicator for UV exposure, 
as well as inclusion of a smoking indicator for analyses of other cancers. It would have been interesting to see a discussion of the value and potential 
limitations of such variables tailored to each cancer analysis. 
 
Response: Thank you for your comments, the acquisition of sunlight data from the UK Meteorological office, as well as, the calculation of the 
lifetime UV exposure measure was a challenge. I have included in the discussions the merits and limitations of the inclusion of such proxy 
indicator as adjustments in our BCC models. See chapter 4 (section 4.3.4, page 109, lines 8-20) 
 
3.2. External examiner: The presence of numerous possible confounders in an ecological design makes the task of focusing on arear-level potential 
confounders particularly challenging. Although adjustment for Strategic Health Authority (SHA) was included in the models, the presence of multiple 
possible confounders at smaller area level suggests that some further discussion of the potential role of factors operating at area level, such as 
variability in the practice of pathologists proving histological report for BCC in particular but also other cancers, variability in the ascertainment rate 
of such cancers by different primary care/hospitals arrangements, and their overlapping with spatial variation in the exposure model. 
 
Response:  Thank you for your comments. Please see the responses made for comments numbered as 1.4. 
 
 
4. Comment on choice of health endpoints 
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4.1. External examiner: I consider that cancers were appropriate endpoints for this analysis, as they are of grave concern to society and cancer 
registry ascertainment is among the most complete for any chronic disease. This is not the case for BCC, and although its inclusion may be justified by 
the literature on arsenic effects, the possible error in BCC risk estimates arising from differential ascertainment within SHA (due among others to 
variation in practice by GPs and /or pathologists providing histology diagnosis), and methods for minimising this error could be more explicitly 
recognised in the discussion. Among cancers, a more toxicologically-based discussion of choices for selection of relevant endpoints might have been 
conducted, but as illustrated of a new method, those selected appear relevant. 
 
Response: Thank you for your comments. Please see the responses made for comments numbered as 1.4. 
 
5. Comments on causality discussion 
 
5.1. External examiner: Dose-response and plausibility were mentioned, consistency with other evidence was alluded to. Although the conclusions 
arrived at would have appeared stronger if a more full discussion of possible bias due to selection or confounding had been provided, on the whole 
they appear reasonable. 
 
Response: No changes made 
6. Comments on suggested future work 
 
External examiner: All the activities mentioned in section 7.3 (page 232) appear desirable, but in my view before proceeding with any of them, it 
would be important to document the achievements of the present thesis with a detailed account of two related topics (which might be combined) to 
produce possible future peer-reviewed publications: 
 
(a) exposure results for this population, entirely based on the work already completed, and providing tables with information accounting for the 
methods considered from the population point of view, and quantitative estimates of potential exposure estimated based on these methods. Such 
results could be described by explicitly adopting the concepts and language of environmental epidemiology, in other words defining population based 
exposure indicators derived from the information available. These indicators could be computed by making explicit all the assumptions required in 
applying soil concentrations of metals considered implicitly as proxies for doses ingested by human beings over relevant time periods; 
(b) suggested protocol for the ideal epidemiological analysis, that would include new elements for the design (such as the access to individual level 
THIN data as mentioned by the candidate), an exposure model (such as based on exposure as reported in (a) but adding a validation study in a 
subsample of the population using biomarkers of exposure), and several choices for health endpoints and confounders. 
 
Response: Thank you for your comments, a protocol has been added to chapter 7, section 7.3.1, pages 244-247 
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